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Abstract 
Epidural opioids and local anesthetics may depress the neonatal reflexes necessary for 
breastfeeding success. Literature review yielded no data for hydromorphone and conflicting 
results for fentanyl. This study investigated whether breastfeeding effectiveness would be less in 
infants whose mothers received epidural analgesia with hydromorphone compared with those 
whose mothers received no analgesia, and whether the total amount of drugs given or the 
presence of multiple stressful events or interventions would be related to the effectiveness of 
breastfeeding.  
Breastfeeding behaviors were studied in 51 infants whose mothers chose epidural analgesia 
compared with 51 infants whose mothers chose to have no analgesia. Women with epidural 
analgesia received 1.5% lidocaine with 1:200,000 epinephrine as a test dose and/or 0.25% 
bupivacaine with 1:200,000 epinephrine as a bolus, and 100 µg hydromorphone followed by 
continuous infusion of 0.05% bupivacaine with 3 µg/mL hydromorphone at 14  mL/hour. The 
hospital setting strongly supported breastfeeding. Effectiveness of breastfeeding was measured 
with the LATCH Breastfeeding Assessment Tool at 3, 12, and 24 hours after birth.  
Cynthia Ann French – University of Connecticut, 2015 
 
 
 
 
LATCH scores did not differ significantly between groups at any time point and were not 
related to total amount of drugs administered. The presence of multiple stressful events and 
interventions, e.g., long duration of labor, large amount of IV fluids, oxytocin administration, 
induction of labor, and meconium staining/suctioning of the baby, did not significantly affect 
breastfeeding behavior in the overall study population (n=102), altogether contributing not more 
than 8% of the variability of LATCH scores in the regression model. The group receiving 
epidural analgesia (n=51) had significantly longer duration of labor, higher rates of oxytocin 
administration and induction of labor, and larger amounts of IV fluid administration. These 
factors contributed approximately 30% of the variability of LATCH scores at 3 and 24 hours. 
However, this finding was not significant.  
Although the study was limited by its nonrandomized nature, these data indicate that, by 
itself, epidural analgesia with hydromorphone does not decrease effectiveness of breastfeeding 
behaviors. Epidural analgesia increases risk of multiple stressful events or interventions, which 
may contribute to breastfeeding difficulties and necessitate intensive help from the nurse to 
achieve success in breastfeeding. 
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Chapter 1: Introduction 
Chapter one provides background information on the importance of breastfeeding and the 
nurse’s role in supporting mothers who breastfeed. The chapter describes the problem presented 
by potential negative effects of epidural analgesia on breastfeeding and discusses the significance 
and rationale for studying the effects of labor epidural analgesia with hydromorphone. The 
chapter also defines key terms; discusses the theoretical framework, assumptions of the 
researcher, study purpose, and specific research questions; and gives an overview of the study 
methods. 
The benefits of breastfeeding to mother and neonate in both the short- and long-term are 
significant. Infants who are breastfed have a lower risk of respiratory tract infections, necrotizing 
enterocolitis, sudden infant death, asthma, diabetes, leukemia, and lymphoma, as well as 
improved neurodevelopment outcomes (Eidelman, 2012). Maternal benefits of breastfeeding in 
the short term include decreased postpartum blood loss and more rapid involution of the uterus. 
Long-term maternal benefits include decreased risk of hypertension, diabetes, and ovarian and 
breast cancer (Eidelman, 2012). The American Academy of Pediatrics (AAP) recommends 
exclusive breastfeeding for about 6 months, with continuation up to 1 year or more (Eidelman, 
2012). The American College of Obstetrics and Gynecologists (ACOG) also supports this 
recommendation (American College of Obstetricians and Gynecologists, 2007).  
Because the benefits of breastfeeding are well known, the rates in the United States 
continue to rise. According to the 2014 Breastfeeding Report Card issued by the Centers for 
Disease Control and Prevention, 79% of infants born in the United States started to breastfeed 
(Centers for Disease Control, 2014). Yet the duration of breastfeeding was not as long as 
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recommended by the AAP and ACOG: According to the 2014 report card, 49% of infants were 
breastfeeding at 6 months and 27% at 12 months (Centers for Disease Control, 2014). The 
reasons cited in the literature for early cessation of breastfeeding are varied. However, it has 
been consistently reported that mothers who perceive breastfeeding initiation as problematic are 
more likely to wean than those who perceived breastfeeding as non-problematic (Leff, Gagne, & 
Jefferis, 1994; Matthews, 1991). The goal of Healthy People 2020 is to increase the proportion of 
infants who start to breastfeed to 81.9%, continue to breastfeed at 6 months, 60.6%; and at 1 
year, 34.1% (CDC BF Report Card 2014).  
The literature identifies multiple factors affecting the initiation of breastfeeding, including 
milk insufficiency, sore nipples, discontented crying baby, socioeconomic status, social support, 
social norms, and hospital practices (American College of Obstetricians and Gynecologists, 
2013). One consistent factor is that women who perceive breastfeeding as difficult, no matter the 
reason, are more likely to stop breastfeeding during the first week postpartum than women who 
perceive no problems (Leff et al., 1994). If breastfeeding is established in the first hours after 
delivery, many of these factors can be overcome to improve breastfeeding success and duration.  
The Nurse’s Role in Supporting Breastfeeding 
In the US, 98% of all births occur in a hospital where nurses are the primary caregiver 
supporting women through labor, birth and discharge home (AWHONN, 2015).  Nurses have a 
crucial role in preparing, educating supporting women to breastfeed and are instrumental in 
facilitating the initiation and continuation of breastfeeding. 
Nurses are in a unique position to provide an environment conducive to breastfeeding 
initiation in the immediate postpartum period. The profession of nursing has always had the goal 
of using knowledge to advance the goals of the health of people in their environment. 
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Breastfeeding places the mother and infant in the best possible situation of health. Given the 
benefits of breastfeeding and the recommendations for its promotion, nurses should help nature 
by providing an environment that is conducive to breastfeeding success. The nurse’s knowledge 
and attitude are crucial. To succeed at providing an optimal environment for nature to act on 
breastfeeding, nurses must know which factors are beneficial and which factors are detrimental 
to establishing effective breastfeeding. Thus, nurses and other health care providers who care for 
mother/infant dyads should acquire the knowledge and competence to provide evidence-based 
breastfeeding information and support throughout the preconception, prenatal, and postpartum 
periods.  
Statement of the Problem 
One factor that may affect the success of early breastfeeding is the administration of pain 
medicine during labor. The advent of labor epidural analgesia allowed small amounts of 
narcotics to be placed directly into the epidural space instead of high doses of opioids 
administered systemically, thus providing intense pain relief without depression of the central 
nervous system (CNS). Epidural analgesia has been shown to provide more effective pain relief 
during labor than other types of pain medication (Anim-Somuah, Smyth, & Jones, 2011), and its 
use during labor has increased exponentially over the past few decades. It was estimated that in 
2001, 77% of infants born in the United States were exposed to epidural analgesia during labor 
and birth, a rise from 21% in 1981 (Bucklin, Hawkins, Anderson, & Ullrich, 2005). However, 
epidural analgesia may be a barrier to breastfeeding success.  
The most common drugs used for epidural analgesia contain a combination of local 
anesthetics with an opioid, which may affect neonatal behavior. To establish lactation, the 
neonate must be awake, alert, and able to latch on to the breast and suck, swallow, and breathe in 
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a coordinated pattern in order to express milk from the breast (Auerbach, 1988; Kuhnert, Linn, & 
Kuhnert, 1985; L'Esperance & Frantz, 1985; Lawrence & Lawrence, 2011; Marmet & Shell, 
1984; Neifert & Seacat, 1986; Shrago & Bocar, 1989). Epidural opioids and local anesthetics are 
known to readily cross the placenta (Reynolds, 1991) and may depress these reflexes (Chang & 
Heaman, 2005), thus decreasing the likelihood of breastfeeding success. However, despite 35 
years of research, scientists still cannot unequivocally answer the question of whether maternal 
use of labor epidural analgesia affects the success of breastfeeding (French, Cong, & Chung, in 
press). Therefore, it is imperative to continue to investigate whether maternal epidural analgesia 
affects early establishment of breastfeeding behaviors.  
Rationale and Significance of the Study 
Bupivacaine is the standard local anesthetic used for labor epidural analgesia and is 
commonly combined with fentanyl. The dosage frequently used in this setting for continuous 
labor epidural infusions is 0.125% bupivacaine with 2-3 µg/mL fentanyl. The results of research 
on effects of epidural analgesia with these drugs on breastfeeding so far remain inconclusive. For 
example, two studies have shown an adverse effect of increasing doses of fentanyl on the success 
of breastfeeding (Beilin et al., 2005; Jordan, Emery, Bradshaw, Watkins, & Friswell, 2005), 
although another study showed no effect (Wieczorek, Guest, Balki, Shah, & Carvalho, 2010).  
At Yale New Haven Hospital, the standard protocol for otherwise healthy parturients who 
request epidural analgesia for vaginal delivery calls for continuous infusion of 0.05% 
bupivacaine with 3 g/mL hydromorphone instead of fentanyl. Hydromorphone has not been 
widely accepted in the management of pain in the obstetric setting. However, clinical evidence 
suggests its safety and efficacy in management of labor pain (Sinatra et al., 2002; Sinatra, Levin, 
& Ocampo, 2000). Hydromorphone has been used at Yale New Haven Hospital in continuous 
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labor epidurals since the 1990s and is believed to exhibit the pharmacodynamics necessary to 
promote analgesia without the clinically significant adverse effects—such as excessive maternal 
sedation, profound hypotension, respiratory depression, sensory motor blockade, and severe fetal 
bradycardia—that are seen with traditional opioid infusions (Sinatra et al., 2000). The use of 
hydromorphone as the narcotic in the epidural infusion appears to represent a promising 
alternative to fentanyl and may deliver acceptable analgesia without the unintended side effects 
seen with traditional opioid infusions. If so, neonates whose mothers received labor epidural 
analgesia with hydromorphone and those whose mothers did not receive labor analgesia may 
show similar breastfeeding behaviors and neurobehavior. No data on hydromorphone and 
breastfeeding are available. Thus, a study comparing infants whose mothers received labor 
epidural analgesia containing hydromorphone with infants whose mothers received no labor 
analgesia would provide valuable information needed to decide whether to use epidural analgesia 
during labor. 
Definition of Key Terms 
The key terms used in the study are defined as follows: 
Breastfeeding  
The failure of many studies to define terms relating to breastfeeding has led to 
misinterpretation of data and difficulty of comparisons across studies. In an attempt to provide 
consistent terminology for researchers and agencies involved in breastfeeding, Labbok and 
Krasovec recommended the terms full, partial, and token to describe the types of breastfeeding 
behaviors (Labbok & Krasovec, 1990). For this study breastfeeding was defined as the process 
by which milk is expressed from the lactiferous sinuses in the nipple of the breast, by the 
compression of the soft palate by rhythmic pulsations of the infants tongue (Weber, Woolridge, 
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& Baum, 1986). Exclusive breastfeeding was defined as the infant taking all nourishment from 
the breast, with no other liquid or solid consumed. 
Breastfeeding Behaviors  
Breastfeeding behaviors are a series of suckling behaviors necessary for the infant to draw 
the nipple into the mouth, remove the milk, and consume the milk. Breastfeeding behaviors 
include latching on to the breast, sucking, swallowing, and breathing in a coordinated pattern in 
order to express milk from the breast (Lawrence & Lawrence, 2011). The coordination of tongue 
movements, swallowing, and breathing was described by Bu'Lock and colleagues (Bu'Lock, 
Woolridge, & Baum, 1990), based on the historic cineradiographic studies of Ardran and 
colleagues (Ardran, Kemp, & Lind, 1958), with confirmation by the ultrasound studies of Weber 
(Weber et al., 1986). “A bolus of fluid is delivered to the pharynx by a phased application of the 
dorsum of the tongue to the nipple or teat in an anteroposterior peristaltic wave of contraction. 
Coordinated movement of the mandible and apposition of the gums traps the milk in the lacteal 
sinuses of the breast or teat of the bottle. Milk is then expressed by the teat, into the pharynx. 
From the pharynx, a series of reflex muscular contractions and relaxations transfer milk into the 
oesophagus and onward into the stomach by peristalsis. At the same time milk is prevented from 
entering the nasal/tracheal airway by elevation of the soft palate and closure of the larynx” 
(Bu'Lock et al., 1990). 
The LATCH Breastfeeding Assessment Tool is a charting system that provides a systematic 
method for measuring breastfeeding behaviors in individual breastfeeding sessions (D. Jensen, 
Wallace, & Kelsay, 1994). 
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Epidural Analgesia  
Epidural analgesia involves placement of an indwelling catheter placed in the epidural 
space of the lower lumbar spinal column for pain management. Continuous infusions of local 
anesthetic and opioids provide pain relief and allow sufficient motor function for labor patients. 
For this study an infusion of bupivacaine and hydromorphone were used for labor and delivery. 
Neonatal Neurobehaviors  
Neonatal neurobehaviors are physiologic and behavioral patterns that measure function of 
the CNS. The Neurologic and Adaptive Capacity Score (NACS) is a screening test for full-term 
neonates to detect CNS depression from drugs and also to differentiate these effects from those 
found after birth trauma and perinatal asphyxia (Amiel-Tison et al., 1982b).  
Theoretical Framework of the Study 
The theoretical framework of this study is rooted in Brazelton’s theory that neonates exist 
in six newborn behavioral states and cycle through these states on a continuum at all times 
(Brazelton & Nugent, 2011). The neonate’s skill in organizing these behavior states determines 
the ability to accomplish developmental tasks such as feeding, as well as forming relationships 
and learning about the world (Gottesman, 1999). Factors that negatively affect the CNS and lead 
to a disorganized behavioral state may hinder the effectiveness of breastfeeding (Karl, 2004; 
Radzyminski, 2005). 
Brazelton’s Newborn Behavioral States 
Brazelton’s newborn behavioral states include two sleep states (deep or quiet sleep and 
light or active sleep), a transitional state (drowsy); and three alert states (quiet alert, active alert, 
and crying). Each state has identifiable behaviors, and as an infant’s state changes, its 
physiological and behavioral patterns change as well (Brazelton & Nugent, 2011). For instance, 
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when the baby moves from sleep state to crying, autonomic functions such as respiratory rate and 
heart rate increase, muscle tone increases, and reflexes become stronger (Brazelton & Nugent, 
2011; Karl, 2004). As the neonate moves from alert to crying, smooth movements of the body 
transition to jerky disorganized movements, often accompanied by tremors. During quiet alert, 
alertness is at its peak; however, responsiveness diminishes during the active alert state and 
completely disappears with crying as the neonate is no longer cued into the environment.  
The neonate’s ability to achieve the quiet alert state is important, because this is when the 
neonate is able to accomplish new tasks (White, Simon, & Bryan, 2002). The neonate is 
responsive to environmental stimuli, and more likely to be able to make eye contact and interact 
with others during the quiet alert state. The neonate may respond to voices or animate objects, 
letting the parent know the neonate is a capable and willing participant. 
Newborns who are unable to experience state organization have greater difficulty with 
important undertakings such as latching on to the breast and making eye contact with their 
parent. Neonates who are neurologically intact experience states in defined organizational 
patterns. The patterns are consistent with developmental success (Brazelton & Nugent, 2011). 
Each state has a particularly purpose, and an infant that is organized uses all the behavioral 
states. For instance, crying signals for needs, sleep is for rest and recovery and quiet alert is for 
learning and interacting (Karl, 2004). Active alert and drowsiness are transitional states that 
signal where the neonate has been and where they are going on the behavioral continuum. 
Neonates who use all states accomplish tasks with less difficulty than infants who linger in one 
state with the exclusion of others (Karl, 2004). 
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CNS Integrity 
The neonate’s ability to achieve behavioral organization of state, muscle tone, and sucking 
reflexes depends on CNS integrity. Neonatal behaviors such as sucking represent a measure of 
CNS function (behavioral organization) and suggest the infant has achieved the level of maturity 
required for effective oral feeding (Radzyminski, 2005). A delayed CNS response can manifest 
itself as difficulty latching on or as an uncoordinated suck/swallow reflex.  
Breastfeeding behaviors are a series of complex interactive maternal and neonatal 
behaviors typically involving rooting, sucking, and swallowing by the infant and milk ejection 
by the mother. Milk production and milk let-down are induced by maternal hormonal changes 
that occur with labor, birth, and delivery of the placenta. Neonates are born with an instinct to 
root, latch on to, and suck the breast. When the infant sucks, afferent impulses from sensory 
stimulation of nerves on the areola travel to the mother’s CNS, where they promote the release of 
oxytocin from the posterior pituitary. In women, oxytocin release is often associated with the 
sight, sound, or even thought of their infant, indicating a psychological component of the 
neuroendocrine reflex (Neville, 2001). The mother must have all the functioning anatomical 
components to allow passage of milk from the alveoli into the ducts and the subareolar sinuses. 
For the neonate, sucking is a complex motor and behavioral skill. For the infant to successfully 
suck, the brainstem pathway must be intact and impulses must be transmitted through cranial 
nerves to healthy musculature of the tongue, mouth, and pharynx. To suck, the lips close around 
the nipple or breast, and the tongue seals the pharynx posterior forming a closed intraoral cavity. 
Successful breastfeeding behavior requires coordinated intraoral movements of the rhythm of 
sucking, breathing, and swallowing in synchronicity, with the mother allowing the pressure to 
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carry milk into the infant’s mouth (Bu'Lock et al., 1990). The sinuses refill as the action of 
oxytocin continues to force milk from the alveoli to the ducts.  
On the one hand, epidural analgesia preserves the beneficial stress response of the fetus to 
labor and reverses the negative maternal physiological and biochemical changes of labor 
(Westgren, Lindahl, & Norden, 1986). In this respect, epidural analgesia may exert a positive 
influence on breastfeeding. On the other hand, epidural analgesia may also negatively affect 
breastfeeding success. Studies on the impact of labor epidural analgesia have noted subtle 
changes in the CNS function of neonates whose mothers received continuous epidural infusions 
containing a narcotic (Beilin et al., 2005; Loftus, Hill, & Cohen, 1995). These changes may 
influence breastfeeding behaviors. Thus, epidural analgesia may impair the CNS response, 
decreasing the likelihood of successful breastfeeding.  
Various other factors during labor and delivery may affect CNS integrity in the newborn 
and thus influence the success of breastfeeding. The overwhelming physiologic stress in labor 
experienced by the mother can cause physiologic stress to the fetus, which may delay the infant’s 
initiation of breastfeeding at birth (Montgomery, Hale, & Academy of Breastfeeding Medicine, 
2012). Furthermore, in addition to the direct negative effects of epidural analgesia on neonatal 
behavior, epidural analgesia may indirectly decrease the success of breastfeeding through its 
effects on the labor process and maternal condition. A 2011 Cochrane review analyzed 38 of the 
most rigorous studies on epidural analgesia and concluded that, compared with other methods of 
pain relief, epidural analgesia was associated with significantly longer second stage of labor, 
higher rates of instrumental delivery, increased use of oxytocin to augment labor, lower maternal 
blood pressure, and increased risks of motor blockade and maternal fever (Anim-Somuah et al., 
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2011). The combination of these factors may account for at least a portion of any negative effects 
of epidural analgesia on the success of breastfeeding. 
Researcher Assumptions 
The premise of the study was that fetal exposure to epidurally administered opioids used 
for maternal labor pain may affect breastfeeding by interrupting the neonate’s CNS. Specifically, 
the effects of epidural hydromorphone have never been investigated. The neonate may be 
impaired to the point of being unable to initiate breastfeeding behaviors that are crucial for 
lactogenesis to occur during the first 24 hours postpartum. The neonate must possess the ability 
to latch onto the breast and suck in a coordinated matter for breastfeeding to successfully occur. 
The underlying assumptions were: 
 The defining characteristic of mammals is the provision of milk which is a fluid 
composition of exactly what the young of the species needs. 
 The young of the mammalian species are born with the innate ability to suckle known as 
breastfeeding behaviors. 
 Humans are mammals and lactation is critical to the development, growth and survival of 
mammalian species. 
 In order for the mother to produce milk the neonate must suckle at the breast. 
 Many intrapartum and postpartum factors can influence the ability of the neonate to suck 
at the breast. 
 An intact CNS is necessary for the neonate to exhibit breastfeeding behaviors that 
produce correct suckling for milk removal. 
 An impaired CNS with depression of the neonate will interfere with these breastfeeding 
behaviors. 
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Purpose of the Study and Research Questions 
The primary purpose of this study was to determine whether a relationship exists between 
labor epidural analgesia containing hydromorphone and breastfeeding behaviors the first 24 
hours postpartum. The addition of this knowledge is expected to give healthcare workers the 
information needed to assist new mothers in making informed decisions related to their care, find 
effective techniques for managing these issues, and enable provision of breastfeeding support to 
women who need it postpartum. 
Based on current knowledge from review of the literature, the following specific research 
questions were formulated: 
1) Does the administration of epidural analgesia with hydromorphone to the mother for labor 
pain have a negative effect on breastfeeding behaviors in healthy term infants?  
2) Is the duration of infusion/amount of drug given for epidural analgesia with 
hydromorphone for labor pain in the mother negatively related to effectiveness of 
breastfeeding behaviors in healthy term infants?  
3) During labor or immediately after birth, is the presence of multiple stressful events or 
interventions that may affect the condition of the mother or infant during labor (e.g., 
oxytocin administration, induction of labor, ruptured membranes, total amount of 
intravenous fluids administered, longer long duration of labor, meconium staining, and 
need for baby suctioning) negatively related to the effectiveness of breastfeeding behaviors 
in healthy term infants?  
Overview of Methodology 
A prospective observational cohort study was performed to gather data in answer to these 
questions. The study assessed breastfeeding behaviors in neonates whose mothers received a 
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continuous epidural infusion containing bupivacaine (local anesthetic) and hydromorphone 
(narcotic) for labor pain compared with infants whose mothers received no analgesia during 
labor and delivery. The neonate’s ability to feed was measured at 3, 12, and 24 hours after birth 
by the LATCH Breastfeeding Assessment Tool (D. Jensen et al., 1994). 
Organization of the Dissertation 
This dissertation is organized into five chapters. Chapter 1 provided background on the 
importance of breastfeeding and the nurse’s role in fostering its success. The problem to be 
addressed in this research is that, because of potential effects on the CNS of the neonate, epidural 
analgesia for labor pain management may be detrimental to the success of breastfeeding. 
Research on this subject has remained inconclusive; in particular, no data exist regarding the 
effects of epidural analgesia with hydromorphone. Therefore, the purpose of the study was to 
determine whether a relationship exists between labor epidural analgesia containing 
hydromorphone and breastfeeding behaviors the first 24 hours postpartum.  
Chapter 2 reviews the literature on the history, physiology, and benefits of breastfeeding 
and the factors that influence its success, including epidural analgesia during labor and other 
maternal or neonatal variables that may interfere with breastfeeding initiation. Chapter 3 presents 
the research design and describe the selection of subjects, the setting of the study, the study 
procedures and methods used for data collection and analysis, and the methods used to ensure 
rigor of the study and protection of human subjects. Chapter 4 describes the findings of the 
study. Chapter 5 discusses the results in relation to the study aims and in the context of the 
literature review, as well as the study limitations and implications for nurses and other health 
care providers. 
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Chapter 2: Review of the Literature 
To provide background for the study, Chapter 2 reviews the literature on the history and 
physiology of breastfeeding, the benefits breastfeeding provides to the infant, the mother, and the 
public, and factors that influence its success. The chapter also reviews literature on 
pathophysiology and factors that influence labor pain, analgesia during labor, including epidural 
analgesia, and other maternal or neonatal variables that may interfere with breastfeeding 
initiation. It should be noted that in some areas older references were included because of their 
significance as classics works, or because no more current research on the topic exists. 
History of Breastfeeding 
Breastfeeding throughout history has been shaped by cultural values, beliefs, and customs. 
From prehistoric times to the preindustrial period found customs varied little and the likely 
survival of the infant was related to breastfeeding or by utilizing a wet nurse as a substitute. 
When a wet nurse was not available, infants were suckled directly on animal udders, given milk 
using a vessel, or given pre-chewed foods that were poor in nutrients and contaminated, which 
caused high mortality rates (Diez Castilho & de Azevedo Barros Filho, 2010; Fildes, 1986).  
During prehistoric times when humans hunted and gathered their food, if a woman could 
not breastfeed her child, the child died unless another woman took her place. It is thought at that 
time the child would breastfeed until they were able to find their own food. Even the Neolithic 
period, when humans began planting, harvesting and raising livestock, it would still be a long 
time before animals would be milked (Colon & Colon, 1999; Diez Castilho & de Azevedo 
Barros Filho, 2010). With the formation of domestic herds, children survived after they were 
given animal milk with a vessel or directly on the animal udder (Diez Castilho & de Azevedo 
Barros Filho, 2010; Fildes, 1986; Greenberg, 1980).  
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From about 1800 BC, regulations on the practice of wet nursing were contained in 
Hammurabi's Code. Feeding cups were found throughout Europe and Greece in the graves of 
infants dating from 2000 BC. Even the story of Moses in the Old Testament describes Hebrews 
and Egyptians utilizing wet nurses for the survival of infants separated from their mothers (Diez 
Castilho & de Azevedo Barros Filho, 2010). In 200 BC, teachings in the Talmud emphasized that 
breastfeeding during the first 2 years of life was important to the preservation of life (Fildes, 
1986). The people of Mesopotamia, Hebron, and Egypt cared for their children in the same way 
for millennium despite their cultural differences (Colon & Colon, 1999; Fildes, 1986). Children 
were considered divine gifts from God. After Egypt was dominated by Rome, the Greco-Roman 
culture came to prevail and children lost their value. The problem of abandoned children during 
this time paralleled information about feeding techniques. Families would contract wet nurses, 
who took the children into their own homes and return them years later. In fact so many infants 
were abandoned during the time of the early popes in Rome, foundling homes were started. This 
custom spread through the Greek and Roman Empire and throughout Europe (Lawrence & 
Lawrence, 2011).  
In the 1700's French foundling homes were staffed by carefully selected wet nurses, whose 
lives were monitored to insure proper nutrition for the abandoned infants (Lawrence & 
Lawrence, 2011). Infant feeding habits changed when it was discovered that infants fed goat or 
mule milk in the Foundling Hospitals or who were given substitute foods did not survive as long 
as infants given breast milk (Fildes, 1986). After “infirmaries” were set up, the relationship was 
confirmed when mothers breastfed during the first few days immediately after delivery and 
onwards (Colon & Colon, 1999). 
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Wealthy Englishwomen did not nurse their infants from A.D. 1500 to 1700 (Fildes, 1986). 
It was well known in Great Britain during this time that breastfeeding was a means to delay 
another pregnancy, however these women preferred to have 12-20 babies rather than breastfeed 
them (Yalom, 1997). They believed breastfeeding aged them and ruined their figures. Wet nurses 
were soon replaced by cereal or bread gruel fed to infants from a spoon. The death rate was close 
to 100% in the foundling homes that practiced this feeding technique. 
From the 15th through the 18th century, as poor rural women who had breastfed their own 
children as well as those of wealthy women moved to the city, century-old feeding practices 
changed. In this era no method for preserving fresh milk had been discovered yet, so other foods 
were introduced earlier. During this time, mothers started to prefer giving “paps” and “bread 
sops” rather than having wet nurses (Diez Castilho & de Azevedo Barros Filho, 2010). The first 
recipes for this were recorded in the 15th century. The recipe called for the use of a liquid, beer, 
wine, vegetable or meat stock, water, a cereal, bread, rice, wheat or flour, and an additive sugar, 
meat, eggs, honey, spices, herbs, or meat (Colon & Colon, 1999; Fildes, 1986). Mortality rates of 
100% during the first week of life were reported with pap feeding (Radbill, 1981). 
The American Industrial revolution saw identical changes in feeding practices. 
Urbanization changed the way families lived; they needed money for survival because they were 
no longer farming and raising livestock for sustenance. The living conditions were poor, with 
people crowded together in slums with little hygiene. Labor was exploited through low wages 
and women were forced to work. There were few wet nurses and little money to pay for them. 
Infants were left at home and cared for by elderly women or very young girls who fed them an 
array of artificial foods, some of which were laced with opiates so the infants would sleep until 
the mothers returned home (Fildes, 1986). These areas contained the highest rates of infant 
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malnutrition, morbidity and mortality in the country (Fildes, 1986). Rural areas, which 
maintained a 90% breastfeeding rate, with duration of breastfeeding 6 months or greater, had the 
lowest infant mortality (Fildes, 1986). 
During the 20th century there were dramatic changes in the way infants were fed (A. L. 
Wright & Schanler, 2001). In the early 1900s, approximately two-thirds of mothers breastfed 
(Hirschman & Butler, 1981). Then both the incidence and duration of breastfeeding began to 
decline, dropping from almost 70% of women in 1911-1915 to about 50% in 1926-1930, and 
only 25% in 1946-1950 (Hirschman & Butler, 1981). The lowest level was reached in 1972, 
when only 22% of women breastfed (Eckhardt & Hendersgot, 1984). 
The 20th century was a time of unprecedented cultural, technological, and social changes 
involving the roles of women, their education and income and their childbirth practices. 
Beginning in the 1920's the emancipation of women was symbolized by short skirts, short hair, 
birth control, cigarette smoking, and bottle feeding (Lawrence & Lawrence, 2011). The early 
portion of the 20th century also brought the development of formula milk and the use of milk 
from other mammals to feed infants, a move away from breastfeeding (Radbill, 1981). 
Sterilization practices improved which resulted in significant drops in mortality to infants who 
were not breastfed (Barness, 1987). After WWII there was an increase in commercially prepared 
infant formula and women were entering the work force.  
During the 1930s, medical societies no longer stressed the importance of breastfeeding and 
came to the believe in the healthfulness of formula for infants. Bottle feeding directions for 
commercial or home use came from the physician or physician surrogate, such as a nurse (Apple, 
1994). Women acted on the belief that what the medical community recommended was best for 
the baby. At the same time, cow's milk was being introduced earlier and earlier, with a further 
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decrease in breastfeeding rates between 1930 and 1970 (Fomon, 2001; Jelliffe & Jelliffe, 1978) 
Commercial formula was often used only for a short time because of the expense compared with 
cow's milk (Fomon, 2001). 
In the 1940's formula was made at home mixing water with pasteurized cow's milk or 
evaporated milk with sucrose or corn syrup. The processed milk was fortified with vitamin D, 
and children could be given juice which contained vitamin C thereby eliminating the threat of 
scurvy or rickets. Medical doctors at that time felt there was no difference between breastfeeding 
and formula regarding safety or satisfaction (Fomon, 2001).  
At the start of the 20th century, laboratories were investing in the development of a good 
substitute for breast milk, producing modified milks or industrial formula. It was becoming 
increasingly difficult even for physicians to choose an appropriate formula because there were so 
many options on the market. With WWII causing birth rates to fall, manufacturers wanting to 
increase profits started a promotion of breast milk substitutes (Rea, 1990). After the war, in 
response to huge advertising campaigns and with the baby boom sales increased and formula 
dominated between 1950 and1960. Interestingly, in 1956, as women who wanted to breastfeed 
were met with resistance from the medical profession the La Leche League was formed in 
Chicago to provide mothers with support to breastfeed. Women wanted to be informed and many 
wanted the right to choose how they would feed their infants. 
The feminist movement and the contraceptive pill caused birth rates to fall again in 1960. 
The attitude of the female breast changed from one of the ability to nurture to the breast as a sex 
object. Feeding bottles became symbols of women's liberation (Diez Castilho & de Azevedo 
Barros Filho, 2010). The food industry increased its advertising diversifying even more and 
expanded into the third world (Rea, 1990). Composition of the formula was also changing based 
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on new discoveries in nutrition with manufacturers increasing sales by promoting their formulas 
advantage over similar products at reduced costs (Diez Castilho & de Azevedo Barros Filho, 
2010; Fomon, 2001; Jelliffe & Jelliffe, 1978). All these changes caused breastfeeding rates to 
drop and the increased use of supplementation reaching the nadir in 1972 of only 22% of US 
women breastfeeding (Eckhardt & Hendersgot, 1984). 
In 1978, Dr Derrick Jelliffe coined the term “commerciogenic malnutrition” to refer to the 
infant starvation caused by the promotion and use of infant formula in areas of poor water 
supplies and low income, triggering a renewed interest in the promotion and practice of 
breastfeeding on an international level (Jelliffe & Jelliffe, 1978). Increased awareness of the 
health consequences of corporate promotion of infant formula led to the “Baby Killers Scandal” 
and the boycott of Nestle, because of accusations that industry was using aggressive advertising 
campaigns and interfering with breastfeeding (Joseph, 1981). The prevailing mentality began to 
change in the 1970s, shifting to support breastfeeding in.  
Physiology of Breastfeeding 
Anatomy 
Complex neuroendocrine reflex responses are involved in mammary gland growth, the 
production of breast milk, the removal of milk, and the maintenance of lactation. The human 
breast is composed of glandular (secretory) tissue and fat tissue and is supported by loose 
connective tissue. The breast is made up of 15-20 lobes that extend from the nipple to the wall of 
the thorax in a tree like fashion. The lobes are composed of lobules which each contain between 
10-100 alveoli. It is thought that 15- 25 ducts drain the alveoli. Alveoli join their ducts 
(intralobular ducts), forming a distinct lobar duct, which then converges separately to the nipple 
via lactiferous ducts. The lactiferous ducts open into lactiferous sinuses on the surface of the 
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nipple that serve as small reservoirs for milk (Buhimschi, 2004). Alveoli are composed of 
epithelial cells, myoepithelial cells, contractile cells for milk ejection and connective tissue that 
contains fat and a generous blood supply (Neville, 2001). The interstitial space is where plasma 
cells are formed which secrete immunoglobulin's into milk during lactation. Milk is constantly 
secreted into the alveolar lumina and stored, until the let-down reflex causes the myoepithelial 
cells to contract and milk is ejected (Neville, Morton, & Umemura, 2001). The hormones of 
pregnancy contribute to complete alveolar-lobular development (mammogenesis) and maturation 
of the epithelium (lactogenesis). 
Lactogenesis 
Lactogenesis refers to the evolution of the mammary gland as it develops the ability to 
secrete milk. Progesterone and prolactin are necessary for the final steps of mammary growth 
and secretory differentiation which begins with a rise in mRNA for milk proteins and enzymes 
important for milk formation and secretion (E. Jones & Spencer, 2007; Neville & Morton, 2001). 
The secretory differentiation is known as stage I lactogenesis and occurs at midpoint of the 
pregnancy. During this stage the mammary gland has developed extensive lobular clusters and 
secretes small amounts of milk, the gland continues to grow until parturition, with milk secretion 
held in place by the high levels of progesterone in the blood (Kuhn, 1969; Neville, McFadden, & 
Forsyth, 2002). 
After delivery of the neonate and the expulsion of the placenta there is a sudden drop in 
progesterone, estrogen and placental lactogen levels and a simultaneous rise in prolactin levels. 
The sudden drop in progesterone levels and concurrent rise in prolactin levels prompt 
lactogenesis II which is the onset of copious milk secretion and occurs at 30-40 hours 
postpartum. Mothers do not typically notice the sensation of full breasts until 50-73 hours after 
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birth. The milk composition also changes significantly at this time with a decrease in sodium and 
chloride concentration and an increase in lactose concentration which is complete usually by 72 
hours after delivery (E. Jones & Spencer, 2007; Neville et al., 1991). Immunoglobulin IgA and 
lactoferrin rise substantially during this period after delivery and despite their concentration 
decline due to the increased milk production, the secretion rate remains significant the duration 
of lactation. Lactogenesis II is hormonally driven and milk removal is not necessary during this 
phase for most women (Kulski, Hartmann, Martin, & Smith, 1978). Nonetheless, the milk must 
be removed by day 3 for lactation to continue successfully. 
Prolactin is crucial to milk synthesis, as shown in a study that intentionally inhibited 
prolactin using bromocriptine(Peters, Del Pozo, Conti, & Breckwoldt, 1986). Prolactin is found 
in the lactating breast and in milk and the prolactin in milk originates in the pituitary lactotroph 
(Buts, 1998; Nolin & Witorsch, 1976). Pituitary lactotrophs have automatic secretory action (M. 
E. Freeman, Kanyicska, Lerant, & Nagy, 2000), and the pituitary gland functions primarily under 
a hypothalamic dopamine inhibitory effect. The most important stimuli for prolactin release are 
high levels of estrogen and suckling stimulus (de Greef, Plotsky, & Neill, 1981; Neill, Freeman, 
& Tillson, 1971). Estrogen levels decline after delivery of the fetus and placenta, therefore it is 
necessary for frequent suckling at this time to maintain elevated prolactin levels that are crucial 
for milk synthesis. Dopamine inhibits prolactin release, but  the stimulation of suckling interferes 
with the inhibitory response (de Greef et al., 1981). Evidence suggests the release of prolactin 
occurs via a neurogenic pathway from nipple to hypothalamus, with the amount released related 
to the number of breastfeeding sessions and the strength of the mechanical suckling. Further 
evidence backs catecholamine and serotonin control on the prolactin release and the 
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consequences of changes in the hypothalamic dopamine turnover (de Greef et al., 1981; Tyson, 
1977). 
Oxytocin and Milk Ejection 
Removal of milk from the breast is accomplished by contraction of the myoepithelial cells 
which the processes of form a basket like network around the alveoli where the milk is stored 
(Neville, 2001). When neonates are suckled, afferent impulses from sensory stimulation of nerve 
terminals in the areolas travel through the CNS, where they promote release of oxytocin from the 
posterior pituitary gland (Neville, 2001). Oxytocin release in women has been associated with 
stimuli such as the thought, sight, or sound of the infant, illustrating a substantial psychological 
component of the neuroendocrine reflex. The oxytocin travels through the blood stream to the 
mammary gland, where it interacts with specific receptors on myoepithelial cells, initiating the 
contraction and the expulsion of milk from the alveoli into the ducts (Neville, 2001). The 
passage of milk into the ducts is aided by myoepithelial cell possesses which are arranged 
longitudinally that shorten and widen during contraction and allow the milk to flow freely to the 
nipple. The process by which the milk is forced through the alveoli is milk ejection or let-down 
and is necessary for the removal of milk from the lactating breast. 
The release of oxytocin is necessary for milk removal and only the mechanical forces of 
suckling can remove it (Neville, 2001). Removal of the milk is necessary to continued milk 
secretion. When milk ejection is inhibited, milk cannot be removed from the breast and cells 
cease milk secretion. The mammary gland loses its ability to secrete milk when milk removal 
stops completely. Therefore, frequent suckling combined with adequate milk ejection, 
demonstrates the most crucial stimuli needed for milk production.   
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Human Milk Composition 
It is important to outline the significance of breast milk to infant and mother as part of a 
review on breastfeeding. The composition of human breast milk is biologically uniquely suited to 
the nutritional needs of the neonate. Human milk contains both the optimal nutrition composition 
and non-nutritive bio molecules that contribute to organ development, immune maturation, and 
healthy microbial colonization and protect against inflammation and infection. Human milk is a 
dynamic fluid that changes its composition from colostrums to mature milk, and varies with 
feedings, time of day between mothers and populations.  
Stages of Lactation 
After delivery, the first fluid produced by the mother is colostrum, which has a unique 
composition, volume, and appearance (Ballard & Morrow, 2013). The first days after delivery 
low volumes are produced which contain immunological components such as secretory IgA 
(sIgA), leukocytes, lactoferrin, and developmental factors such as epidermal growth factor 
(Castellote et al., 2011; Kulski & Hartmann, 1981; Pang & Hartmann, 2007). Colostrum contains 
low levels of lactose indicating the function is immunological not nutritional. Colostrum contains 
higher levels of sodium, magnesium, and chloride and lower levels of potassium and calcium 
than late milk (Kulski & Hartmann, 1981; Pang & Hartmann, 2007). As mammary epithelial 
cells change, the sodium to potassium ratio declines and lactose concentration increases, leading 
to the production of transitional milk. 
Transitional milk is the “ramped up”' period of milk production, still containing 
characteristics of colostrum while keeping up with the nutritional and developmental needs of 
the growing neonate 5-14 days postpartum. After this time, the breast milk is considered 
relatively mature. Four to six weeks postpartum, breast milk is considered fully matured and 
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remains relatively fixed in composition, unlike the changing milk composition seen the first 
weeks of life (Ballard & Morrow, 2013).  
Mature human milk is a complex fluid composed of several phases that can be separated 
either by centrifuge or sitting out for several hours (Neville, 2001). The milk fat globules 
containing the milk liquids rise to the top forming the cream layer over the skim milk. In human 
and bovine milk the fat accounts for 4% of milk volume (R. Jensen, 1989) and contains other 
milk components such as phospholipids, cholesterol, and steroid hormones. Cellular components, 
of breast milk are primarily sloughed epithelial cells, neutrophils, macrophages, T-cells, stem 
cells, and lymphocytes (Neville, 2001). The transfer of maternal living cell offers protection 
against pathogens while stimulating the infant’s own immune system.  
The composition of mature human milk is reasonably consistent, varying slightly for most 
components with stage of lactation and for some constituents, such as fatty acids, more with diet 
(Koletzko & Rodriquez-Palmero, 1999). A few components of milk, such as the B vitamins and 
selenium, are greatly affected by diet (Neville, 2001). Nutrition received by the fetus through the 
placenta is completely dependent on maternal metabolism; however, the nutrients the breastfed 
infant receives are not. For almost all the components of milk, the secretory mechanism is 
separate from the regulatory mechanism that controls nutritional influx from the mothers making 
sufficient milk of adequate composition available to the infant regardless of maternal inadequate 
food intake.  
Macronutrients 
The major macronutrients of milk are lactose, a disaccharide unique to milk, 
oligosaccharides, triglycerides, milk fat in the form of proteins, including casein, lactoferrin, α 
lactalbumin, sIgA, many others that are present in lower concentrations and minerals, including 
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potassium, chloride, sodium and magnesium. The proteins in breast milk can be divided into two 
categories—casein and whey—in a ratio of 40:60 (Lonnerdal, 1985). The major casein of human 
milk is b-casein, which forms micelles of little volume that form soft curds in the infant’s 
stomach. Whey proteins are α lactalbumin, lactoferrin, sIgA, and serum albumin (Lonnerdal, 
1985). 
Secretory IgA is the principal immunoglobulin of breast milk and the specificity of sIgA 
antibodies reflects the mother’s exposure to infection and is independent of the specific profile of 
blood borne IgA (Mata, 1986). Many of the proteins in breast milk have multiple functions. For 
example, lactoferrin transports and promotes iron absorption, is bacteria static to many 
organisms and acts as a nutritional protein by manufacturing amino acids to be absorbed when 
digested (Lonnerdal, 1985; Prentice et al., 1987).  
More than 98% of the fat in human milk is constructed by the mammary epithelial cells 
and is in the form of triglycerides. Palmitic acid and oleic acid are the most abundant fatty acids 
in breast milk triglycerides. Half of the triglycerides molecules in breast milk contain palmitic 
acid attached to a carbon of the glycerol component making breast milk easier to digest, 
increasing absorption and mineral balance (Carnielli et al., 1995; R. Jensen, 1989). Long chain 
polyunsaturated fatty acids, arachidonic acid (AA), and docosahexaenoic acid (DHA) are 
synthesized from the essential fatty acids linolic acid and linolenic acid respectfully. These fatty 
acids are the constituents of brain and neural tissue and are needed in early mental and visual 
development of the neonate (Ballabriga, 1994). The lipid component of human milk provides the 
transport of fat-soluble micronutrients such as vitamins A, D, E, K and prostaglandins. 
The major carbohydrates of human milk are lactose and oligosaccharides. Lactose is the 
principal sugar of milk and appears to be specific for newborn growth. It has been shown to 
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increase calcium absorption. Lactose is a source of galactose, which is necessary for the 
production of galactolipids. Galactolipids are essential for CNS development. For the neonate, 
human milk oligosaccharides are non-nutritive bioactive factors (Ballard & Morrow, 2013) that 
are prebiotic in that they enhance the growth of beneficial flora such as L. bifidus, indirectly 
protecting against gastrointestinal tract infections (Lawrence & Lawrence, 2011). They also have 
a role in defenses against other bacteria, as well as viruses and many toxins. The human milk 
oligosaccharides are recognized as pathogen-binding inhibitors that function as a “decoy” 
receptor for pathogens that have an affinity for binding to oligosaccharide receptors on the 
infant’s intestinal wall (Ballard & Morrow, 2013). Oligosaccharides have demonstrated effects 
against Helicobacter pylori, E. coli, Streptococcus pneumoniae, and influenza viruses (Lawrence 
& Lawrence, 2011). 
Protection against infection is also provided by other constituents of human milk, such as 
lactoferrin, an iron-binding glycoprotein belonging to the transferrin family, which has enzyme 
activity that interferes with microbial function and protects against various bacteria, fungi, and 
viruses (Ballard & Morrow, 2013; Beljaars et al., 2004; Sherman, Bennett, Hwang, & Yu, 2004). 
Lactoferrin also functions in cell growth regulation, antitumor activity, and immunologic 
functions. 
Growth Factors 
Human milk contains many growth factors that have effects on the intestinal tract, nervous 
system, and endocrine system of the neonate. Epidermal growth factor is found in early breast 
milk and is critical to the maturation and healing of the intestinal mucosa (Chailler & Menard, 
1999; Hirai et al., 2002; Wagner, Taylor, & Johnson, 2008). The immature gut of the infant 
includes the enteral nervous system, a branch of the nervous system that governs the function of 
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the gastrointestinal tract. For its development, the enteral nervous system requires glial cell-line 
derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF), which are 
detected in human milk 90 days after birth (Fichter et al., 2011; Li, Xia, Zhang, & Wu, 2011). 
BDNF enhances peristalsis of the infant intestine and GDNF increases neuron growth and 
survival (Fichter et al., 2011).  
Also found in human milk are insulin-like growth factors (IGF), which increase tissue 
growth, stimulate erythropoiesis, and increase hematocrit (Kling, Taing, Dvorak, Woodward, & 
Philipps, 2006; Peterson et al., 2000). Human breast milk contains high amounts of 
erythropoietin (Epo), which is the main hormone involved in the production of red blood cells.  
Hormones 
Adiponectin is a hormone found in breast milk that actively regulates metabolism and 
suppresses inflammation. Adiponectin can cross the intestinal barrier and appears to modify 
infant metabolism (Martin et al., 2006; Newburg, Woo, & Morrow, 2010). High levels of 
adiponectin in breast milk have an inverse correlation to infant weight and BMI, leading 
researchers to speculate that adiponectin in breast milk may reduce the incidence of obesity in 
later life (Newburg et al., 2010; Woo et al., 2012). Other metabolism-controlling hormones in 
breast milk are leptin, ghrelin, and resistin which all appear to play a role in energy conservation, 
appetite control, and body composition (Dundar et al., 2010; Palou, Sanchez, & Pico, 2009; 
Savino & Liguori, 2008; Savino et al., 2012). 
Comparison of Human Milk with Formula 
Breast milk is unique in composition when compared to cow’s milk, the basis for most 
formula. The protein in formula contains a-casein and beta lactoglobulin; the ratio of casein to 
whey protein is 80:20, double that of human milk. The curd formed by casein is hard and 
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difficult to digest. Formula cannot replicate the hormones, live living cells immunoglobulins, 
active enzymes, and unique chemical compounds found in human milk (Benson & Masor, 1994). 
The long chain of fatty acids from breast milk triglycerides, DHA and AA, are not found in cow 
milk based formula and if added as a supplement is not absorbed completely; furthermore the 
positional difference of fatty acids on the glycerol molecule is lacking. There is no lactose in 
some formulas an important carbohydrate for brain development and deficiency in 
oligosaccharides which promote intestinal health and fight infection. All of these deficiencies 
may impede normal infant growth and development. 
Human milk is very complex. Although the composition of formula may be similar, it 
cannot duplicate breast milk. The exact composition of breast milk is still unknown, and even 
though science continues to increase understanding of breast milk and improve formula, it may 
never find a perfect match. Human breast milk contains at minimum 100 ingredients not found in 
formula. Breast milk is the perfect food for the growing and developing infant, containing just 
the right amount of lactose, fatty acids water, and proteins that are easy for the infant to digest. 
Even when formula contains the same nutrients, such as vitamins and minerals, as in breast milk, 
they are not absorbed or used in the same way. The differences can affect the infant’s ability to 
digest and absorb nutrients. 
Benefits of Breastfeeding 
Benefits to Infant 
If an infant is breastfed exclusively for more than 4 months the risk of hospitalization for 
upper respiratory tract infections is reduced by 72% the first year (Ip et al., 2007; Ip, Chung, 
Raman, Trikalinos, & Lau, 2009). The severity of respiratory syncytial virus bronchiolitis, 
measured by the oxygen requirement and duration of hospital stay, is reduced by 74% in infants 
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who breastfed exclusively for 4 months compared with infants who partially or never breastfed 
(Nishimura, Suzue, & Kaji, 2009). The incidence of otitis media was reduced by 23% if infants 
had ever been breastfed compared with exclusive formula, and the risk of otitis media was 
reduced by 50% in exclusive breastfeeding for more than 3 months (Ip et al., 2007). Ear and 
throat infections and serious colds were reduced 63% in infants exclusively breastfed for 6 
months (Duijts, Jaddoe, Hofman, & Moll, 2010). There was a 64% reduction in the incidence of 
nonspecific gastrointestinal tract infections if an infant had ever been breastfed, with this effect 
lasting 2 months after breastfeeding stopped (Duijts et al., 2010; Ip et al., 2007; Ip et al., 2009; 
Quigley, Kelly, & Sacker, 2007). A study of preterm infants noted a 77% reduction in 
necrotizing enterocolitis in infants exclusively fed breast milk compared to those fed breast milk 
supplemented by cow’s milk–based formula (Sullivan et al., 2010). 
There have been consistent differences in neurodevelopmental outcomes between breastfed 
and formula fed infants reported however outcomes have been confounded by differences in 
home environment, education of parents intelligence and socioeconomic status (Der, Batty, & 
Deary, 2006; Ip et al., 2007). In a large open-label cluster-randomized study, the Promotion of 
Breastfeeding Intervention Trial, hospitals in the Republic of Belarus were randomized to 
promote and support exclusive breastfeeding (particularly among mothers who had already 
decided to breastfeed), or to continue their usual institutional policies. The experimental 
intervention led to a large increase in exclusive breastfeeding at age 3 months (43.3% for the 
experimental group vs 6.4% for the control group; p < 0.001). Cognitive development of the 
children was tested at age 6.5 years with subtests and IQ scores on the Wechsler Abbreviated 
Scales of Intelligence and teacher evaluations of academic performance in reading, writing, 
mathematics, and other subjects. Adjusted outcomes of intelligence scores and teacher’s ratings 
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were significantly higher in children from hospitals which promoted exclusive breastfeeding 
(Kramer, Aboud, et al., 2008; Kramer et al., 2001; Kramer, Fombonne, et al., 2008). In another 
study, significant effects of human milk on long-term neurodevelopment were observed in 
preterm infants, a population more at risk for adverse neurodevelopmental outcomes (Isaacs et 
al., 2010; Lucas, Morley, & Cole, 1998; Vohr et al., 2007; Vohr et al., 2006). 
Maternal Benefits 
Mothers who breastfeed have health benefits both long and short term, including more 
rapid involution of the uterus and decreased postpartum blood loss (American Academy of 
Pediatrics Section on Breastfeeding, 2012). Continued breastfeeding causes lactational 
amenorrhea, leading to increased child spacing. Studies on the effects of breastfeeding on 
postpartum weight loss have been inconclusive, given the large numbers of confounding factors 
that contribute to weight loss (diet, baseline weight, ethnicity, and activity). In a study of 14,000 
women postpartum with covariates adjusted, found women who breastfed more than 6 months 
weighed 1.38 kg less than those who did not (Krause, Lovelady, Peterson, Chowdhury, & 
Ostbye, 2010). The Nurse’s Health Study found a decreased risk of type 2 diabetes mellitus of 
4% to 12% for each year of breastfeeding (Stuebe, Rich-Edwards, Willett, Manson, & Michels, 
2005). Another study of 2233 women found that risk of type 2 diabetes increases when term 
pregnancy is followed by less than 1 month of lactation (Schwarz et al., 2010). 
A report by the Women's Health Initiative, a longitudinal study of 139,000 postmenopausal 
women found an association between cumulative breastfeeding experience and cardiovascular 
disease (Schwarz et al., 2009). Women who breastfed for 12 to 23 months had significant 
reductions in hypertension, high cholesterol, diabetes, and heart disease.  
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Cumulative breastfeeding experience also correlated with a reduction in ovarian and breast 
cancer (Ip et al., 2007; Ip et al., 2009; Stuebe, Willett, Xue, & Michels, 2009). Breastfeeding for 
12 months or longer is associated with a 28% decrease in ovarian and breast cancer 
(Collaborative Group on Hormonal Factors in Breast Cancer, 2002). It has been calculated that 
each year of breastfeeding results in a 4.3% reduction in the risk of breast cancer (Collaborative 
Group on Hormonal Factors in Breast Cancer, 2002; Lipworth, Bailey, & Trichopoulos, 2000). 
Public Benefits 
In addition to the health benefits there are financial benefits to the family, society, public 
and private insurers, government programs, and employers (AWHONN, 2015). A cost analysis 
of the financial benefits of breastfeeding estimated that if 90% of mothers breastfed exclusively 
for 6 months, 13 billion health care dollars would be saved (Bartick & Reinhold, 2010). 
According to the US Surgeon General, the family of a breastfed infant saves approximately 
$1500 per year in costs directly related to feeding supplies and formula. Because breastfed 
infants are less likely to be sick, the family saves indirectly on health care costs because there are 
fewer medical bills and fewer lost days of work (US Department of Health and Human Services 
Office of the Surgeon General, 2011). When employers invest in a lactation program and support 
breastfeeding, they receive $3 return for every $1 invested (Tuttle & Slavit, 2009). This reduced 
costs for health insurance claims, reduced absenteeism reduced turnover rates leading to cost 
savings in recruitment and training (US Department of Health and Human Resources Health 
Resources and Services Administration, Undated). 
Because it does not require packaging, a manufacturing plant, storage, refrigeration, or 
transportation, breastfeeding is also beneficial to the environment (Fairfield, 2012). Researchers 
have estimated that for every 1 million infants fed formula, 150 million containers used to 
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package the formula were disposed of, many in landfills (US Department of Health and Human 
Services Office of the Surgeon General, 2011). 
Factors Influencing Breastfeeding in the First Days Postpartum 
Maternal Intention to Breastfeed 
Maternal intention to breastfeed is the strongest modifiable predictor of breastfeeding 
duration (Blyth et al., 2002; DiGirolamo, Thompson, Martorell, Fein, & Grummer-Strawn, 2005; 
Forster, McLachlan, & Lumley, 2006). Often women have made the decision to breastfeed 
before they became pregnant or in the first trimester before their first prenatal visit (Earle, 2002; 
J. Henderson & Redshaw, 2011). The influence of the primary care clinician on breastfeeding is 
significant (Bentley et al., 1999; Guise et al., 2003; Lu, Lange, Slusser, Hamilton, & Halfon, 
2001). Responses of 1229 women in a nationally representative sample showed that, in 
population groups that were least likely to breastfeed, the most significant influence was prenatal 
encouragement and support (Lu et al., 2001). At office visits during the prenatal period, nurses 
and midwives have an opportunity to provide guidance and education. During well-child visits, 
pediatric nurses and nurse practitioners trained and certified in lactation can provide 
breastfeeding support and discuss a variety of issues (family support, returning to work, sore 
nipples etc). 
Institutional Practices and Breastfeeding Support 
For hospital births, the practices of the institution can act as a barrier or facilitator to 
breastfeeding initiation. Such factors must be considered when collecting and interpreting data 
from the proposed study. The groundbreaking work by Righard and Alade showed that delivery 
room routines are strongly associated with the infant’s ability to initiate breastfeeding (Righard 
& Alade, 1990). Of infants placed on the mother’s chest immediately after delivery, 63.2% 
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initiated rooting behaviors within 20 minutes and were breastfeeding successfully within the 
hour, 10.5% sucked incorrectly, and 26.3%, who were born to women who had narcotic epidural 
analgesia, did not exhibit rooting behavior. When infants were separated from their mothers for 
routine weighing and exams, only 20% sucked correctly, and none of these infants had received 
narcotic epidural analgesia (Righard & Alade, 1990).  
Professional breastfeeding support from postpartum nurses and lactation consultants 
strongly correlates with breastfeeding initiation (Persad & Mensinger, 2008). In the immediate 
postpartum, mothers require professional guidance and support in breastfeeding initiation. A 
study in Finland (Tarkka, Paunonen, & Laippala, 1998) used multivariate analysis of predictors 
related to breastfeeding success and found five variables that contributed to the establishment of 
breastfeeding: the mother’s experience of breastfeeding in the hospital postpartum, the time 
when breastfeeding was first initiated, the opinions of the mother’s significant other and the 
healthcare staff on her decision to breastfeed, the amount of professional breastfeeding assistance 
available to her, and whether she was upset while in the hospital (Tarkka et al., 1998). Mothers 
who had a positive experience breastfeeding and started lactating 2 to 3 days postpartum coped 
better than those whose experience was not as positive and who did not start lactating until later. 
In addition, the more emotional support and interactive lactation assistance the mother received 
from her significant other and healthcare staff the better she coped with breastfeeding. In 
comparison, the mothers who were upset during their hospitalization did not cope well with 
breastfeeding. 
A 2005 Cochrane review analyzing interventions for promoting initiation of breastfeeding 
showed that breastfeeding education had a significant effect on increasing breastfeeding 
initiation compared to standard care (Dyson, McCormick, & Renfrew, 2005). Five studies with a 
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total of 582 women on low incomes in the USA showed breastfeeding education clearly 
increased breastfeeding rates compared to providing routine care (Brent, Redd, Dworetz, 
D'Amico, & Greenberg, 1995; Coombs, Reynolds, Joyner, & Blankson, 1998; Hill, 1987; Ryser, 
2004; Serwint, Wilson, Vogelhut, Repke, & Seidel, 1996). One trial with 165 women showed 
peer support for women considering breastfeeding also increased breastfeeding rates (Chapman, 
Damio, Young, & Perez-Escamilla, 2004). Needs based, one-to-one, informal education or 
support sessions, delivered either before or before and after the birth by a trained breastfeeding 
professional or peer counsellor, was the most effective intervention among women of different 
ethnicity and feeding intention in three studies. 
Breastfeeding usually begins in the hospital so it is reasonable to examine hospital 
practices and the association to breastfeeding initiation. Because breastfeeding has so many 
positive health benefits, the United National Children's Fund and World Health Organization 
launched a program in 1991 called the Baby-Friendly Hospital Initiative (BFHI) to promote 
exclusive breastfeeding for the first 6 weeks of life. The Ten Steps to Successful Breastfeeding 
were formulated to address the negative impact of maternity care birth practices in hospitals had 
on the initiation, exclusivity, and maintenance of breastfeeding (World Health Organization & 
UNICEF, 1989). The 10 steps to successful breastfeeding as stated by the BFHI are to: (1) have a 
written breastfeeding policy; (2) train staff with skills to implement the breastfeeding policy; (3) 
inform all pregnant women of the benefits/ management of breastfeeding; (4) help mothers 
initiate breastfeeding within an half hour of birth; (5) show mothers how to breastfeed, and how 
to maintain lactation even if they should be separated from their infant; (6) give newborn infants 
no food or drink other than breast milk unless medically indicated; (7) use proactive rooming- in 
to allow mothers and infants to remain together 24 hours a day; (8) encourage breastfeeding on 
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demand; (9) give no artificial teats or pacifiers to breastfeeding infants; (10) Foster the 
establishment of breastfeeding support groups and refer mothers to them on discharge from the 
hospital or clinic. Additionally, procedures that may interfere with breastfeeding are to be 
limited. 
The 10 steps were operational targets for hospitals and became the basis for the BFHI 
(Brodribb, Kruske, & Miller, 2013). The implementation of BFHI accreditation brought about 
increases in the initiation of breastfeeding, any breastfeeding and exclusive breastfeeding the 
first days postpartum (Braun et al., 2003; Broadfoot, Britten, Tappin, & MacKenzie, 2005; 
Merewood, Mehta, Chamberlain, Philipp, & Bauchner, 2005; Philipp, Malone, Cimo, & 
Merewood, 2003; Philipp et al., 2001; Venancio, Saldiva, Escuder, & Giugliani, 2012), and 
increased duration of breastfeeding (Braun et al., 2003; Duyan Camurdan et al., 2007; Merten, 
Dratva, & Ackermann-Liebrich, 2005; Venancio et al., 2012), most notably in hospitals with low 
breastfeeding rates to begin with. However, it was found that, in hospitals with high rates of 
breastfeeding initiation and where infant-friendly practices are the norm, breastfeeding initiation 
and duration rates did not increase when BFHI accreditation was achieved (Brodribb et al., 
2013). Women who received at least four of the 10 Baby-Friendly Hospital practices, including 
implementing skin-to-skin at birth, attempted breastfeeding in the first hour, no formula 
supplementation, and 24-hour rooming in, had an increased probability of breastfeeding at 1 and 
4 months compared with women who experienced fewer than four of these practices (Brodribb et 
al., 2013). The authors concluded that baby-friendly, evidence-based practices in the hospital 
environment were more important than the accreditation.   
The Ten Steps are relevant to the research described here because the facility where the 
study took place (Yale New Haven Hospital) is in the process of achieving the BFH designation 
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and has initiated these steps. The process requires each nurse to complete 20 hours of formal 
breastfeeding education and requires that patients receive initial breastfeeding instruction within 
6 hours after delivery. A hospital environment strongly supportive of breastfeeding may be able 
to at least partially offset any potential negative effects of epidurals on breastfeeding (Halpern et 
al., 1999; Wieczorek et al., 2010). 
Literature regarding the steps relevant to the current study will be discussed in the 
following sections. 
Immediate Skin-to-Skin Contact and Immediate Breastfeeding Initiation 
The early postpartum period is an important time for mother and infant to develop this 
synchrony and reciprocity (Kennell, Trause, & Klaus, 1974). Skin-to-skin contact between the 
neonate and the mother within the first hour postpartum, which is known as the “sensitive 
period,” enhances the long-term interaction between mother and neonate. When the newborn is 
placed skin-to-skin between the mother's breasts, oxytocin is released as the newborn exhibits 
instinctual behavior by rooting, finding the breast, and sucking at approximately 1 hour of age 
(Matthiesen, Ransjo-Arvidson, Nissen, & Uvnas-Moberg, 2001; Nissen, Gustavsson, Widstrom, 
& Uvnas-Moberg, 1998). Endogenous oxytocin during labor and birth is necessary for the 
development of maternal behavior that facilitates the process of breastfeeding. Oxytocin induces 
the milk ejection reflex and contributes to the release of prolactin, which is linked to milk 
production (Dawood, Khan-Dawood, Wahi, & Fuchs, 1981).  
Oxytocin and prolactin are pivotal to breastfeeding and are associated with behavioral and 
physiological adaptations in breastfeeding women (Jonas et al., 2009; Nissen et al., 1998; Uvnas-
Moberg, Widstrom, Werner, Matthiesen, & Winberg, 1990). When this early contact occurs, 
mothers are more likely to be breastfeeding at 1 and 4 months or longer after delivery (Bystrova 
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et al., 2009; E. R. Moore, Anderson, Bergman, & Dowswell, 2012; Salariya, Easton, & Cater, 
1978; Wiberg, Humble, & de Chateau, 1989). 
Skin-to-skin contact immediately postpartum allows development of innate neonatal 
behaviors such as temperature regulation, crying, respiration, and nursing behavior. It assists the 
neonate in the transition to extrauterine life by decreasing the stress of birth through the mother’s 
warmth, touch, and odor, guiding the neonate to her nipple, and triggering release of maternal 
oxytocin. Unmedicated spontaneous vaginal deliveries with immediate maternal-infant skin-to-
skin contact have an increased likelihood of successful baby-led breastfeeding (E. R. Moore et 
al., 2012; Righard & Alade, 1990; Widstrom, Liilja, & Aaltomaa, 2011). The timing of the first 
breastfeed is associated with duration of breastfeeding. Bramson and colleagues analyzed data 
from a prospective cohort of 21,842 mother-infant pairs and determined that the longer the 
mother experienced skin-to-skin contact with the infant in the first 3 hours after delivery, the 
more likely she was to be exclusively breastfeeding during her hospital stay (Bramson et al., 
2010) A systemic review of 59 studies found increased breastfeeding initiation rates in hospitals 
that promoted early mother-neonate contact as part of their initiatives (Fairbank et al., 2000). The 
earlier the initiation of the first breastfeed and/or mother-neonate contact, the longer the duration 
of breastfeeding with decreased incidence of early postpartum breastfeeding cessation (Berra et 
al., 2003; Buxton et al., 1991; Salariya et al., 1978). Step 4 of the 10 steps encourages that 
neonates be placed near the breast immediately after birth to initiate a latch-and-feed response, 
preferably within the first hour of delivery (DiGirolamo, Grummer-Strawn, & Fein, 2008; Hung 
& Berg, 2011; Mahmood, Jamal, & Khan, 2011; E. R. Moore et al., 2012; Murray, Ricketts, & 
Dellaport, 2007; Thukral et al., 2012). 
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Neonatal-Maternal Interaction and Infant Neurobehavior 
Early contact between mother and neonate establishes the interaction necessary for 
breastfeeding. Lower neurobehavior scores at birth are associated with slower initiation of 
optimal sucking behavior (Beilin et al., 2005; Chang & Heaman, 2005; Radzyminski, 2005). 
Persistence of neurobehavior disorganization can interfere with development of optimal mother-
infant synchrony necessary for the establishment of sucking and feeding (A. D. Murray, R. M. 
Dolby, R. L. Nation, & D. B. Thomas, 1981; A.D. Murray, R.M. Dolby, R.L. Nation, & D.B. 
Thomas, 1981). If mothers identify their neonate as being too sleepy and unable to latch onto the 
nipple and suck during the first day of life, mothers may perceive their neonate’s disorganized 
behavior as difficult to care for and behave in ways to reinforce and confirm the behavior (A.D. 
Murray et al., 1981). Such factors may result in a vicious circle, preventing good feeding 
behaviors in the first 24 hours of life, which may prompt the mother to quit breastfeeding too 
soon.  
Use of Infant Formula in the Hospital 
Step 6 of the 10 steps says that unless medically necessary no food or drink other than 
breast milk should be given to the newborn. Despite this recommendation, recent data from the 
US Centers for Disease Control and Prevention found that 42% of infants breastfed in US 
hospitals were given supplemental formula (Grummer-Strawn, Scanlon, & Fein, 2008). Many 
birth facilities give formula, water or glucose water as a first feed or as a supplement to breast 
milk (World Health Organization, 1998). In-hospital supplementation has been associated with 
fewer breastfeeds, lower maternal milk supply, and shorter breastfeeding duration (DiGirolamo 
et al., 2008; Grummer-Strawn et al., 2008; Nylander, Lindemann, Helsing, & et al., 1991; 
Semenic, Loiselle, & Gottlieb, 2008). Research has found infants were most likely to receive 
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supplemental formula between 7 pm and 9 am, regardless of time of delivery (Gagnon, Leduc, 
Waghorn, Yang, & Platt, 2005). This study also found that the infants who had a breastfeed on 
the maternity unit were 'protected' from the use of formula up to 10 hours of age (Gagnon et al., 
2005). Despite an early meta-analysis showing the use of infant formula not having a statistically 
significant effect on breastfeeding outcomes (Bernard-Bonnin, Stachtchenko, Girard, & 
Rousseau, 1989), recent studies from the United States, Turkey, and Italy found the use of 
formula during the postpartum hospital period had a negative affect after adjusting for 
confounding factors (Alikasifoglu et al., 2001; DiGirolamo, Grummer-Strawn, & Fein, 2001; 
Riva et al., 1999).  
For US hospitals, the most challenging aspect of fulfilling step 6 is that the BFHI requires 
certified hospitals to abide by provisions of the International Code of Marketing of Breastmilk 
Substitutes to not distribute any commercial materials from formula manufacturers and to pay 
fair market value for formula. Almost all hospitals in the US receive heavily discounted or no-
cost formula directly from manufacturers. Although the practice is decreasing, many hospitals 
also receive formula promotional materials in the form of a “diaper bag” gift to new mothers 
(Sadacharan, Grossman, Sanchez, & Merewood, 2011). These promotional gift packs have been 
shown to lead to decreased rates of exclusive breastfeeding (Howard et al., 2000; Rosenberg, 
Eastham, Kasehagen, & Sandoval, 2008). 
Rooming In 
Neonates who room-in with their mothers have a greater likelihood to be put at the breast 
to suck, leading to more continual breastfeeding and less supplementation. Mothers were able to 
identify feeding cues sooner, and the infants cried less and weighed more after the first week. 
When an infant stayed with the mother 24 hours a day, she produced more milk and her 
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confidence in both parenting and bonding with her infant increased (Bystrova et al., 2007; Keefe, 
1987; Yamauchi & Yamanouchi, 1990b). Infants have a better quality of sleep when they room-
in compared to those in the nursery, and interestingly mothers sleep the same amount of time 
whether they room-in or not, with rooming-in mothers reporting higher scores measuring quality 
of sleep (Keefe, 1987, 1988). 
Studies conducted on rooming-in have not been rigorous in their methods; however the 
practice has been shown to have a positive association with breastfeeding outcomes (Perez-
Escamilla, Segura-Millan, Pollitt, & Dewey, 1992; Scott, Landers, Hughes, & Binns, 2001) with 
even partial rooming-in having a positive influence (Buxton et al., 1991).  
Breastfeeding on Demand 
It is now accepted that fixed or set breastfeeding schedules lead to insufficient milk supply 
and breastfeeding problems. BFHI acknowledges that breastfeeding does not occur at scheduled 
time points and places no restriction on the amount or duration of breastfeeding. Allowing a 
neonate unrestricted breastfeeding allows them to self-regulate their own feedings by indicating 
their readiness. A recent study examined the volume and fat content of breast milk over a 24 
hour period and found there is variation in feeding patterns between infants and from day to day 
(Kent et al., 2006). Unrestricted breastfeeding increased volume of milk intake on day 3, 
lactogenesis occurred earlier, meconium passed earlier, neonates glucose levels stabilized, higher 
weight nadir day 3-4 with increases in the rate of weight gain, less supplementation, and lower 
rates of hyperbilirubinemia (De Carvalho, Klaus, & Merkatz, 1982; De Carvalho, Robertson, 
Friedman, & Klaus, 1983; Hawdon, Ward Platt, & Aynsley-Green, 1992; Yamauchi & 
Yamanouchi, 1990a). Increased breastfeeding frequency was also shown to decrease breast 
soreness, nipple pain, and engorgement (Hill & Humenick, 1996).  
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Rooming-in from birth enables and encourages mothers to pursue a baby-led demand 
feeding schedule and allow them to successfully initiate breastfeeding. 
Breastfeeding Support 
Women may need breastfeeding support from healthcare providers in the immediate 
postpartum in assisting the mother to position and attach their babies at the breast. In a study 
using focus groups to determine factors mothers felt contributed to their decision to wean early, 
the dominant themes that emerged were overworked nurses or lack of nurses, lack of skill of 
nursing staff to assist with breastfeeding and getting the infant to latch on, conflicting advice, 
lack of privacy, and noise (Vogel & Mitchell, 1998). The main problem the women identified 
was that the infant was unable to latch on and suck. The mothers attributed this to the lack of 
nurse's skill.  
Another study reported five variables associated with breastfeeding success and duration. 
They included the time of breastfeeding initiation, the mother’s experience of breastfeeding 
during her hospitalization, whether the mother was upset with her hospital stay, the attitudes of 
the professional staff and her significant other about her decision to breastfeed, and the 
availability of help from the nursing staff to breastfeed (Tarkka et al., 1998). The main source of 
the mother’s unhappiness was the infant’s inability to latch on and feed. When the staff was 
unable or unavailable to remedy the situation, her ability to cope decreased and she became 
unhappy with her hospital care. She was more likely to quite breastfeeding if she was coping 
poorly. 
The primary cause of sore nipples is thought to be due to incorrect breastfeeding 
mechanics, such as improper positioning, dysfunctional or disorganized sucking, improper latch 
or failure of the infant to form a teat, i.e., the ability of the infant to draw the nipple and part of 
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the areola into the mouth (Righard, 1998; Righard & Alade, 1992; Tait, 2000; Walker, 2007). 
Limiting the time at breast has no effect on nipple soreness, but correct latch and position are 
crucial. It is important to address the nipple pain and implement corrective action as up to a third 
of these mothers will switch to formula feeding postpartum (Briggs, 2003). Many women are 
surprised and the intensity and extent of the pain they experience which can result in unwanted 
rejection toward the infant, inability to trust their body and early cessation of breastfeeding 
(Kelleher, 2006). 
Maternal Satisfaction with Breastfeeding 
Maternal dissatisfaction with breastfeeding may lead to early cessation. The top reasons 
that a mother stops breastfeeding in the early postpartum is her perception that her infant is not 
satisfied by her breast milk alone (Li, Fein, Chen, & Grummer-Strawn, 2008; Murray et al., 
2007), concern she is not producing enough milk (Murray et al., 2007), and nipple pain 
(Morland-Schultz & Hill, 2005). In another study (O'Leary, Kopsell, & Haller, 1997), the main 
reasons for formula supplementation was the mother’s perception that she did not have enough 
milk, and the formula was easier to give. A further study similarly reported that the main reasons 
mothers supplemented with formula was the perceived inadequacy of their milk supply, sore 
nipples, frequency of night feedings, and the baby's preference for formula (Chapman & Perez-
Escamilla, 1999). Upon further analysis of these themes, the mothers determined that lack of 
milk supply was related to infant behaviors such as fussiness, slow weight gain, rashes, and the 
infant's rapid consumption of formula with sound sleep afterwards, whereas when breastfed, the 
infants were fussy and discontented.  
Consistently reported as a reason of early of weaning is insufficient milk supply (Meedya, 
Fahy, & Kable, 2010; Thulier & Mercer, 2009). Despite the fact 50% of women report they 
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perceive their milk supply to be insufficient, only 5% actually suffer from a physiological 
insufficient milk supply (Meedya et al., 2010; Thulier & Mercer, 2009). Many women 
supplement with infant formula in response to their perception of having insufficient milk 
supply. The reduction in demand for the breast milk decreases the maternal supply, multiplying 
the problem. There is a strong psychological component to this biologically factor as perception 
of insufficient milk supply is associated with low maternal self-efficacy for breastfeeding 
(Meedya et al., 2010). 
Specific infant behaviors valued by the mother have been linked to maternal satisfaction 
(Vandiver, 1997). Fifty primigravida who had given birth to term healthy infants completed 
questionnaires on infant temperament, caregiver flexibility, and their perception of breastfeeding 
in their third trimester and then again when their infants were 12 weeks old. Thirty of the 
mothers were additionally watched in their homes for 2 hours while interacting with their infants 
at 2, 6, and 12 weeks postpartum. Significantly longer duration of breastfeeding was correlated 
with higher rates of mothers’ interactive behaviors with their infants and their perception that the 
infants had an easy temperament.  
This led researchers to examine the relationship between infant fussiness, discontent 
behavior and poor weight gain, and the mother’s perception of poor milk supply and sore 
nipples. Two researchers independently concluded that it was correct infant position and sucking 
of the breast that avoided the majority of problems that led to early breastfeeding cessation 
(Fisher, 1981; K. B. Frantz & Fleiss, 1980). They determined that the infant had an oral search 
reflex which is stimulated when the lips are close to the nipple. The reflex allows correct sucking 
at the breast which they defined as the infants mouth is wide open, tongue under the areola with 
the milk expressing in slow deep sucks. The determined manipulation of the nipple into the 
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infant’s mouth led to faulty sucking, and once the infant learned faulty sucking, it was 
problematic to retrain the infant to suck correctly at the breast. The introduction of artificial 
nipples on formula supplement bottles or pacifiers contributed to the infant learning faulty 
sucking technique (Fisher, 1981; K. B. Frantz & Fleiss, 1980).  
Maternal self-efficacy in the prenatal period has been examined in relation to breastfeeding 
outcomes. A longitudinal study conducted in the United States evaluated 64 minority women 2 
months postpartum (Ertem, Votto, & Leventhal, 2001). The women who during the prenatal 
period were not confident about breastfeeding were 12 times more likely to stop breastfeeding 
than those who were confident. Lack of confidence in breastfeeding was associated with 
mothers’ perception of insufficient milk supply, which led to a decrease in breastfeeding and an 
increase in formula supplementation (Dennis, 2002). In another study, lower breastfeeding rates 
were found at 6 weeks postpartum in women who perceived their milk production to be 
insufficient who also scored lower on maternal confidence (Hill & Humenick, 1996). 
Maternal Perception of Infant Behavior 
Breastfeeding requires mother and infant fully participate in an interactive process each 
learning to fulfill their new roles. The maternal task of initiating and facilitating breastfeeding 
has been recognized. However, it has only recently been acknowledged that the infant plays a 
part in this process. Research in past decades established that newborns are interactive, proactive 
and individualized in their reaction to the world (Klaus & Klaus, 1998). 
Studies of mother-infant interaction have highlighted the role of infants perceptual, 
communicative, and interactive competency (Brazelton, Cramer, Kreisler, Schappi, & Soule, 
1983). The bi-directionality of the mother-infant interaction is characterized by synchrony and 
reciprocity (Tronick & Cohn, 1989). The infant’s behavior is not only influenced by the mother 
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but it may also affect the mother’s behavior. In this way, the infant’s signals may affect the 
quantity and quality of caregiver exchanges (Mazet & Stoleru, 1993). If this interaction is 
interrupted due to the direct effects of epidural medication, and the baby is less alert, less able to 
orient, and less able to show organized movement, this may interfere with the mother-infant 
relationship (A.D. Murray et al., 1981; Sepkoski, Lester, Ostheimer, & Brazelton, 1992). 
Research has demonstrated how these infant behaviors are useful for breastfeeding. 
Mothers appear to associate certain infant behaviors with satisfaction with breastfeeding. In one 
study (Lothian, 1995), a group of mothers who—regardless of support, motivation or intent—
continued breastfeeding only if they believed their newborn was satisfied and “attached easily, 
sucked well and appeared content” (p.333). In related studies, maternal satisfaction with 
breastfeeding was associated with competent infant feeding behaviors (Matthews, 1991), and an 
infant demonstrating attachment behaviors (Brandt, Andrews, & Kvale, 1998). Both of these 
studies established satisfied infants breastfed longer than an infant perceived to be unsatisfied. 
Descriptions of their newborn’s satisfaction by the mother were related to behavioral state 
organization. The behaviors described included the infants’ ability to come to a quiet alert state 
(Brandt et al., 1998), calm themselves (Leff et al., 1994; Lothian, 1995), make eye contact and 
maintain a mutual gaze with the mother (Lavelli & Poli, 1998) and exhibit cuddliness and 
consolability without irritability (R. B. Hughes, Townsend, & Branum, 1988; Karl, 2004). 
Infants who were able to organize their behavioral states breastfed more effectively and for a 
longer duration than those who were not (R. B. Hughes et al., 1988; Lothian, 1995). The early 
infant behaviors at the breast may affect the mother’s decision to continue to breastfeed based on 
the mother’s perception of whether or not her infant enjoys breastfeeding. 
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Demographic and Socioeconomic Factors 
A number of demographic and socioeconomic factors may decrease incidence and duration 
of breastfeeding. Such factors include returning to work (Brand, Kothari, & Stark, 2011; 
Johnston & Esposito, 2007), lack of social support (Brand et al., 2011), racial minority, level of 
education high school or less (Chin, Myers, & Magnus, 2008), low socioeconomic status (Chin 
et al., 2008), parity (Lind, Perrine, & Ruowei, 2014), marital status (Lind et al., 2014), biological 
and physiological conditions (Chin et al., 2008), and smoking (Lind et al., 2014). Research has 
shown that mothers who are married (Avery, Duckett, Dodgson, Savik, & Henly, 1998), are 
older than age 30 years (Bolton, Chow, Benton, & Olson, 2009; Brand et al., 2011), have a high 
income (Avery et al., 1998; Dennis, 2002), and are well educated (Avery et al., 1998; Haas et al., 
2006; Wen, Baur, Rissel, Alperstein, & Simpson, 2009) had higher incidence of breastfeeding 
initiation and duration. Elevated maternal body mass index was also found to negatively 
influence the initiation, intention, and duration of breastfeeding significantly (Guelinckx, 
Devlieger, Bogaerts, Pauwels, & Vansant, 2012).  
Infant’s Ability to Latch and Suck 
In order for the infant to effectively breastfeed, the infant must be correctly positioned at 
the breast to stimulate the neonate’s oral searching reflex. While mothers must develop the skills 
for successful breastfeeding, the infant is born with two specific innate reflexes to assist him in 
taking in the nutrients required for survival. The first of these is the rooting reflex, which is 
initiated by the mother. The rooting reflex has two components (1) tactile stimulation of the skin 
around the infant’s mouth will cause the infant to turn his head in that direction and (2) his 
mouth gapes in preparation of the nipple (Woolridge, 1986). When the infant’s mouth gapes, the 
mother must take the initiative to bring infant and breast together so that the second reflex—the 
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sucking reflex—can be elicited (Woolridge, 1986). The infant should be supported to open the 
tongue wide, thrust the tongue forward to take the breast, then with the tongue under the areola 
express milk from the breast with deep slow sucks (Righard, 1998; Righard & Alade, 1992). The 
nipple and surrounding breast tissue is drawn into a teat by suction created in the infant’s mouth. 
The teat is 3 times as long as the nipple is at rest, and extends back into the infants mouth to the 
junction between the soft and hard palates (Ardran et al., 1958). At its base it is held between the 
upper gum and the tongue, which covers the lower tongue (Woolridge, 1986). The lateral 
margins of the tongue cup around the nipple crating a central trough in which the nipple lies 
(Weber et al., 1986). Milk is expressed from lactiferous sinuses and is propelled toward the back 
of the mouth by a posterior directed peristaltic action of the tongue (Ardran et al., 1958; Weber 
et al., 1986). The cycle of sucking is initiated by an upward curving of the anterior tongue, 
followed closely by pressure from the lower gum caused by elevation of the jaw (Woolridge, 
1986). The raising of the tongue continues to move the milk into the pharynx. If the volume of 
milk is sufficient to trigger swallowing, the soft palate rises and closes off the nasal cavity. The 
larynx, which separates the trachea from the esophagus, moves up to close the trachea, which is 
aided by a downward movement of the epiglottis resulting from pressure from the fluid bolus 
and rear portion of the tongue (Woolridge, 1986). The pharyngeal space is progressively reduced 
until it is obliterated propelling the milk into the esophagus (Logan & Bosma, 1967).   
There are two features of normal sucking that deserve a closer look because their 
disturbance can lead to sore nipples. The first is that normal sucking is devoid of frictional 
movement. If a significant amount of breast tissue has been formed into a “teat,” then there 
should be very little movement of the teat in and out of the infant’s mouth; there should be a 
unidirectional exchange of milk into the infant’s mouth (Woolridge, 1986). Thus, there should be 
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minimal friction from the tongue and gums against the skin of the breast. This picture is 
consistent with reports made by cineradiographic and ultrasound observation (Ardran et al., 
1958; W. Smith, Erenbery, Nowak, & Franken, 1985; Weber et al., 1986). The second feature is 
that the application of positive pressure on the nipple by the tongue surface is the primary force 
in evacuating milk from the nipple and into the esophagus.  
The infant also generates a negative pressure in his mouth during the process of milk 
removal. The role of negative pressure has not been determined, but the two most likely 
functions are 1) to retain the nipple and breast in the mouth in the correct position (countering 
the natural retractile nature of the tissue), thereby retaining the teat shape of the nipple and breast 
tissue; and 2) to aid in the refilling of the nipple by sinuses and ducts (Woolridge, 1986). 
Evidence for the former suggestion can be seen in Ardran’s cineradiographic films (Ardran et al., 
1958). 
Survival of the newborn is reliant on establishing effective feeding. Effective and efficient 
feeding requires coordination of breathing with sucking and swallowing and involves the 
functional interaction of lips, jaw, palate, tongue, larynx, pharynx, and esophagus (Bu'Lock et 
al., 1990; A. Miller, 1982). To accomplish this, the neonate uses cerebral and brainstem 
structures, 6 of the 12 cranial nerves (V, VII, IX, X, XI, and XII), 22 bones connecting at 34 
sutures, and 60 voluntary and involuntary muscles in a process that occurs at 40 to 60 cycles/per 
minute, 10-30 minutes at a time, 8-16 times a day (Smyth, Alldred, & Markham, 2007). 
Newborns must have oropharyngeal muscle patterns with the coordination and strength to obtain 
milk from the breast, as well as the psychomotor ability to cue that they are ready to feed (L. 
Smith, 2010). The muscles that control the sucking, opening and closing of the mouth during 
breastfeeding are innervated by motor fibers. If compromised, this may interfere with the 
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neonate’s ability to root, latch, and suck adequately (L. Smith, 2010). An intact CNS is essential 
for the infant to physiologically latch and feed (Radzyminski, 2005). 
Methods for Assessment of Breastfeeding  
Very few studies have used an objective breastfeeding assessment scoring tool (J. J. 
Henderson, Dickinson, Evans, McDonald, & Paech, 2003; Volmanen, Valanne, & Alahuhta, 
2004; Wiklund, Norman, Uvnas-Moberg, Ransjo-Arvidson, & Andolf, 2009; Wilson et al., 
2010). There is no standardized method to assess the breastfeeding encounter, but several tools 
have been developed for breastfeeding assessment. These include the LATCH scoring system, 
Infant Breastfeeding Assessment Tool (IBFAT), and the Mother Baby Assessment Tool (MBA). 
The LATCH scoring system (D. Jensen et al., 1994) is used extensively by nurses at birthing 
centers and hospitals and is the breastfeeding assessment tool used at Yale New Haven Hospital 
(YNHH). It has been used by researchers (Baumgarder, Muehl, Fischer, & Pribbenow, 2003b; 
Chang & Heaman, 2005) in their assessment of the effects of labor analgesia on breastfeeding 
and was used for the current study. LATCH is a breastfeeding charting system that assesses 
individual breastfeeding sessions using a systemic model to gather information (D. Jensen et al., 
1994). The LATCH score includes all aspects of latching behavior by providing a score of 0, 1, 
or 2 for key components of breastfeeding. L= is the infants ability to latch onto the breast, A= is 
the audible sound of swallowing, T=Type of nipple the mother has, C= Comfort of the mothers 
breast and nipple, H=Holding which is the amount of assistance the mother needs to hold the 
neonate. To obtain the score all the areas of assessment are added to get a total for that 
breastfeeding session. For example a mother with previous breastfeeding experience, everted 
nipple, and an alert and vigorous infant could get a score of 9 or 10 (D. Jensen et al., 1994). 
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Successful breastfeeding defined by LATCH is a score >7 at two feeds in 24 hours (Baumgarder 
et al., 2003b; Bramson et al., 2010). 
The interrater reliability of the LATCH tool was high and ranged from 85.7%-100% and 
strong construct validity (Adams & Hewell, 1997; J. M. Riordan & Koehn, 1997). Riorden and 
Koehn (1997) found a significant correlation between nurses’ and mothers’ assessment scores, 
and both assessment scores positively correlated with duration of breastfeeding. These findings 
support previous research that assessed the validity and reliability of LATCH tool (Adams & 
Hewell, 1997; Matthews, 1988). Matthews (1988) found interrater reliability between raters’ 
scores and mothers’ scores to be 91%. A more recent study (Altuntas et al., 2014) found positive 
and significant correlations between researchers' scores for 46 observations using the IBFAT, 
MBA, and LATCH. They reported that all three assessment tools were compatible in the 
assessment of breastfeeding performance.  
Methods for Assessing Infant Well-being  
One of the primary concerns of obstetrical anesthesia is neonatal well-being. The greatest 
challenge for researchers has been how to accurately measure neurobehavior. Clinical and 
laboratory measurement scales, including Apgar scores (Apgar, 1953), umbilical blood venous 
and arterial acid-base balance analysis (Bax & Nelson, 1993), and neonatal neurobehavioral 
testing scales have been developed to assess neonatal well-being (Als, Tronick, Lester, & 
Brazelton, 1977). 
Apgar Scores 
Early studies used Apgar scores at 1 and 5 minutes, cord blood pH, and respiratory 
depression to evaluate the effects of epidural analgesia on the neonate. Whereas these tests 
evaluate depression of vital function, they are not sensitive to the subtle differences in neonatal 
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neurobehavior, such as variation in muscle tone, motor movements, and sleep cycles, which may 
be differentially influenced by narcotics, resulting in impairment of the neonate’s ability to 
breastfeed effectively.  
Nearly every infant born in the developed world is assigned an Apgar at 1 and 5 minutes 
with virtually all studies on epidural analgesia and neonatal outcomes including Apgar scores. Dr 
Virginia Apgar, an anesthesiologist, developed a scoring system in 1952 to rapidly assess the 
status of the newborn after delivery and the need for prompt intervention to establish breathing 
(Apgar, 1953). The Apgar score is comprised of five components: Heartrate, respiratory effort, 
muscle tone, reflex irritability, and color, each of which is given a score of 0, 1, or 2. The score is 
reported at 1 and 5 minutes after birth, and higher scores indicate optimal condition of the 
neonate in the transition to extrauterine life. 
Apgar and her team established the relationship between blood gas data and Apgar scores, 
verifying that newborns with low scores were acidotic and hypoxic and needed treatment. Once 
the mechanism of low Apgar scores was understood, she then applied them to assess labor, 
delivery, and the effects of anesthetics given to the mother on the baby. She and her colleagues 
demonstrated that cyclopropane, which was commonly used for cesarean and vaginal deliveries 
at that time, caused depression of babies and low Apgar scores when given to the mother. On the 
basis of their data, they concluded that epidural analgesia provided the best outcomes for mother 
and newborn (Apgar, Holaday, James, Prince, & Weisbrot, 1957), starting the trend toward 
regional anesthesia in obstetrics.  
The 5 minute Apgar score has been shown to be more predictive of survival than the 1 
minute score (Apgar, 1966; Drage, Kennedy, & Schwarz, 1964). A report from the Collaborative 
Study of Cerebral Palsy, which involved 17,221 babies at 13 institutions, showed that the Apgar 
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score, especially the 5-minute score could predict neonatal survival and neurologic development 
(Drage et al., 1964). Several large cohort studies since then have documented that a 5-minute 
score <7 is associated with increased risk of neonatal death (Casey, McIntire, & Leveno, 2001; 
Moster, Lie, Irgens, Bjerkedal, & Markestad, 2001; Nelson & Ellenberg, 1981; Thorngren-
Jerneck & Herbst, 2001) and cerebral palsy in term infants (Drage, Kennedy, Berendes, Schwarz, 
& Weiss, 1966; Thorngren-Jerneck & Herbst, 2001). This is significant because labor epidural 
analgesia administered to the mother has been shown to produce a mild but significant decrease 
in Apgar scores at 1 and 5 minutes (Greenwell et al., 2012; Herrera-Gomez et al., 2015). In a 
population study of 1 million term births in Sweden (Thorngren-Jerneck & Herbst, 2001), 
epidural analgesia was found to be a risk factor for Apgar scores <7, along with several other 
obstetric risk factors. The authors concluded that 5-minute Apgar scores <7 are associated with 
an increased risk of neonatal morbidity, infant mortality, and neurologic impairment (Thorngren-
Jerneck & Herbst, 2001).  
Neonatal Neurobehavior Tests 
Neonatal neurobehavior scales describe the individual infants’ autonomic, motor, state, and 
social-attentional systems as they interact with each other and become integrated, how the 
neonate is affected by environmental factors, and what the neonate contributes to the 
development of the emerging parent-child relationship (Brazelton & Nugent, 2011). Such tests 
can assess the neonatal depressant effects of drugs given to the mother intrapartum. Various 
neurobehavioral tests have been designed to capture these subtle aspects the Apgar score cannot 
detect. Three assessment tools have been used to examine the association between epidural 
analgesia and neonatal behavior: the Brazelton Neonatal Assessment Scale (NBAS) (Brazelton, 
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1973), the Scanlon Early Neonatal Neurobehavioral Scale (ENNS) (Scanlon, Brown, Weiss, & 
Alper, 1974), and the NACS (Amiel-Tison et al., 1982b). 
The NBAS, which takes the longest to administer (30-45 min) and requires significant 
training to carry out, has been described as the most comprehensive neonatal neurobehavior 
examination (Kuhnert, Linn, et al., 1985).  
The ENNS was developed by an anesthesiologist to examine neurobehavioral changes that 
occur with anesthetic drugs. The test takes 10 minutes to perform and places more emphasis on 
muscle tone, reflexes and decrement to stimulation than the NBAS because it is believed these 
would be most affected by anesthesia drugs (Kuhnert, Linn, et al., 1985). It covers many of the 
same areas as the NBAS, including assessment of state and interaction so it provides a general 
evaluation. 
The NACS was specifically designed to detect CNS depression of the neonate from drugs 
and to differentiate those effects from birth trauma and perinatal asphyxia (Amiel-Tison et al., 
1982a, 1982b). This test does not specifically assess breastfeeding but uses 20 criteria to assess 5 
general areas: adaptive capacity, passive tone, active tone, primary reflexes, and general 
neurologic status (Amiel-Tison et al., 1982b). The NACS was proposed as a simple, noninvasive, 
5 minute neurobehavior exam to assess subtle effects of drugs and distinguish drug effects from 
birth trauma. No special training is required to perform the NACS. It has been widely embraced 
by the obstetrical anesthesia community and is used worldwide, despite criticism of its reliability 
and validity (Brockhurst, Littleford, Halpern, & Fisher, 2000; M. D. W. Camann & Brazelton, 
2000) and its ability to differentiate effects among different drugs (Kuhnert, Linn, et al., 1985).  
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Labor Pain 
Pathophysiology of Childbirth Pain 
To understand the nature of labor pain it starts with understanding how nociceptive stimuli 
that is centrally received by the parturient called pain. During the first stage of labor dilation) 
visceral pain predominates, with pain (nociceptive) stimuli arising from mechanical distention of 
the lower uterine segment and cervical dilation (McDonald, 2001; Ward, 1997). High-threshold 
mechanoreceptors in the myometrium may also generate nociceptive stimuli in response to 
uterine contractions, particularly in long protracted labors (Faure, 1991). The increasing intensity 
of pain commonly observed in the progression of dilation may be partially attributed to lower 
activation threshold in the mechanoreceptors, and to chemoreceptor stimulation produced by the 
repeated stimulation of uterine contractions (Bonica & McDonald, 1990; Brownridge, 1995). 
These nociceptive stimuli of the dilation phase are predominately transmitted to the posterior 
root ganglia at T 10 through L1 (McDonald, 2001; Ward, 1997). Similar to other types of 
visceral pain, labor pain may be progressively referred to the abdominal wall, lumbosacral 
region, iliac crests, gluteal areas and thighs (McDonald, 2001). Although virtually all laboring 
women experience lower abdominal pain during contractions, 15-74% may also experience 
contraction-related low back pain, which for some is continuous even between contractions 
(Labrecque, Nouwen, Bergeron, & Rancourt, 1999; Melzack & Schaffelberg, 1987). Some 
women experience very widespread and diffuse pain sensations, whereas others feel very 
localized pain in specific well defined areas (Melzack, Kinch, Dobkin, Lebrun, & Taenzer, 
1984). As the pelvic or descent phase of labor advances (first stage and second stage), somatic 
pain predominates from distention and traction on pelvic structures surrounding the vaginal vault 
and from distention of the pelvic floor and perineum. Sharp and generally well localized, these 
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stimuli are transmitted via the pudendal nerve through the anterior rami of S2 through S4 
(McDonald, 2001; Ward, 1997). 
In the dorsal horn of the spinal cord, the nociceptive stimuli are processed and transmitted 
via the spinothalamic tract to the thalamus, brain stem, and cerebellum, where spatial and 
temporal analysis occurs, and to the hypothalamic and limbic systems where emotion (affect) 
and autonomic responses originate (Terman & Bonica, 2000). At the level of the dorsal horn, 
motor and sympathetic relax activity is stimulated, and modulation of nociceptive impulse 
transmission may occur through several complex inhibitory systems activated at many 
supraspinal levels of the CNS. 
Knowledge of the anatomy of labor pain defines the current treatments of labor pain with 
epidural analgesia. The visceral pain of the first stage of labor and sacral somatic pain caused by 
descent of the fetus in the birth canal can be completely blocked by epidural analgesia, resulting 
in decreased maternal stress response.  
The local anesthetics widely used in labor epidurals work by blocking voltage-gated 
sodium channels preventing conduction of an action potential in afferent C and A delta fibers 
(Lirk, Picardi, & Hollmann, 2014). During the first stage of labor unmyelinated C fibers transmit 
slow, dull, poorly localized, visceral pain. Myelinated A delta fibers transmit the rapid, sharp 
well localized somatic pain seen in the second stage of labor. Spinal opioid receptors are 
positioned to modulate noxious afferent input in the central/spinal axis. Opioids work on the 
dorsal horn of the spinal cord, binding with mu, delta, and kappa opioid receptors, causing G-
coupled proteins to activate, and inhibiting the release of Ca++, and K channels. Activation of 
the kappa receptor directly inhibits the release of substance P, by blocking Ca++ influx required 
for transmitter release at primary afferent terminals. Mu and delta receptors are coupled to 
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voltage-dependent K channels and inhibit depolarization of the nerve. Central/ spinal pain 
modulation occurs by inhibiting excitatory neurotransmitters such as glutamate and substance P, 
from presynaptic afferent nerve terminals that ascend the spinal cord to the brain. 
Physical and Psychological Factors Affecting Perception of Pain 
The severity and duration of labor pain and suffering are influenced by a number of 
physical and psychological factors. Physical factors such as maternal age and parity, maternal 
condition, condition of the cervix at the onset of labor, and the relationship of the size and 
position of the fetus to the size of the birth canal (Sheiner, Sheiner, & Shoham-Vardi, 1998). 
Many of these factors are interrelated. Generally, older nulliparas experience longer and more 
painful labors than younger nulliparas (Melzack et al., 1984). The parous cervix begins to soften 
before the onset of labor and is less sensitive than the nullipara cervix. The intensity of uterine 
contractions in early labor tends to be greater in nulliparas than parous women, whereas the 
reverse is true as labor progresses (Wong, 2009).  Dystocia caused by a contracted pelvis, a large 
baby, or abnormal presentation or position is likely to cause more pain. Women who go on to 
have a cesarean delivery after labor have more breakthrough pain during epidural analgesia and 
require higher opioid doses during systemic analgesia than women who deliver vaginally 
(Alexander, McIntire, & Leveno, 2001; Hess, Pratt, Soni, Sarna, & Oriol, 2000). A history of 
dysmenorrhea, maternal fatigue, and general debility are associated with higher levels of pain 
(Melzack, 1984). 
Psychological factors, including fear, apprehension, and anxiety, and the presence of 
family members or birthing companions, also influence pain and suffering during childbirth 
(Henneborn & Cogan, 1975; Kennell, Klaus, McGrath, Robertson, & Hinkley, 1991; Lang, 
Sorrell, Rodgers, & Lebeck, 2006). Education, intense motivation, and cultural factors influence 
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the affective and behavioral dimensions of pain, although they probably affect actual pain 
sensation minimally. For example, Bonica observed that women who had predelivery training in 
psychoprophylaxis manifested little or no pain behavior during childbirth, although when 
questioned the next day, most of them indicated the process had been quite painful (Bonica, 
1969). 
Labor Pain and Its Effects on Mother and Fetus 
During the first stage of unmodified labor, maternal respiration increases by 75-100% 
(Hagerdal, Morgan, Sumner, & Gutsche, 1983). Maternal hyperventilation in response to pain 
has long been known to have negative effects on the fetus (Huch, 1986; Motoyama, Rivard, 
Acheson, & Cook, 1966). This leads to hypocarbia and respiratory alkalosis, which can disrupt 
placental transfer of oxygen (Reynolds, 2010). A compensatory metabolic acidosis becomes 
progressively more severe as labor advances, and is conveyed to the fetus (Thalme, Belfrage, & 
Raabe, 1974). Episodes of hypoventilation that occur between contractions lead to oxygen 
desaturation (Minnich, Brown, Clark, Miller, & Thompson, 1990). Maternal hyperventilation 
causes vasoconstriction which affect the uterine arteries (Huch, 1986). There is a shift in the 
oxygen disassociation curve. It was demonstrated years ago in sheep that maternal 
hyperventilation resulted in reduced oxygen content in umbilical venous blood, and restoring the 
carbon dioxide to normal reversed this effect (Levinson, Shnider, DeLorimier, & Steffenson, 
1974).  The adverse effects of hypocarbia at first were harder to demonstrate in humans (Huch, 
1986). However, a reversal of this phenomenon could explain the reduction of metabolic acidosis 
seen in regional anesthesia. Maternal hyperventilation lowers the partial pressure of carbon 
dioxide (pCO2) of the umbilical artery, but as labor progresses this change is overcome by an 
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increased severity of metabolic acidosis to the extent that the longer the second stage of labor 
(pushing to delivery) the lower the cord pH will be at birth (Pearson & Davies, 1974b). 
Maternal stress and pain adversely affect the fetus. The stress of labor also leads to the 
release of maternal cortisol and catecholamines and prolongs labor (Lederman, Lederman, Work, 
& McCann, 1978; J. Moore, 1993; Myers, 1975). Painful labor activates the stress response with 
release of β lipotropin and ACTH thus β endorphin and cortisol with the βendorphin having very 
little analgesic effect. The increased sympathetic/ adrenal activity can lead to uncoordinated 
uterine movement and decreased uteroplacental perfusion (Loo & Irestedt, 2000). The metabolic 
outcome of the stress response is hyperglycemia with poor insulin response, lipolysis with 
release of free fatty acids, ketones and lactate (Reynolds, 2010). Catecholamines, along with the 
metabolic acids, readily cross the placenta, increasing the oxygen requirement of the fetus, 
another outcome of maternal metabolic acidosis compounded in the fetus (Thalme et al., 1974).  
Although the maternal stress response is relatively counterproductive, it can be suppressed 
by epidural analgesia. In contrast, the fetal stress response is beneficial for adaptation to 
extrauterine life and is not suppressed by maternal epidural analgesia (Irestedt, 1993; Westgren 
et al., 1986). Particularly during the second stage (complete cervical dilation to delivery of 
neonate), labor induces a massive catecholamine (epinephrine and norepinephrine) surge in the 
fetus, which helps to preserve blood flow to brain, heart, and adrenals and to promote postnatal 
adaptive circulatory changes and surfactant release (Reynolds, 2010).  
The amount of pain a woman feels when she is in labor is influenced by a number of 
physical factors, including oxytocin augmentation, dysfunction of labor, and the duration and 
progress of the labor. Women experience pain in a variety of ways, and the way a woman copes 
with the pain is influenced by psychological and environmental factors, the circumstance of her 
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labor, her cultural background, the support available to her, and her preparation for labor (Anim-
Somuah et al., 2011). Suffering during labor can have a negative effect on her psychologically, 
lead to labor dysfunction and postpartum depression which all can influence breastfeeding 
negatively (Montgomery et al., 2012). The overwhelming physiologic stress in labor experienced 
by the mother can cause physiologic stress to the fetus which may affect breastfeeding initiation 
at birth (Montgomery et al., 2012). 
Labor induces a massive catecholamine (epinephrine and norepinephrine) surge in the 
fetus, particularly in the second stage, which helps to preserve blood flow to brain, heart, and 
adrenals and to promote postnatal adaptive circulatory changes and surfactant release (Reynolds, 
2010). Although this stress response is advantageous to the fetus, unmedicated labor produces 
maternal physiological changes that can affect the fetus adversely. Maternal hyperventilation in 
response to pain has long been known to have negative effects on the fetus (Hutch, 1986; 
Motoyama et al., 1966). This leads to respiratory alkalosis and a left shift in the oxygen 
disassociation curve which can disrupt placental transfer of oxygen (Reynolds, 2010). A 
compensatory metabolic acidosis, which becomes progressively more severe as labor advances 
and is conveyed to the fetus (Thalme et al., 1974), episodes of hypoventilation between 
contractions leading to oxygen desaturation (Minnich et al., 1990) and uterine vasoconstriction 
(Hutch, 1986). Additionally the stress of labor also leads to the release of maternal cortisol and 
catecholamine's, which may prolong labor and impair placental flow (Lederman et al., 1978; 
Ohno et al., 1986; Segal & Wang, 2008). Stress hormones also bring about lipolysis (with release 
of free fatty acids that readily cross the placenta) and hyperglycemia, which exacerbate fetal 
hypoxia (Reynolds, 2010). All these changes tend to intensify fetal metabolic acidosis which 
becomes progressively worse as labor progresses (Thalme et al., 1974). 
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History of Labor Analgesia 
On January 19, 1847, James Young Simpson used diethyl ether to anesthetize a woman 
with a deformed pelvis for delivery of her child. The era of obstetrical anesthesia had begun. 
Simpson was highly criticized for his etherization of childbirth. The medical community, 
including obstetricians, believed that uterine pain was inseparable from contractions, and any 
drug that abolishes pain would alter contractions (Caton, 2014). Clergy argued that childbirth 
pain is God’s punishment to Eve and her descendents for disobedience in the garden of Eden, 
and it was wrong to avoid the pain of divine punishment (Caton, 2014).  The controversies 
continued until 1853 when John Snow administered chloroform to Queen Victoria during the 
birth of her 8th child, Prince Leopold. Queen Victoria's decision to use an anesthetic during labor 
shattered the clergy’s argument and empowered women. Women lost their skepticism, 
announced they wanted anesthesia, and essentially forced their physicians to provide it to them. 
By 1860, because of the demands of women, anesthesia for childbirth became part of medical 
practice. Physicians used obstetric anesthesia sparingly until the early twentieth century, when 
suffragettes recognized that they could not participate fully in the economic and political life of 
the country unless they were healthy. For this reason they made obstetric care, including 
anesthesia, part of their campaign for political party (Caton, 2014). 
Early feminists had a good reason to be concerned about obstetric care. Despite many 
improvements to medicine, maternal morbidity and mortality hardly changed between 1830 and 
1930. Women were debilitated by the sequelae of poorly managed deliveries and exhausted by 
frequent pregnancies and management of large families. Accordingly feminists sought care by 
obstetricians rather than midwives, deliveries in hospitals rather than at home, and adequate time 
for recuperation before returning to their normal responsibilities (Caton, 2014).  
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They also campaigned for obstetric anesthesia. Feminists and physicians alike believed 
that the pain of childbirth, in and of itself, contributed to the disability of women later in life. To 
improve the quality and availability of anesthesia, feminists founded two organizations. The 
National Twilight Sleep Association began in the US just before the beginning of World War I, 
and The National Birthday Trust Fund started in Great Britain in 1928. Both organizations 
influenced the practice of obstetric anesthesia. Physicians explored new ways to manage labor 
pain, including use of rectal ether and intravenous opioids. They also performed many important 
studies on the use of regional anesthesia (Caton, 2014).  
A major development in obstetric anesthesia occurred around 1910 with the development 
of Dämmerschlaff or “twilight sleep.” It combined opioids and scopolamine to make women 
amnestic and provide some comfort during labor while they remained awake. However, it left the 
women disoriented and uncoordinated where they were no longer actively involved in the birth 
of their infant. Recovery was long after these medications, preventing mothers from caring for 
their infants. Hence, they were taken to the nursery and cared for by nurses. The infants would 
subsequently be fed formula. The period from 1860 through 1940 was referred to as the “dark 
ages of obstetric anesthesia and analgesia,” with minimal progress in obstetric analgesia and 
anesthesia (Bonica, 1995). The introduction of regional anesthesia would be the next major 
change in obstetric anesthesia. 
In 1885, Leonard Corning, a new York neurologists inadvertently performed the first 
epidural analgesia by injecting cocaine in the lower back of a gentleman with the intention to 
cure him of his complaint of masturbation (Corning, 1885). Based on the description of the 
results and the manner of onset of analgesia, there is little doubt that this was an epidural. In 
addition, it was a “walking epidural”; the man experienced dizziness but his motor function was 
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intact, and he displayed no observable uncoordinated movements. He left an hour after his 
injection. After this account, Corning introduced the term “spinal anesthesia” (Brill, Gurman, & 
Fisher, 2003).  
The first papers describing obstetric applications of spinal and lumbar epidural appeared 
between 1900 and 1930 (Caton, 2014). The origin of epidural analgesia began with Jean Enthuse 
Sicard, a neurologist who treated sciatica and tabes by injecting cocaine through the sacral 
hiatus. Known as caudal anesthesia, this method was used to provide surgical anesthesia. Fidel 
Pages-Mirave, a Spanish surgeon, first used the lumbar approach to the epidural space for 
surgical anesthesia in 1921. He introduced the idea of “segmental anesthesia,” where loss of 
sensation is limited to an area supplied by one or two spinal nerves. This was a huge contribution 
to the field because it eliminated the side effects of complete spinal anesthesia blocks. Sadly, 
Pages-Mirave died in a motor vehicle collision before he could publish his findings. In 1931, 
Achille Dogliotti independently identified the epidural space and described its anatomy and 
physiology in detail. Dogliotti developed the modern “loss of resistance” technique used to find 
the epidural space. He also published a report on the introduction of local anesthetics into the 
epidural space. The technique at this time involved a single bolus of local anesthetic, limiting the 
duration of anesthesia provided by epidural anesthesia (Dogliotti, 1931). This dilemma was 
solved in 1947, when Manuel Martinez Curbelo of Cuba used a Tuohy needle and a small 
ureteral catheter to provide "continuous lumbar epidural infusion for analgesia” (Curbelo, 1949).  
Major change in obstetric anesthesia and analgesia came when John Bonica, who later 
became the first chairman of the Department of Anesthesiology at the University of Washington, 
took over his wife’s pain management during her labor in 1943. She had a close to fatal 
complication with open-drop ether, and his management of her anesthesia probably saved her 
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life. From the moment he intervened to save his wife’s life, he devoted his career to pain 
management and advancing anesthesia care of the mother and fetus (Chadwick, 2005).  
Caudal anesthesia was the primary means of providing labor pain relief when Bonica was 
chief of anesthesia. In 1943, Hingson and Edwards published a method for continuous caudal 
analgesia for labor in which a malleable needle remained in the sacral canal throughout labor and 
tetracaine (Pontocaine) was introduced (Hingson & Edwards, 1943). In 1970, small flexible 
catheters replaced the needles. Only when commercially produced catheters became readily 
available in the 1970s did labor epidural analgesia become more popular (H. S. Chadwick, 
2005). 
For obstetricians, regional anesthesia had many advantages. First, it appeared safe and easy 
to manage, which was important because qualified anesthesia providers were in short supply. 
Second, regional anesthesia allowed obstetricians to make more liberal use of operative 
techniques for vaginal delivery (e.g., episiotomy, use of forceps), which were just coming into 
vogue. No less important, regional anesthesia appeared to satisfy the desires of women who 
wanted more comfortable deliveries. These motives prompted the use of more regional blocks, 
including presacral, paravertebral, spinal lumbar epidural, and caudal epidural anesthesia.  
In 1967, the first volume of Bonica’s classic textbook Principles and Practice of Obstetric 
Analgesia and Anesthesia was published (Bonica, 1967). The book was a comprehensive 
discourse on almost everything known in obstetric anesthesia. It examined the anatomy and 
physiology of uterine function and childbirth pain, including the neurologic pathways involved 
in the perception of childbirth pain. It brought together studies of placental structures and 
function pointed to the transmission of drugs and the effects the drugs may have on the infant. 
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The studies of the anatomy and physiology of the uterus worked to identify the effects of 
inhalation and regional anesthesia on the labor process.   
In 1978, Philip Bromage published the book Epidural Analgesia, which took the practice 
of epidural analgesia to the modern era and played an essential role in the acceptance and use of 
epidural analgesia in obstetrics and pain management (Bromage, 1978). Subsequent problems 
with the use of epidurals during labor stimulated detailed and accurate studies of the effects of 
anesthesia with modifications of techniques. The introduction of opioids to either the spinal or 
epidural space was a significant development in obstetric anesthesia, making labor and delivery 
even less painful. This stirred practitioners in the 1980s and 90s to reexamine the effects of drugs 
on the fetus, neonate, mother, and the labor process. As a result of these studies, a number of 
modifications were made to minimize adverse effects.  
Systemic Analgesia 
Systemic opioids are still the most widely used medication for labor analgesia worldwide 
(Pandya, 2010). Systemic analgesia is dependent upon an effective concentration of drug in 
maternal circulation and any drug that affects the maternal CNS crosses the blood-brain barrier 
and also the placenta. Drugs given systemically over time affect the mother as well as the fetus. 
Because of the effects the doses of these medications are limited and pain relief is insufficient to 
reduce any of the adverse effects of labor pain.  
The most common parenteral opioids used for labor pain relief are morphine and pethidine 
(Demerol), administered IV or intramuscularly (IM). Respiratory depression of the neonate is a 
common and the most serious adverse effect of intrapartum opioid administration (B. A. 
Lieberman et al., 1979; Schnider & Moya, 1964; Wiener, Hogg, & Rosen, 1979). Studies have 
demonstrated systemic opioids decreased neonatal alertness (Belsey et al., 1981), lower neonatal 
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neurobehavior scores (Hodgkinson, Bhatt, & Wang, 1978), impairing mother-infant interaction 
(Moreau & Birch, 1974; Richards & Bernal, 1972; Scanlon et al., 1974; Standley, Soule, Copans, 
& Duchowny, 1974), inhibition of sucking (Kron, Stein, & Goddard, 1966; Nissen et al., 1995; 
Righard & Alade, 1990), and a delay in effective feeding (Crowell, Hill, & Humenick, 1994; 
Matthews, 1989). The neonatal behavior variables measured at delivery and found to be affected 
were reduced alertness, more likely to cry when handled, and decreased measures of 
consolability which is the ease with which the tester could quiet the infant (Belsey et al., 1981). 
CNS depression affects the infant’s tone, with fewer and less well directed movements, less 
spontaneous motor activity when awake, impaired success in the infants ability to move the hand 
to mouth all impairing the infants ability to breastfeed (Belsey et al., 1981; Kraemer, Korner, & 
Thoman, 1972). Drug exposure reduced the infant’s ability to quiet himself after arousal, with 
frequent state changes from sleep through wakefulness to crying (Belsey et al., 1981; Emde, 
Swedborg, & Suzuki, 1975). 
The majority of studies on maternal systemic opioid and its effects on the fetus/neonate 
have focused on pethidine (meperidine) because it has been in frequent use worldwide for a long 
time. Detrimental effects could last up to 72 hours postpartum due to the accumulation of 
norpethidine (normeperidine) (Kuhnert, Kuhnert, Philipson, & Syracuse, 1985). Maximal fetal 
exposure of respiratory depression (Belfrage, Boreus, Hartvig, Irestedt, & Raabe, 1981; Hamza 
et al., 1992), and metabolic acidosis (Sosa et al., 2006) were seen when pethidine was given 3 to 
5 hours before delivery; however, if administration was 1 hour before delivery, effects were 
barely noticeable. Infants whose mothers received pethidine during labor sucked at significantly 
lower pressures and rates and consumed less milk than those whose mothers received no 
medication (Kuhnert, Kuhnert, et al., 1985).  
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In summary, the adverse effects on the neonate of parenteral opioids given during labor are 
well documented, and there is no evidence to support their continued use. 
Epidural Medications 
The most common drugs used for epidural analgesia contain combinations of local 
anesthetics with an opioid and are set on a continuous infusion, often for many hours. 
Bupivacaine is the mainstay local anesthetic used and is commonly combined with fentanyl. The 
dosage frequently used in this setting for continuous labor epidural infusions is 0.125% 
bupivacaine with 2-3 µg/mL fentanyl. At Yale New Haven Hospital, the standard protocol for 
otherwise healthy parturients who request epidural analgesia for vaginal delivery calls for a 
continuous infusion of 0.05% bupivacaine with 3 g/mL hydromorphone instead of fentanyl.   
Low-Dose Local Anesthetic Epidurals 
In the early years of labor epidurals, bupivacaine doses of 0.2-0.25% were used to maintain 
labor pain relief by blocking both somatic and visceral pain. The high concentration of local 
anesthetics produced very dense pain relief but also caused many unwanted side effects, such as 
motor block, hypotension, extreme sensory deficit, and rarely toxicities to the fetus. The 
discovery of opioid receptors on the dorsal horn of the spinal cord changed epidural analgesia. 
Opioids administered in the epidural space bind directly on the opioid receptors on the spinal 
cord without the effects seen when administered intravascular. Intrathecal opiates could relieve 
the visceral pain of the first stage of labor but to relieve the somatic pain of the late first stage to 
second stage of labor a local anesthetic needed to be combined. 
When combined, epidurally administered local anesthetics and lipid-soluble opioids work 
together to provide analgesia (Lyons, Columb, Hawthorne, & Dresner, 1997; Polley, Columb, 
Wagner, & Naughton, 1998; Vercauteren & Meert, 1997). During the past 10 years, 
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concentrations of local anesthetics have decreased to 0.0625 %- 0.125%, lowering the total 
amount of local anesthetic used and eliminating many of the side effects, such as motor 
blockade, associated with the higher doses of local anesthetics. In addition, the lower doses of 
opioid needed for analgesia reduce the side effects seen with systemic absorption of high doses 
of opioids. An important aspect of labor analgesia is latency. The supplement of a lipid-soluble 
opioid to long acting/long latency local anesthetics shortens latency (Justins, Francis, Houlton, & 
Reynolds, 1982). Hence, present day labor epidural analgesia usually combines a low-dose long 
acting local anesthetic with an opioid. Bupivacaine is the mainstay local anesthetic used and is 
commonly combined with fentanyl. Bupivacaine is highly protein bound, so placental transfer is 
low with a duration of analgesia of 2 hours. 
Ropivacaine is a homologue of bupivacaine with a latency and duration similar to that of 
bupivacaine (J. A. Katz, Bridenbaugh, Knarr, Helton, & Denson, 1990) without the cardio 
toxicity bupivacaine. Studies on potency have suggested that ropivacaine is 40% less potent than 
bupivacaine (Polley, Columb, Naughton, Wagner, & van de Ven, 1999). However, clinical 
studies have shown no difference in terms of sensory blockade between low-concentration 
epidural infusions of ropivacaine and bupivacaine (Beilin et al., 2007; Lee, Ngan Kee, Ng, Lau, 
& Wong, 2004). When equal potent sensory doses were compared ropivacaine may be associated 
with less motor blockade than bupivacaine (Beilin et al., 2007; Lacassie, Habib, Lacassie, & 
Columb, 2007). This characteristic is probably not clinically significant when low doses of 
bupivacaine are used (Wong, 2009). 
A 2013 meta-analysis (Sultan, Murphy, Halpern, & Carvalho, 2013) that included 15 
articles involving 1,997 patients compared the effect of low-concentration epidural bupivacaine 
(≤0.1%) or ropivacaine (≤0.17%) versus high concentration of local anesthetics on obstetric and 
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anesthetic outcomes. Although 1-minute Apgar scores <7 favored the high concentration group, 
low concentrations of labor epidural solutions improved obstetric outcomes (decrease in 
frequency of assisted vaginal delivery, shorter duration of second stage of labor) and reduced 
maternal side effects (less motor blockade, better ambulation, and decreased urinary retention) 
without compromising analgesia. The authors recommended the use of low concentrations of 
local anesthetics for epidural analgesia to optimize obstetric outcome. 
Properties of Epidural Opioid Analgesia 
Lipid solubility of an opioid is one of the most important factors in determining its 
individual effects (Wagemans, Zuurmond, & de Lange, 1997). Lipid solubility determines how 
the drug is absorbed into local tissue, traverse the dura and gain access to the cerebral spinal fluid 
(CSF) or be absorbed systemically (Brose, Tanelian, Brodsky, Mark, & Cousins, 1991). Once the 
drug is administered in the epidural space, the pharmacology and pharmacodynamics of the drug 
allocate its unique profile of analgesia and side effects. 
Pharmacokinetic studies have shown that highly lipophilic opioids such as fentanyl and 
sufentanil diffuse freely from the epidural space into the maternal blood and across the placenta 
(de Barros Duarte et al., 2009; Desprats et al., 1991). Because fentanyl is so frequently used in 
this setting, it has been well researched and its effects documented. The side effects of fentanyl, 
such as sedation, vomiting, pruritus, and, although rare, neonatal respiratory depression, are 
known (Carrie, O'Sullivan, & Seegobin, 1981; M. Kumar, Chandra, Ijaz, & Senthilselvan, 2014; 
M. Kumar & Paes, 2003; Noble, Morrison, Brockway, & McClure, 1991, 1994). Most studies 
have focused on neonatal outcomes in the delivery room, ignoring the possibility of late-
occurring side effects that can arise up to several hours after exposure because of the longer 
terminal half-life of fentanyl in neonates. Because it is bound principally to albumin and 
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becomes unbound during the first day of life, increasing the free concentration of fentanyl, 
secondary peaks in plasma drug concentration can occur (R. Katz & Kelly, 1993; Koehntop, 
Rodman, Brundage, Hegland, & Buckley, 1986; Leighton & Halpern, 2002; E. Lieberman & 
O'Donoghue, 2002; McClain & Hug, 1980; Reynolds, 2011). A 2014 case-control study showed 
a positive association between exposure to traditional fentanyl-bupivacaine infusate in maternal 
epidural analgesia and respiratory distress in neonates at ≥34 weeks gestation within 24 hours of 
life who required supplemental oxygen ≥2 hours and/or positive pressure in the neonatal 
intensive care unit (M. Kumar et al., 2014). 
Neonatal Drug Exposure After Epidural Analgesia During Labor  
Placental Drug Transfer by Diffusion 
Most drugs, including those used for analgesia and anesthesia cross the placenta by passive 
diffusion. Diffusion is dependent on a concentration gradient across the placenta with drugs 
passively moving from areas of high concentration to low. The placenta is a lipid membrane and 
lipophilic molecules diffuse readily across lipid membranes. Drugs with a molecular weight of 
<500 Da readily diffuse across the placenta. Most drugs used in anesthesia, including opioids and 
local anesthetics have molecular weights <500 Da.  
Only the non-ionized portion of a partially ionized drug crosses the placenta (Griffiths & 
Campbell, 2014). The pH of maternal blood and the pKa of the drug determine the degree to 
which the drug is ionized. Most drugs used in anesthesia are poorly ionized in blood therefore 
un-ionized unbound drug readily crosses the placenta. If the pH of maternal blood changes, such 
as in labor, then changes in the degree of ionization of the drug and placental transfer can occur. 
The transplacental distribution of lipophilic substances whose unbound and un-ionized 
particles readily cross the placenta is influenced by the transplacental gradient for protein 
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binding and pH. Fetal pH is lower than maternal pH, therefore free bases tend to stay on the fetal 
side due to ion trapping, and weak acids to the reverse (Reynolds, 2010). If the fetus becomes 
acidotic basic drugs such as local anesthetics and opioids can accumulate in the fetus called “ion 
trapping” (Griffiths & Campbell, 2014). Ion trapping occurs when the lower pH of the fetus 
produces an increased portion of ionized drug, which is then unable to cross the placenta 
increasing the exposure to the drugs. 
Acidic drugs bound mainly to albumin do not diffuse across the placenta. Only the 
unbound portion of the drug is free to cross the placenta. For most basic drugs, the major binding 
protein is α1-acid glycoprotein, the concentration which is always higher in maternal than fetal 
plasma (Krauer, Dayer, & Anner, 1984). For drugs that are mainly bound to α1-acid 
glycoprotein, higher maternal than fetal binding reduces the equilibrium fetal/maternal ration 
(Reynolds, 2010).  
Placental Transfer of Epidural Medications 
Bupivacaine, the local anesthetic most frequently used in labor epidural analgesia has a 
high degree of protein binding in maternal and fetal circulation. It has been established there is 
excessive bupivacaine binding to maternal α1-acid glycoprotein (90%) compared to fetal protein 
binding (50%) and that the difference in protein binding affects placental transfer of bupivacaine 
(R. F. Johnson et al., 1995; Mather, Long, & Thomas, 1971). When both maternal and fetal 
plasma have normal physiologic serum protein levels, the maternal-to-fetal bupivacaine transfer 
ratio decreased and the fetal-to-maternal transfer increased (R. F. Johnson et al., 1995). This 
difference in transfer is due to the amount of free (un-ionized) drug available for placental 
transfer. It has been definitely established in these studies that drugs that are demonstrate more 
protein binding potentials express these elements in the maternal-fetal gradient. For example 
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placental bupivacaine transfer increased as the amount of protein in the receiving perfusate was 
increased (Hanshaaw-Thomas & Reynolds, 1985). Increased bupivacaine clearance across the 
placenta is also related to the maternal-fetal gradient of unionized bupivacaine. This is clinically 
significant under pathological conditions when maternal and fetal plasma levels of protein are 
not normal. For instance, in severe pre-eclampsia maternal protein binding is reduced leading to 
greater transfer of bupivacaine across the placenta to the fetus.   
Using pregnant rabbit (Gaylard, Carson, & Reynolds, 1990) and ewe (Biehl, Shnider, 
Levinson, & Callender, 1978; Pickering, Biehl, & Meatherall, 1981) models, researchers found 
increased bupivacaine concentration in the umbilical vein related to lower pH of fetal circulation. 
It has been proposed decreased fetal pH results in ion trapping leading to the higher fetal 
bupivacaine concentration. It has further been determined that the increases in fetal bupivacaine 
concentration may also be due to the decreased ability of the fetus to clear the drug and changes 
in tissue distribution (Finster, Ralston, & Pedersen, 1993). Regardless this information is 
extremely important to the safety of the fetus. Researchers have established increased sensitivity 
of the fetus during times of hypoxia and fetal acidosis to the harmful effects of bupivacaine (R. 
F. Johnson et al., 1995; Morishima & Covino, 1981; Morishima et al., 1989). During fetal 
acidosis, bupivacaine transfer may be increased by a large factor.  
The transfer of lipophilic drugs by diffusion across the placenta and equilibrium takes 
longer in fetal than maternal tissue because the fetal compartment is deep. Fetal exposure is 
dependent on blood flow on both sides of the placenta (flow-dependent transfer), duration of 
exposure and equilibrium ratios (Reynolds, 2010). The immediate effect of the drug is related to 
the concentration of free unbound drug however a large albumin-bound portion is a storehouse 
for the neonate (Reynolds, 2010). During the first days after delivery, albumin binding declines, 
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increasing free concentrations of drugs such as fentanyl and diazepam (Nau, Luck, Kuhnz, & 
Wegener, 1983). 
Bader et al. (1995) evaluated umbilical vein and maternal vein concentrations of fentanyl 
and bupivacaine after continuous epidural infusion during labor (Bader et al., 1995). In their 
study, 21 parturients received 0.125% bupivacaine and 2 g/mL fentanyl at a constant rate of 10 
mL/h (12.5 mg/h bupivacaine and 20 g/h fentanyl). Maternal vein (MV) and umbilical vein 
(UV) concentrations were measured at birth. Length of infusion ranged from 1 to 15 hours. The 
mean value of bupivacaine in MV was 0.50 ± 0.16 and UV 0.15 ± 0.06 with an UV/MV ratio 
0.03. Bader et al. (1995) did not find a statistically significant relationship between duration of 
infusion and accumulation of either drug but did suggest rapid placental transfer and 
equilibration of fentanyl between maternal and neonatal blood and a maternal-neonatal gradient 
for bupivacaine concentration, attributed to placental deposition and protein binding (Bader et 
al., 1995). 
Data from the study by Bader et al (1995) are consistent with those of Abboud and 
colleagues (Abboud et al., 1984), who observed patients receiving 0.125% bupivacaine at a rate 
of 14 mL/h. Their data showed a MV bupivacaine concentration of 0.54±0.10 and a UV 
concentration of 0.18 ± 0.04, with a UV/MV ratio of 0.33. The low UV/MV ration is reflective 
of bupivacaine high protein binding and lipid solubility. In vitro studies examining isolated 
human placental cotyledons support these theories, showing a fetomaternal concentration 
gradient mean of 0.58 (Ala-Kokko, Plenimaki, Hollmen, & et al., 1993). Although bupivacaine 
rapidly crossed from the MV to the fetal reservoir, the fetomaternal concentration was low, 
suggesting placental deposition of this extremely lipid-soluble drug. These two studies showed 
no correlation with cord blood level of bupivacaine and duration of infusion. Radzyminski did 
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find a significant correlation between bupivacaine concentration in cord blood and length of 
infusion time (Radzyminski, 2005). The dose of bupivacaine in that study was 0.044% at a 
continuous infusion of 14 mL/h. The longer the epidural infusion ran, the greater the 
concentration of bupivacaine in cord blood at delivery. However, the levels of bupivacaine were 
low when compared to the amount of drug infused, and she found no difference in breastfeeding 
or neurobehavior between the epidural group and the nonmedicated group. 
Fentanyl is also detectable in the cord blood after birth. Bader and colleagues reported MV 
concentration of 0.17 ± 0.10 ng/mL, UV concentration 0.16 ± 0.09 ng/mL, and a UV/MV ratio of 
0.94 (Bader et al., 1995). The UV/MV ratio was quite high, suggesting placental transfer was 
rapid, and UV concentration quickly reached equivalence with MV concentration. Fentanyl is 
highly lipid soluble and it would be expected to cross the placenta rapidly. Animal studies 
support this theory. An early animal study examined maternal and fetal fentanyl concentrations 
1-60 minutes after a bolus of medication was given (Craft et al., 1983). There was a rapid decline 
in maternal concentration, demonstrating rapid redistribution and uptake in maternal tissue, with 
the fetal concentration profile running parallel to maternal decline. The UV/MV ratio in both 
studies remained equal over time not changing with longer infusion times. In addition, an in vitro 
human placental study that examined uptake and distribution of fentanyl reported equal M→F, 
F→M clearance of fentanyl (Zakowski, Schlesinger, Dumbroff, & et al., 1993). They found that 
the transfer of fentanyl reached a plateau within 40-80 minutes of continuous infusion, alluding 
to passive transfer of fentanyl across the placenta. They also found a high amount of fentanyl in 
placental tissue, suggesting the placenta serves as a storehouse for fentanyl. To date there have 
been no studies that have examined whether there is an interaction between bupivacaine and 
fentanyl facilitating or inhibiting transfer of either drug. The results of these three studies show 
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MV and UV fentanyl concentrations are low and fentanyl levels did not correlate with infusion 
time.  
Fetal Tissue Uptake 
UV samples do not mirror fetal tissue uptake. In animal studies fentanyl showed a large 
distribution to all tissue and a clearance rate dependent on dose (Murphy, Hug, & McClain, 
1983). Clearance rate for the neonate is slow due to immature liver enzymes, and may at first 
distribute to the brain or heart (Gauntlett et al., 1988). Maternal half-life of fentanyl is 
approximately 8 hours (Moises et al., 2005); however, fetal half-life is difficult to measure 
quantitatively after exposure to maternal epidural analgesia because of the fetal tissue uptake 
(Desprats et al., 1991; Paech, Westmore, & Speirs, 1990). Therefore, because of the unknown 
amount of fentanyl accumulation in fetal tissue of this highly lipophilic drug, UV measurements 
of fentanyl may not be accurate (Capogna & Camorcia, 2004). 
The importance of fetal tissue accumulation of bupivacaine is unknown. Tissue uptake by 
the nonvital organs of the fetus may impede increased bupivacaine levels in fetal heart and brain. 
It has been suggested that the fetus metabolizes and excrete bupivacaine like an adult (Mango, 
Berlin, Karlsson, & et al., 1976). Small amounts of bupivacaine metabolites have been found in 
neonatal urine 36 hours after delivery (Kuhnert, Zuspan, Kuhnert, Syracuse, & Brown, 1987). In 
the absence of observable neurobehavioral deficits, it would convey that there is not enough 
bupivacaine accumulation to impair CNS function in the neonate. 
Epinephrine 
Epinephrine is frequently added to the local anesthetic to slow the vascular uptake of the 
local anesthetic and opioids from the spinal space. The addition of epinephrine to bupivacaine 
has been shown to reduce plasma levels of bupivacaine by approximately 17% in the fetus and 
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30% in maternal circulation (Abboud et al., 1989). Some studies suggest the effects of 
epinephrine on fetal drug levels were smaller than the effect on maternal plasma levels; 
therefore, the fetal/maternal concentration gradients were higher for bupivacaine plus 
epinephrine than for bupivacaine alone (Beazley, Taylor, & Reynolds, 1972; Belfrage, Berlin, 
Raabe, & Thalme, 1975; Belfrage, Raabe, Thalme, & Berlin, 1975; Reynolds & Taylor, 1971). 
Other studies did not confirm the increased fetal/maternal ratios following co-administration of 
epinephrine. Hence, most authors regard the addition of epinephrine to the local anesthetic as 
unnecessary, especially since the duration of anesthesia was not prolonged (Jouppila et al., 1978; 
Nesheim, 1983), and epinephrine can alter uterine blood flow leading to uteroplacental 
insufficiency and prolong labor (Nesheim, 1983).   
Epidural Hydromorphone 
Hydromorphone is a mu receptor agonist with pharmacokinetic properties intermediate 
between highly hydrophilic morphine and highly lipophilic opioids such as fentanyl and 
sufentanil (Reisine & Pasternak, 1996). After epidural administration, the amount of drug that 
penetrates dura and pia-arachnoid to enter the CSF and spinal compartments is inversely 
proportional to its lipid solubility and polarity (Chrubasik, Chrubasik, & Martin, 1993; Herz & 
Teschemacher, 1971; Plummer, Cmielewski, Reynolds, Gourlay, & Cherry, 1990; Sinatra et al., 
2000; Yaksh, Al-Rodhan, & Jensen, 1988). For example, high lipid solubility increases systemic 
absorption and reduces availability of the drug in the dorsal horn of the spinal cord thereby 
continually needing more drug to extend their limited duration of action (Bernards et al., 2003; 
Sinatra et al., 2000). Hydrophilic opioids have more difficulty traversing neural and vascular 
membranes, staying in the spinal compartment, increasing the availability of drug on the dorsal 
horn of the spinal cord, and ensuring lower concentration of drug needed for continued receptor 
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site activity (Sinatra et al., 2000). Placental transfer of hydrophilic opioids is impeded and they 
therefore diffuse across slowly and are unlikely to attain effective concentration in the fetus 
(Reynolds, 2011; Syme, Paxton, & Keelan, 2004). 
This gain in opioid-mediated analgesic effect provides a local anesthetic dose-sparing 
effect, allowing the use of bupivacaine as an adjunct rather than primary analgesic where 
infusions are 2-2.5 times as dilute as those traditionally seen in continuous labor epidural 
infusions (Sinatra et al., 2000).  
Quality of pain relief for continuous epidural infusion containing 0.05% bupivacaine plus 3 
g/mL hydromorphone was evaluated in 1830 parturients requesting analgesia during labor and 
delivery (Sinatra et al., 2002). The infusion provided rapid and effective analgesia and minimal 
adverse events for patients whom differed in parity and at varying stages of labor. Pain relief was 
maintained in most patients without need for epidural reinforcement (Sinatra et al., 2002). 
Clinically significant adverse events including excessive maternal sedation, profound 
hypotension, respiratory depression, clinically significant motor blockade, and severe fetal 
bradycardia were not observed (Sinatra et al., 2002). The fact that patients report highly effective 
pain control with epidural doses comparable to fentanyl is significant, considering that 
intravenous doses of fentanyl are 10-12 times more potent than hydromorphone.  
The author of this dissertation and colleagues conducted a prospective observational study 
in 2012 at Yale New Haven Hospital to determine neonatal and maternal exposure to 
hydromorphone and bupivacaine in the epidural solution (Shah, French, Dai, & Snegovskikh, 
unpublished data, 2012). Ten healthy parturients with uncomplicated pregnancies received an 
initial bolus of 100 g hydromorphone and 9 mL 0.25% bupivacaine, followed by continuous 
infusion of 0.05% bupivacaine and 3 g/mL hydromorphone at 14 mL/h (0.7 mg/h bupivacaine 
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and 42 g/h hydromorphone), which is the standard protocol at Yale New Haven Hospital. If 
necessary, additional boluses of 0.25% bupivacaine were given to maintain analgesia. As 
mentioned above, Sinatra and colleagues (Sinatra et al., 2002) had previously found that this 
protocol achieved a level of analgesic efficacy comparable to that with 0.125% bupivacaine 2 
g/mL fentanyl, despite earlier findings that the IV potency of hydromorphone is only 1/10 to 
1/12 that of fentanyl (Reisine & Pasternak, 1996). Umbilical vein and maternal vein blood 
samples were obtained within 15 minutes of delivery to determine hydromorphone and 
bupivacaine concentrations. The umbilical/maternal vein ratio was calculated for each sample.  
Table 1 compares the results of our study with those of Bader et al. (1995) and with those 
of another study by Abboud et al., who observed patients receiving 0.125% bupivacaine at a rate 
of 14 mL/h (Abboud et al., 1984).   
Table 1. Drug Concentration Data in Maternal Vein (MV) and Umbilical Vein (UV) 
 
MV 
concentration 
UV 
concentration 
UV/MV 
ratio 
Shah et al (unpublished data)    
Bupivacaine, μg/mL 0.23±0.18 0 (0-0)a 0 (0-0.06) 
Hydromorphone, ng/mL 0.26±0.09 0.23±0.09 0.88±0.11 
Bader et al. (1995) 
   
Bupivacaine, μg/mL 0.50±0.16 0.15±0.06 0.30 
Fentanyl, ng/mL 0.17±0.10 0.16±0.09 0.94 
Abboud et al. (1984)    
Bupivacaine, μg/mL 0.54±0.10 0.18±0.04 0.33 
MV = maternal vein; UV = umbilical vein. 
Data are expressed as mean ± SD unless otherwise noted.  
a
Median (interquartile range). The UV concentration was 0 μg/ml in 8 of 10 neonates, 0.10 in one, and 0.16 μg/ml in 
one. 
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Consistent with the results of the Bader et al. study, we found that maternal and umbilical 
vein concentrations were independent of duration of epidural infusion/total amount of infusate. 
Maternal venous concentrations of hydromorphone and bupivacaine were highly correlated, 
consistent with maternal vascular absorption of the infusate from the epidural space. The overall 
concentration of bupivacaine needed to achieve efficacy was much lower when bupivacaine was 
combined with hydromorphone rather than fentanyl, resulting in lower maternal vein 
concentrations of bupivacaine in our study than in the other two studies. Furthermore, whereas 
all 21 UV samples in the Bader et al. study had detectable levels of bupivacaine in the umbilical 
vein, only two umbilical vein samples had detectable levels of bupivacaine in our study, and 
these were from patients who had required more than one additional bolus.  
The infusion concentration and total amounts of hydromorphone infused in our patients 
were higher than those of fentanyl in the Bader et al (1995) study: 3 g/mL hydromorphone (42 
g/h) versus 2 g/mL fentanyl (20 g/h). However, the overall concentration of hydromorphone 
in the umbilical vein was comparable to that of fentanyl, possibly because of the greater 
hydrophilicity of hydromorphone compared with fentanyl. This is significant because other 
studies have found incidences of neonatal respiratory depression with the fentanyl umbilical vein 
concentrations that were found in the Bader et al. study (Carrie et al., 1981; M. Kumar et al., 
2014; M. Kumar & Paes, 2003; Nikkola, Ekblad, Kero, Alihanka, & Salonen, 1997; Noble et al., 
1994). Thus, although the potency of hydromorphone is only 1/10 to 1/12 that of fentanyl, the 
fetus is exposed to a lower opioid dose while achieving comparable pain relief. The use of 
hydromorphone in the epidural solution may therefore be more favorable with respect to limiting 
neonatal exposure to foreign substances. 
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Effects of Epidural Analgesia on Mother and Neonate 
The effects of epidural analgesia on the fetus may be direct by placental transfer and fetal uptake 
with CNS depression or indirect as a result of a change in maternal homeostasis that results in a 
change to the fetal intrauterine environment or both (Bonica & McDonald, 1990). The direct 
effects are potentially more important for drugs that act systemically, where it is dependent on 
the presence of the drug in maternal circulation to exert its effects and placental transfer more 
relevant. Epidurally administered drugs do not require presence in maternal blood to work 
effectively. Therefore, indirect effects of epidural analgesia may be more prominent than direct 
placental transfer.  
Positive Effects  
Epidural analgesia preserves the beneficial stress response of the fetus to labor and 
reverses the negative maternal physiological and biochemical changes of labor. Analgesia 
reduces stress hormones such as epinephrine, cortisol, ACTH, peptide hormones and angiotensin 
II (Shnider et al., 1983) (Cascio, Pygon, Bernett, & Ramanathan, 1997; Eberle, Kinsella, & 
Arrison, 1995; Westgren et al., 1986), reduces hyperventilation (Thalme et al., 1974), maintains 
uterine dilation due to sympathetic blockade (Hollmen, Jouppila, Jouppila, Koivula, & Vierola, 
1982), reduces episodes of hemoglobin oxygen desaturation (Arfeen, Armstrong, & Whitfield, 
1994; Deckardt, Fembacher, Schneider, & Graeff, 1987; R. P. Griffin & Reynolds, 1995), and 
provides better quality pain relief and higher maternal satisfaction than systemic opioids or 
nitrous oxide (L. Jones et al., 2012). 
Neonatal Acid-Base Status 
Three studies published in the 1970s examined intrapartum acid-base changes with or 
without epidural analgesia (Pearson & Davies, 1973a, 1973b, 1974a, 1974b; Thalme et al., 1974; 
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Zador & Nilsson, 1974), one of which was randomized (Thalme et al., 1974). The studies 
demonstrated that labor epidural analgesia reduced maternal hypocarbia and maternal and fetal 
metabolic acidosis and lactate (Zador & Nilsson, 1974), while notably reducing the drop in fetal 
pH that normally occurs during stage 2 of labor (Reynolds, 2011).  
These findings were confirmed by the end 1990’s, when the epidural cesarean and 
backache controversies prompted a number of randomized studies comparing epidural analgesia 
with systemic opioids, allowing for a meta-analysis of acid-base status in over 2000 babies in 12 
studies (Reynolds, Sharma, & Seed, 2002). This confirmed that umbilical artery pH and base 
excess were significantly better in babies born to mothers who received epidural analgesia for 
labor. A Canadian study comparing Apgar scores and need for neonatal resuscitation between 
PCEA (Patient-Controlled Epidural Analgesia) containing bupivacaine and fentanyl with PCIA 
(Patient-Controlled Intravenous Analgesia) showed an improvement in neonatal pH and base 
excess in the epidural group (Halpern et al., 2004). To show that the differences between the 
groups were not simply due to adverse effects of systemic opioids, Schocket and colleagues 
conducted a case-controlled study comparing umbilical artery acid-base status in 110 matched 
pairs of women who had either received epidural analgesia or no analgesia (Schocket, Garrison, 
Wiley, & Sharma, 2005). There were no differences in umbilical artery pH, but both pCO2 and 
base excess were significantly higher in the epidural group suggesting epidural analgesia had a 
beneficial effect on metabolic acidosis rather than an adverse effect of systemic opioids. 
Maternal Stress Reduction  
It has been hypothesized the stress of labor can have long-term behavioral effects on the 
neonate (Taylor, Fisk, & Glover, 2000). Studies in animal models also found an association 
between peripartum stress and long-term behavioral outcomes (W. C. Griffin, 3rd, Skinner, 
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Salm, & Birkle, 2003; Hayashi et al., 1998; Kapoor & Matthews, 2005; Schneider, Roughton, 
Koehler, & Lubach, 1999). Prolonged antepartum maternal stress has been linked to adverse 
neurobehavioral outcomes in children (Van den Bergh, Mulder, Mennes, & Glover, 2005; 
Weinstock, 2005). It is uncertain whether a single stress episode such as one that occurs during 
labor and delivery can lead to long-term neurobehavioral consequences. It is unknown at this 
time if peripartum stress has a role in the development of learning disabilities. Epidural analgesia 
administered for labor decreases markers of both maternal and fetal stress such as cortisol 
(Abboud, Sarkis, Hung, et al., 1983; N. M. Miller, Fisk, Modi, & Glover, 2005; Taddio, Katz, 
Ilersich, & Koren, 1997). If fetal stress has a role in decreased neurobehavioral outcomes, it 
could be that neuraxial analgesia might also affect long-term outcomes after vaginal delivery. 
Negative Effects of Maternal Labor Analgesia on Neonatal Neurobehavior 
Neurobehavior tests have been used in various studies of the effects of maternal analgesia 
on the neonate. These studies introduced the clinical importance of neonatal neurobehavior on 
breastfeeding initiation. However, failure to provide information and inconsistencies in 
medication regimens, definition of variables, sample sizes, and research methods make it 
difficult to draw conclusions. 
Morikawa and colleagues reported a significant relationship between bupivacaine dose and 
neonatal neurobehavior as assessed with the NACS (Morikawa et al., 1990). Abboud and 
colleagues found no relationship between epidural bupivacaine and NACS scores (Abboud et al., 
1984). In a study by Radzyminski and colleagues, infants born to mothers who received epidural 
analgesia with low-dose bupivacaine and fentanyl showed no differences in NACS scores 
compared to infants of mothers who received no pain medication for labor (Radzyminski, 2003). 
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In a second study, the same author found a relationship between bupivacaine passive tone, active 
tone, and total score on the NACS at 1 hour but not at 24 hours (Radzyminski, 2005). 
Abboud and colleagues used the ENNS to compare neurobehaviors differences in 170 
infants; 50 mothers received 2% epidural 2-chloroprocaine, 50 with 0.5% epidural bupivacaine, 
50 with 1.5% lidocaine and 20 in an unmedicated control group (Abboud, Khoo, Miller, Doan, & 
Henriksen, 1982). Patients were randomly assigned to local anesthetic groups. Analysis of 
variance showed no differences in ENNS scores among the groups. In another study, Abboud 
and colleagues found no adverse effects of lidocaine on the early neurobehavioral status of the 
neonate as assessed with the ENNS (Abboud, Sarkis, Blikian, et al., 1983). 
In one study using the NBAS exam, neonatal behavior in a group of infants whose mothers 
received pethidine during labor was assessed at delivery and during the first six weeks of life by 
means of the NBAS. Higher cord blood levels of pethidine were associated with depressed 
attention and social responsiveness, but the changes observed were relatively subtle, and 
comparison of these infants with a control groups whose mothers had received no drugs revealed 
no between-group differences in behavior (Belsey et al., 1981). In another study, the same 
authors found that visual skills and alertness decreased significantly with increases in the cord 
blood concentration of bupivacaine, particularly on the first day of life but also throughout the 
next six weeks. Adverse effects of bupivacaine levels on the infants’ motor organization, ability 
to control their own state of consciousness, and physiological response to stress were also 
observed (Rosenblatt et al., 1981). 
Three studies using the NBAS exam found a marked difference between the groups (B. A. 
Lieberman et al., 1979; A.D. Murray et al., 1981; Sepkoski et al., 1992). Lieberman and 
colleagues described the fewest differences between the groups, finding that the epidural-
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exposed infants responded less to human voice in the delivery room (B. A. Lieberman et al., 
1979). Murray and colleagues compared 15 control infants whose mothers received no analgesia 
for pain relief, 20 infants exposed to bupivacaine 0.25%, and 20 infants exposed to bupivacaine 
and oxytocin (A.D. Murray et al., 1981). The infants in the epidural groups had lower NBAS 
scores at 1 and 5 days and identified marked differences in motor control, response to stress and 
state control. The largest differences were in state control; only 13% of nonmedicated infants had 
poor state control compared with 50% of the epidural-exposed infants. The difference remained 
despite controlling for forceps delivery and there was no dose-response effect seen. Even on day 
5 the state control scale remained significantly different. There were no differences in NBAS 
scores between the groups after 1 month. However, at 1 month, mothers who had had epidural 
analgesia viewed their infants less favorably and in general found them more difficult to care for 
compared with unmedicated mothers (E. Lieberman & O'Donoghue, 2002). Sepkoski and 
colleagues compared 38 epidural-exposed (bupivacaine 0.5%) infants to 20 nonmedicated infants 
using the NBAS at 3 hours, and on day 3, 7, and 28 (Sepkoski et al., 1992). The infants were 
matched for potentially confounding factors such as maternal ponderal index, parity, the number 
of maternal and fetal non-optimal conditions and induction of labor. The epidural group received 
significantly more oxytocin, had longer labors and more forceps deliveries. The infants that were 
exposed to epidural were less alert, had difficulty orienting, and exhibited poor motor function in 
the first month of life. Multivariate analysis examining the dose of bupivacaine demonstrated a 
dose response for both orientation and motor effects similar to those reported by Murray et al. 
(1981). 
The early bupivacaine studies were performed when high concentrations of local anesthetic 
solutions were common. Although the higher concentration of local anesthetic provided dense 
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pain relief, it created many of the unwanted side effects such as motor blockade, hypotension, 
excessive sensory loss, and toxicities (Hess, Pratt, & Oriol, 2006). With the addition of opioids to 
the epidural infusions, the local anesthetic concentration can be decreased, still providing 
effective analgesia with fewer side effects (Breen, Shapiro, Glass, Foster-Payne, & Oriol, 1993; 
S. E. Cohen, Tan, Albright, & Halpern, 1987; Cousins & Mather, 1984). 
It is difficult to determine why there is so much variability in study conclusions. Early 
differences in infant behavior might be attributed to a direct effect of the medication on the infant 
(A.D. Murray et al., 1981; Sepkoski et al., 1992). This explanation can be supported by the dose-
response effect, which only one study was able to establish (Sepkoski et al., 1992). However, 
differences up to 1 month later cannot be attributed to a direct effect of the drugs. Brazelton 
hypothesized that early interactions with a baby who is less alert, less able to orient, and less able 
to show organized movement may interfere with the development of the mother-infant 
relationship (Brazelton, 1973; A.D. Murray et al., 1981; Sepkoski et al., 1992). There may be 
individual characteristics of the mother that determine both how she will interact with her infant 
and what she will choose for pain relief when in labor.  
Indirect Negative Effects of Labor Epidural Analgesia 
Effects of Physical Changes in the Mother 
If the mother develops respiratory depression with hypoxemia from systemic absorption of 
epidurally administered opioids, fetal hypoxemia and hypoxia will follow (Ferouz, Norris, & 
Leighton, 1997). Hypotension in the mother caused by epidural medications may reduce 
uteroplacental perfusion and oxygenation of the fetus (Wong, 2009). Fetal bradycardia can occur 
without maternal hypotension 15-45 minutes after epidural initiation. There is an acute drop in 
maternal plasma epinephrine associated with the onset of analgesia (Shnider et al., 1983). 
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Epinephrine is a tocolytic and it has been postulated that the acute drop in epinephrine results in 
a short term imbalance of uterine tocolytic/tocodynamic forces that result in uterine hypertonus, 
decreased uterine perfusion and subsequently fetal bradycardia (Clark, Smiley, & Finster, 1994; 
Wong, 2009). Although the bradycardia usually resolves by fluid bolus, ephedrine, and/or 
suspension of oxytocin infusion, it still has potential to disrupt the labor process. 
Effects of Epidural-Related Maternal Fever on Neonatal Outcomes  
Intrapartum maternal fever complicates one-third of all deliveries and is defined as a 
maternal temperature increase of 37.5-38ºC. Women develop fever during labor for various 
reasons, with the most common causes related to infection such as chorioamnionitis. However, 
epidural analgesia has been consistently associated maternal fever or temperature increase in a 
number of prospective and observational studies in the absence of infection (W. R. Camann, 
Hortvet, Hughes, Bader, & Datta, 1991; Fusi, Steer, Maresh, & Beard, 1989; E. Lieberman et al., 
1997; Macaulay, Bond, & Steer, 1992; Philip et al., 1999; Ramin et al., 1995; Yancey, Zhang, 
Schwarz, Dietrich, & Klebanoff, 2001). The exact cause of epidural-related fever is unknown, 
but it thought to be associated with an inflammatory state or altered thermoregulation and not 
due to an infectious process (de Orange, Passini, Amorim, Almeida, & Barros, 2011; Fusi et al., 
1989; Goetzl, Evans, Rivers, Suresh, & Lieberman, 2002; Negishi et al., 2001; Yancey et al., 
2001). 
Even when the fever is not related to infection, it can still have significant consequences to 
the neonate which may ultimately affect the success of breastfeeding. As maternal temperature 
increases, the transfer of heat can cause fetal hyperthermia. Primate studies conducted in the 
1970s assessed the effects of maternal fever without infection by artificially warming pregnant 
baboons to 42ºC to evaluate fetal outcomes (Morishima, Glaser, Niemann, & James, 1975). The 
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extreme increase in temperature was associated directly with fetal hypoxia, hypotension, and 
metabolic acidosis. However, because this level of elevation in temperature is rarely seen in 
clinical practice, the relevance to practice remains uncertain. 
Although no data are available on the specific effects of increased maternal temperature on 
breastfeeding, the many studies showing a negative effect of maternal fever on neonatal 
outcomes make it logical to assume a negative effect on breastfeeding. Therefore, early 
identification of maternal fever is imperative to prevent neonatal consequences. Furthermore, 
maternal fever is related to other factors, such as separation of mother and infant, which may 
compound the effect. For example, in one study(E. Lieberman et al., 1997), although no 
difference in the actual rate of sepsis was observed, neonates born to mothers with epidural-
related fever were more frequently evaluated for sepsis (34%) than neonates of mothers who did 
not receive epidural analgesia (10%) and who had a much lower rate of fever. Another study of 
1100 women showed that evaluations for sepsis were more frequent when the mother had 
epidural analgesia even when the mother was afebrile (Goetzl et al., 2001). The immediate 
postpartum period is a crucial time to initiate breastfeeding, and each minute of skin-to-skin 
contact during the first 3 hours after delivery increases the likelihood of exclusive breastfeeding 
(Bramson et al., 2010). Because the neonate is often separated from the mother for an extended 
period of time during such evaluations, this separation may increase the negative effect on 
initiation of breastfeeding. 
Epidural Analgesia and Oxytocin Regulation in Relation to Breastfeeding 
Oxytocin Mechanism During Labor and After Birth. 
Endogenous oxytocin during labor and birth is necessary for the development of maternal 
behavior that facilitates the process of breastfeeding. Large amounts of oxytocin are released 
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during labor and delivery, leading to more forceful contractions, which are necessary for delivery 
of the neonate, detachment of the placenta, and keeping the uterus contracted to prevent 
postpartum hemorrhage. Additionally, as noted in the section on skin-to-skin contact above, 
maternal oxytocin is released by skin-skin contact as the infant exhibits the instinctual behavior 
by rooting, finding the breast, and sucking at approximately 1 hour of age (Nissen et al., 1998), 
and this results in milk ejection and the release of prolactin, which is linked to milk production 
(Dawood et al., 1981). 
Oxytocin and prolactin are also pivotal to breastfeeding and are associated with behavioral 
and physiological adaptations in breastfeeding women (Jonas et al., 2009; Jonas, Nissen, Ransjo-
Arvidson, Matthiesen, & Uvnas-Moberg, 2008; Nissen et al., 1998; Uvnas-Moberg, Widstrom, 
& Nissen, 1990). Animal studies show that oxytocin levels immediately after birth may be 
integral to the development of maternal behavior and the interaction between the mother and 
infant (Jonas et al., 2008; Keverne & Kendrick, 1994). Oxytocin promoted maternal behavior 
and mother/newborn interaction in animal experiments (Keverne & Kendrick, 1994; Pedersen, 
Ascher, Monroe, & Prange, 1982; Williams, Gazal, Leshin, Stanko, & Anderson, 2001) and 
promoted maternal behavior adaptations in human experiments (A. G. Frantz, 1978; Jonas et al., 
2009; A. Levine, Zagoory-Sharon, Feldman, & Weller, 2007; Pedersen et al., 1982; Poulain & 
Wakerley, 1982; Richard, Moos, & Freund-Mercier, 1991; Theodosis, Poulain, & Vincent, 
1981). Thus, it can be concluded that the mother’s endogenous oxytocin facilitates the 
mother/infant interaction and breastfeeding. 
Effects of Synthetic Oxytocin on Breastfeeding. 
The physiology of labor and onset of lactation is clearly understood, but little research has 
been conducted on the effects of synthetic oxytocin on breastfeeding or newborn neurobehavior, 
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although induction and augmentation of labor with synthetic oxytocin is used in the majority of 
births in the United States and is the most frequent medical intervention in childbirth (R. K. 
Freeman & Nageotte, 2007). Another study found a previously unsuspected association between 
reduction in breastfeeding rates and oxytocin administered either alone or combined with 
ergometrine (Jordan et al., 2009). Synthetic oxytocin used during labor was found to disturb 
onset and duration of breastfeeding in women who received higher doses of oxytocin 
experiencing difficulties with neonatal reflexes necessary for breastfeeding (Garcia-Fortea et al., 
2014; Olza Fernández et al., 2012). Oxytocin infusions cause serum levels of oxytocin to be 
much higher than seen naturally. This may interfere with the mother’s endogenous oxytocin 
release and/or sensitivity of oxytocin receptors, which could interfere with maternal/infant 
bonding postpartum (Garcia-Fortea et al., 2014; Jordan et al., 2009). 
Newborn neurobehavior feeding cues in 47 healthy term infants exposed to synthetic 
oxytocin demonstrated a low level of feeding organization, significant for brief and sustained 
hand-to-month cues compared to an unexposed group (Bell, White-Traut, & Medoff-Cooper, 
2010). In another study, the administration of oxytocin was associated with delayed initiation of 
breastfeeding and increased use of formula during the hospital stay (Wiklund et al., 2009). 
Synthetic oxytocin crosses the placenta and reaches the fetus (Melek, Blann, & Mattison, 
1996; M. R. Odent, 2013). Approximately 80% of the blood traveling from the umbilical vein to 
the fetus bypasses the liver, going directly to the vena cava through the patent ductus venosus 
and quickly to the brain. The fetal blood-brain barrier is very immature and permeable. The 
developing brain is exposed to a large amount of oxytocin during labor infusions. Oxytocin 
receptor desensitization induced by oxytocin is well documented (M. Odent, 2010; Phaneuf, 
Rodriguez Linares, TambyRaja, MacKenzie, & Lopez Bernal, 2000; C. Robinson, Schumann, 
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Zhang, & Young, 2003). It seems plausible that interfering with the oxytocin system in the 
developing brain of the fetus at this critical phase may alter neonatal behavior and contribute to 
difficulties with breastfeeding (M. R. Odent, 2013). Furthermore, oxytocin administration causes 
uterine contractions that are much stronger and more painful than natural contractions. Oxytocin 
can cause hyperstimulation of the uterus, producing fetal distress and hypoxia (Simpson & 
James, 2008; Wei, Luo, Xu, & Fraser, 2009). 
Epidural Analgesia and Oxytocin Regulation. 
There is no evidence that oxytocin administration increases epidural use (Bugg, Siddiqui, 
& Thornton, 2011; S. Wei et al., 2009), although in one study, women in whom labor was 
augmented or induced with oxytocin requested an epidural earlier than women who went into 
spontaneous labor (A. R. Moore, Shan, & Hatzakorzian, 2013). When oxytocin infusions and 
amniotomy were implemented together, the rate of epidural use did increase, and this occurred 
earlier in labor (S. Wei et al., 2009). This finding is significant because epidural analgesia 
combined with oxytocin for labor has been associated with negative birth outcomes (Roberts, 
Algert, Douglas, Tracy, & Peat, 2002; Tracy, Sullivan, Wang, Black, & Tracy, 2007). 
Women who receive epidural analgesia for labor pain have higher rates of oxytocin 
augmentation than those who do not receive epidural analgesia (Anim-Somuah et al., 2011; 
Chang & Heaman, 2005; Wiklund et al., 2009). Circulating maternal plasma levels of 
endogenous oxytocin decrease with the use of epidural analgesia during labor (Goodfellow, Hull, 
Swaab, Dogterom, & Buijs, 1983; Rahm, Hallgren, Hogberg, Hurtig, & Odlind, 2002). Research 
with sheep and heifers showed that epidural analgesia inhibited maternal oxytocin immediately 
postpartum in the blood and the brain, leading to hindered acceptance and recognition by the 
mother (Krehbiel, Poindron, Levy, & Prud'Homme, 1987; Williams et al., 2001). Epidural 
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analgesia impedes the binding of oxytocin to receptors located on the uterus, which leads to 
desensitization of the uterine oxytocin receptors, reducing uterine contractility (Phaneuf et al., 
2000; C. Robinson et al., 2003). Subsequently, augmentation with synthetic oxytocin (Pitocin, 
Syntocinon) is required in increasing amounts to maintain labor in women who have received 
epidural analgesia (Anim-Somuah et al., 2011; Chang & Heaman, 2005; E. Lieberman & 
O'Donoghue, 2002; Wiklund et al., 2009). As the concentration of the exogenous oxytocin 
infusions continue to rise, it interferes with the mother’s endogenous oxytocin release and uptake 
via a negative feedback mechanism (Goodfellow et al., 1983; Rahm et al., 2002). Women who 
had both an epidural and an oxytocin infusion for labor had significantly lower mean endogenous 
serum oxytocin levels in response to sucking on the second day postpartum in a dose-dependent 
fashion (Jonas et al., 2009). The shortened breastfeeding duration shown in women who received 
epidural analgesia (Beilin et al., 2005; J. J. Henderson et al., 2003; Torvaldsen, Roberts, 
Simpson, Thompson, & Ellwood, 2006) may be a result of decreased maternal milk production 
due to low levels of maternal oxytocin at birth, which may interfere with the pattern of oxytocin 
secretion for milk production and impact maternal-infant bonding at birth (Jordan et al., 2009). 
Although more than 70% of women in the United States use epidural analgesia during 
labor (Cambic & Wong, 2010), and almost all labors use oxytocin infusions to increase labor 
contractions (R. K. Freeman & Nageotte, 2007), the long-term consequences of these two 
interventions are largely unknown. Animal research has demonstrated perinatal manipulation of 
the oxytocinergic system can have enduring effects on feeding, attachment, and social and sexual 
behavior (Carter, 2003; Olza Fernández et al., 2012). Further research in this area is needed to 
ascertain the effects of intrapartum oxytocin combined with epidural analgesia on breastfeeding 
success and maternal and neonatal behavior. 
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Epidural Analgesia with Instrumental Vaginal Delivery and Breastfeeding 
Epidural analgesia is associated with a significantly higher rate of instrumental vaginal 
delivery (forceps and vacuum) (Anim-Somuah et al., 2011; Nyuyen et al., 2010). Two large 
cohort studies found that the use of epidural analgesia in nulliparous women was associated with 
a 4-fold increase in instrumental vaginal deliveries (Hawkins, Hess, Kubicek, Joyce, & Morrow, 
1995; Paterson, Saunders, & Wadsworth, 1992). Instrumented vaginal delivery can have serious 
ramifications for the neonate and mother. It has been associated with an increase in severe 
maternal perineal lacerations (J. N. Robinson, Norwitz, Cohen, McElrath, & Lieberman, 1999)  
and neonatal birth injuries (L. M. Chadwick, Pemberton, & Kurinczuk, 1996; Gebremariam, 
1999; Gilbert, Nesbitt, & Danielsen, 1999; C. A. Hughes, Harley, Milmoe, Bala, & Martorella, 
1999; M. G. Levine et al., 1984). Women who had epidural analgesia, forceps delivery, and 
episiotomy have been reported to have a 40% higher incidence of anal sphincter tears (Fitzgerald 
et al., 2007). In another study (J. H. Johnson, Figueroa, Garry, Elimian, & Maulik, 2004), 
neonates delivered by forceps showed a significantly greater risk for marks and bruising, 
whereas neonates delivered by vacuum showed significantly more cephalohematoma and caput 
and molding. Epidural analgesia was used frequently in both groups, with more in the forceps 
group, but the study classified according to delivery mode and not epidural use. This study also 
found a statistical significance with epidural and pudendal analgesia and episiotomy, vaginal 
lacerations, and third- and fourth-degree perineal lacerations with forceps, whereas in vacuum-
assisted deliveries periurethral lacerations were most significant (J. H. Johnson et al., 2004). 
A retrospective case-control study was designed to evaluate the relationship between 
epidural analgesia, labor length, and perinatal outcomes in 350 women who received epidural 
compared with 1400 patients without epidural. Epidural analgesia was associated with longer 
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labors and increased rates of vacuum deliveries due to dystocia or fetal distress was higher than 
the control (Hasegawa et al., 2013). The results also demonstrated that Apgar scores and 
umbilical artery pH were significantly lower in the neonates delivered by vacuum, whether they 
had an epidural or not. The instrument delivery adversely affected the neonate more than the 
epidural. 
Lieberman and colleagues evaluated 1233 nulliparous women in spontaneous labor who 
were afebrile at admission to investigate whether there was an association between intrapartum 
temperature elevation and assisted vaginal delivery (E. Lieberman, Cohen, Lang, Frigoletto, & 
Goetzl, 1999). They found that women who had a temperature ˃37.5ºC were three times more 
likely to experience an assisted vaginal delivery (25.2 % vs. 8.5%) in both epidural users and 
nonusers. Even after adjusting for potentially confounding factors such as length of labor, 
women who had an elevated temperature intrapartum were still two times as likely to require an 
assisted vaginal delivery. With more frequent intrapartum temperature elevations in women who 
receive epidural analgesia, perhaps this may be one factor to explain the higher assisted vaginal 
delivery rates in women who use epidural analgesia 
Epidural analgesia causes a longer stage 2 labor (Anim-Somuah et al., 2011) and a four-
fold increase in the risk of fetal occiput position (E. Lieberman, Davidson, Lee-Parritz, & 
Shearer, 2005). This combination can expose the fetal vertex to excessive molding (caput 
succedaneum) (Akmal & Paterson-Brown, 2009; Tamagawa & Weaver, 2012). The extra tension 
and stretch of the cranial nerves caused by the increased molding on the fetal vertex can cause 
hemorrhage when tension is added during instrumental delivery. This substantially increases the 
risk of postpartum complications. 
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Instrument deliveries cause pain during delivery from the episiotomy and perineal 
lacerations. When a repair is needed with stitches, this can create even more discomfort for the 
mother. The tissue damage caused by episiotomies and lacerations can take a long time to repair, 
and this can delay immediate skin-to skin contact between the infant and mother. During early 
skin-to-skin contact, the neonate initiates breastfeeding, inducing the production of maternal 
oxytocin necessary for milk production, uterine contraction, and maternal and neonatal 
behaviors. When delivery is difficult, the baby may need medical assessment, thereby delaying 
immediate skin-to-skin contact during the crucial time. Being in pain may prevent the mother 
from getting breastfeeding off to a good start. The baby may have pain from bruising and facial 
injury caused by the forceps or vacuum delivery which inhibits movements of the baby’s head 
and neck, making it difficult for the baby to get into the breastfeeding position and to latch on 
effectively. Longer stage 2 labor caused by epidural analgesia tires mothers and stresses babies, 
making breastfeeding even more difficult. The delay in breastfeeding that this cascade of events 
creates requires extra support and postpartum follow-up for the mother and neonate. 
Instrument-assisted delivery, longer labor, and maternal-infant separation after delivery 
may lead to increased difficulties in breastfeeding (Rajan, 1994) (Patel, Liebling, & Murphy, 
2003; Tamminen, Verronen, Saarikoski, Goransson, & Tuomiranta, 1983). Labor epidural 
analgesia affects these labor and delivery outcomes, thereby secondarily affecting breastfeeding 
initiation in conjunction with the direct effects of the medications (Anim-Somuah et al., 2011; 
Montgomery et al., 2012). 
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Effects of Epidural Medications on Breastfeeding 
It has been theorized that labor analgesia reduces a mother’s probability of successfully 
breastfeeding her child. One proposed mechanism by which intrapartum labor analgesia may 
decrease breastfeeding success is that women who remain unmedicated during labor experience a 
higher acute stress level, which subsequently prompts their neonate to organize neurobehavior 
including those tied to feeding, more rapidly and effectively during the immediate postpartum 
period (Bell et al., 2010). Those infants who feed most vigorously during the first few days of 
life are more likely to still be breastfeeding at 3 or 6 months (Mizuno, Fujimaki, & Sawada, 
2004). Epidural opioids are known to cross the placenta potentially depressing neonatal CNS 
function (Loftus et al., 1995). The neonatal depression may prevent development of good feeding 
behavior in the initial hours of life predisposing the mother to quit breastfeeding prematurely 
(Wieczorek et al., 2010).  
Empirical Studies on Labor Epidural Analgesia and Breastfeeding 
A review of the literature found 23 empirical studies that were specific to labor epidural 
analgesia and measured a breastfeeding outcome (French et al., in press). Results were 
conflicting: 11 studies found that epidural analgesia was not implicated in adverse breastfeeding 
outcomes (10 found no effect and 1 found a positive effect) and 12 studies showed negative 
associations between epidural analgesia and breastfeeding success.  
Of the 11 studies showing epidural analgesia was not implicated in adverse breastfeeding 
outcomes, 10 showed no effect (Albani et al., 1999; Armani et al., 2013; Bell et al., 2010; Chang 
& Heaman, 2005; Chen, Li, Wang, & Wang, 2008; Halpern et al., 1999; Radzyminski, 2003; 
Rajan, 1994; Wang, Li, & Hu, 2005; Wieczorek et al., 2010; Wilson et al., 2010), and only one 
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reported positive results on initiation of breastfeeding and quantity of milk in a comparison of 
continuous epidural with no analgesia (Wang et al., 2005). 
One study (Wieczorek et al., 2010) recruited 87 multiparas who had previously breastfed 
and who delivered vaginally after receiving continuous labor epidural infusion with various 
doses of fentanyl. A telephone questionnaire was administered during the immediate postpartum 
period and at 1 week and 6 weeks postpartum by an investigator blinded to the total fentanyl 
dose. No dose-response relationship was found. However, because of the high rate of 
breastfeeding (95.4% at week 6), the study did not have sufficient power to detect a difference 
between high and low doses of fentanyl. Another study (Radzyminski, 2003) evaluated 
breastfeeding behaviors using the Preterm Infant Breastfeeding Behavior Scale in 56 healthy 
mother-infant pairs and found no difference in neonatal rooting, latching, or sucking at 1 hour 
and at 24 hours after delivery between neonates born to mothers who received epidural analgesia 
and those whose mothers had no analgesia. They also measured the levels of bupivacaine and 
fentanyl in cord blood and found no significant effects on breastfeeding variables.   
In addition, no dose-response effect was found in a secondary analysis of data from a 
randomized trial in the United Kingdom that assessed the effect of epidural analgesia on mode of 
delivery. A total of 1054 primiparas were randomized to receive high-dose epidural analgesia 
with bupivacaine alone or one of two mobile epidural techniques with low-dose bupivacaine and 
fentanyl, either a combined spinal epidural with a mean fentanyl dose of 107 µg, or a low-dose 
infusion with a mean fentanyl dose of 163 µg (Wilson et al., 2010). A matched comparison 
group of women who did not receive regional analgesia was also recruited. The women were 
interviewed postpartum and mailed a postal questionnaire 12 months after delivery. The authors 
found no differences among the groups with regard to initiation rates or duration of 
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breastfeeding. However, the breastfeeding initiation rate was significantly lower in a subset of 
women in the non-epidural group who received pethidine than in the other groups. 
In a study reported in Chinese with an English abstract, 124 women with vaginal delivery 
were randomly divided into labor analgesia group (n = 75) and control group (n = 49). No 
significant differences in the initial time of lactation, the rate of abundant lactation, or newborn 
weight reduction between mothers receiving epidural analgesia and a control group (Chen et al., 
2008). In another study reported in Chinese with an English abstract, healthy women 
hospitalized for vaginal delivery without obstetric complications were observed, and 96 women 
who received continuous epidural anesthesia were compared with 74 women who did not (Wang 
et al., 2005). The epidural group had a shorter starting time of lactation, a larger quantity of milk 
secretion, and higher prolactin level 48 h after delivery. The women in the epidural group also 
reported better analgesia and postpartum mental state than the control group. 
Twelve studies found adverse effects of epidural analgesia on breastfeeding, either in 
comparisons of women with and those without epidural analgesia (Baumgarder et al., 2003b; 
Dozier et al., 2013; Gizzo et al., 2012; J. J. Henderson et al., 2003; Jordan et al., 2009; Ransjo-
Arvidson et al., 2001; J. Riordan, Gross, Angeron, Krumwiede, & Melin, 2000; Torvaldsen et al., 
2006; Volmanen et al., 2004; Wiklund et al., 2009) or in analyses of dose-response relationships 
of epidural medications and breastfeeding (Beilin et al., 2005; Jordan et al., 2005). 
In contrast to the three studies finding no effects of fentanyl dose level, a retrospective 
cohort study in the UK, in which midwife and obstetric case notes were analyzed in a random 
sample of 425 healthy primiparas identified from a birth registry (Jordan et al., 2005), found a 
dose-response relationship between fentanyl and bottle feeding. Higher fentanyl doses decreased 
breastfeeding rates even after demographic confounders of breastfeeding had been accounted for. 
97 
 
 
 
However, women who had decided antenatally to bottle feed did so regardless of fentanyl dose. 
In addition, a randomized double-blind study (Beilin et al., 2005) found an adverse effect of 
fentanyl dose on neurologic variables at 24 hours after birth but not on breastfeeding behavior 
observed by a lactation consultant. At 6 weeks, more women with high-dose than with low-dose 
fentanyl had discontinued breastfeeding. 
In a prospective cohort study of 1280 women in Australia who responded to mailed 
questionnaires regarding breastfeeding at 1, 8, 16, and 24 weeks postpartum (Torvaldsen et al., 
2006), women with epidural analgesia had an increased likelihood of breastfeeding difficulties 
and partial breastfeeding in the first week postpartum and were more likely to stop breastfeeding 
in the first 24 weeks compared with women who had no analgesia. In another prospective 
observational study conducted in Australia (J. J. Henderson et al., 2003), 992 primiparas were 
enrolled to investigate effects of labor epidural analgesia (n = 690) on breastfeeding duration by 
a self-reported postal questionnaire at 2 and 6 months. Women with labor epidural analgesia had 
a shorter breastfeeding duration and a 1.4-times greater risk of breastfeeding cessation in the first 
6 months postpartum when compared to women who had no analgesia. Similar results were 
found in a retrospective study of 164 primiparas with spontaneous vaginal delivery in Finland 
(Volmanen et al., 2004). Questionnaires were mailed a median of 2.4 years after delivery. 
Women who had epidural analgesia were more likely to report problems of “not having enough 
milk,” and reported more partial breastfeeding or formula feeding during the first 6 months 
postpartum than women who had no epidural. 
A retrospective cohort study was performed in a large obstetric data set from Wales to 
investigate the associations between drugs given routinely in labor and breastfeeding at 48 hours 
(Jordan et al., 2009). Regression analysis confirmed the association between epidural analgesia 
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and lower breastfeeding rates, even after accounting for confounding variables such as age, 
parity, and social class. The authors did not name the epidural medications used. 
A prospective study assessed the effects of different types of analgesia during labor on 
spontaneous breastfeeding movements and behavior (Ransjo-Arvidson et al., 2001). The authors 
videotaped 28 neonates placed skin-to-skin with the mother immediately after birth. Analysis of 
the video tapes blinded to type of analgesia or no analgesia showed that neonates whose mothers 
had received labor analgesia had less frequent infant hand massage–like movements and sucking 
at the breast than infants whose mothers had received no analgesia, with almost half of the 
infants in the analgesia group not breastfeeding within the first 2.5 hours after birth. However, 
some patients receiving epidural analgesia also had parenteral pethidine or multiple types of 
analgesia, and only two patients had only epidural analgesia. Another prospective study of 129 
women in the United States examined labor analgesia and its effect on neonatal sucking and 
breastfeeding duration (J. Riordan et al., 2000). The researchers measured suckling using the 
IBFAT and found reduced neonatal suckling scores in women who had labor analgesia, although 
there was no difference in duration of breastfeeding through 6 weeks postpartum compared to 
women who had no analgesia. Similarly, a study in the United States of 52 mixed-parity healthy 
women with spontaneous vaginal delivery found that epidural analgesia (n = 34) was associated 
with reduced sucking among the female neonates during their first feed compared with the 
nonmedicated group (Armani et al., 2013; Bell et al., 2010). 
In a retrospective comparative study carried out in Sweden (Wiklund et al., 2009), all 
maternity records of women who received epidural analgesia for labor between January 2000 
and April 2000 were assessed. After exclusions, 351 charts were included. Each epidural chart 
was matched to a control record similar in age, parity, and gestational age. Compared to matched 
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controls, neonates born to mothers who had epidural analgesia during labor had significantly 
lower rates of suckling at the breast during the first 4 hours after delivery, were given formula 
more often while in the hospital, and fewer were fully breastfeeding at discharge. 
Discussion of Studies on the Effects of Epidural Analgesia on Breastfeeding 
Studies on the relationship between epidural analgesia and breastfeeding success yielded 
conflicting results, with 1 study showing a positive association, 12 studies yielding negative 
associations, and 10 studies finding no effect of epidural analgesia on breastfeeding. The level of 
evidence was evaluated using the criteria shown in Table 2.  
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Table 2. Criteria for Evaluating Levels of Evidence 
 Therapeutic Studies—Investigating the Results of Treatment 
Level I 1. Randomized controlled trial 
a. Significant difference 
b. No significant difference but narrow confidence intervals,  
2. Systematic review of Level I randomized controlled trials (studies were 
homogeneous) 
Level II 1. Prospective cohort study,  
2. Poor-quality randomized controlled trial (e.g., <80% follow-up) 
3. Systematic review  
a. Level II studies 
b. Nonhomogeneous Level I studies 
Level III 1. Case-control study 
2. Retrospective cohort study 
3. Systematic review of Level III studies 
Level IV Case series (no, or historical, control group) 
Level V Expert opinion 
Source:  Wright, J. G., Swiontkowski, M. F., & Heckman, J. D. (2003). Introducing levels of evidence to the journal. 
The Journal of Bone and Joint Surgery. American volume, 85-A(1), 1-3. 
 
The studies are summarized in Table 3. The level of evidence ranged from II to IV. 
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Table 3. Studies on the Effects of Epidural Analgesia on Breastfeeding 
 Type of Study EDA  
(n) 
Comparison 
Group  
(n) 
Assessment Methods Findings Limitations Evidence 
Level 
Rajan,  
1994 
Retrospective 
study – 
secondary 
analysis of 
UK survey of 
pain relief in 
labor  
(n = 1064) 
Lignocaine 
(Lido)  
No EDA  Questionnaire mailed 
at 6 weeks asked 
whether mother was 
breastfeeding  
No negative effects of EDA, but 
breastfeeding rate decreased 
when mothers received 
pethidine  
Retrospective study; not 
able to separate use of 
lignocaine in EDA 
from use as local 
anesthetic; doses 
unknown; pethidine 
used in some EDA 
patients; chi-square 
analyses 
III 
Albani et al.,  
1999 
Prospective 
cohort study; 
vaginal 
delivery (n = 
1920); mixed 
parity 
Drugs unknown No analgesia Recorded feeding 
modality at 
discharge 
No difference in breastfeeding 
rate between EDA and no 
analgesia in women with 
vaginal delivery 
Article in Italian, only 
abstract in English; 
unknown medication 
and doses; chi-square 
analyses 
II 
Halpern et al.,  
1999 
Prospective 
cohort study, 
mixed parity 
(n = 189) 
Combined 
spinal/EDA 
(Bupi + Suf) (n 
= 79) or pure 
EDA (Lido or 
Bupi) (n = 34); 
maintained 
with Bupi or 
Fent if needed. 
Total EDA 
n =113  
No EDA (n = 
76) 
Breastfeeding 
assessment at 6 
weeks by structured 
telephone interview; 
multivariate logistic 
regression analysis 
(n = 171) 
No significant effect of EDA or 
other types of labor analgesia 
on breastfeeding when leaving 
hospital or 6 weeks later; 74% 
were fully breastfeeding at 6-8 
weeks 
Study included only 
women intending to 
breastfeed; EDA was 
combined with spinal 
and/or IM opioid in 
some patients  
II 
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 Type of Study EDA  
(n) 
Comparison 
Group  
(n) 
Assessment Methods Findings Limitations Evidence 
Level 
Riordan et al.,  
2000 
Prospective 
multisite 
cohort study; 
unknown 
parity 
Assorted drugs, 
usually Bupi + 
Fent or Suf 
(n=27) in 
varied doses 
No medication 
(n=37); IV 
opioids 
(n=52); both 
IV opioids 
and EDA 
(n=13) 
Sucking (IBFAT) 
during hospital stay; 
duration of 
breastfeeding 
assessed by 
telephone at 6 
weeks; ANCOVA 
Significant negative effect of 
medication vs no medication 
on IBFAT (suck scores, 
LATCH. No difference 
between EDA and IV opioids 
but mothers with both had 
significantly lower scores. 
Medication diminished sucking 
but not duration of 
breastfeeding, although 
duration shorter with low 
IBFAT scores  
Multiple medication and 
doses; unclear whether 
IBFAT assessment was 
properly blinded; post 
hoc analysis of EDA vs 
IV opioids 
II 
Ransjo-Arvidson 
et al.,  
2001 
Prospective 
cohort study;  
parity 
unknown 
Bupi via EDA or 
parenteral 
pethidine or 2-3 
types of 
analgesia 
(n=12) 
Pudendal block 
with 
mepivacaine 
(n=6) or no 
analgesia 
(n=10) 
Video recordings of 
immediate PP skin-
to-skin (assessed 
blindly) - rooting, 
latch on, sucking, 
swallowing, activity 
state, and 
neurobehavior. Age 
at and duration of 
first suck and 
number of sucks 
Negative effect of EDA: 
Medicated babies had less 
frequent hand movements than 
nonmedicated babies. Nearly 
half of the medicated group did 
not feed in the first 2.5 hours of 
life, had higher temps (p = 
0.03) and cried more (p=0.05) 
Small sample size, some 
patients with EDA had 
parenteral pethidine or 
multiple types of 
analgesia; only 2 
patients had EDA alone 
II 
Radzyminski  
2003, 2005 
Randomized 
trial 
Bupi + Fent + 
Epinephrine in 
an ultralow-
dose infusion 
(n=28) 
No analgesia 
(n=28) 
PIBBS/NACS at birth 
and 24 hours;  
high NACS = 
increased 
breastfeeding 
success. Measured 
duration of epidural 
infusion and amount 
of drug in cord 
blood at birth 
No significant difference 
between EDA and no analgesia 
in PIBBS/NACS scores. No 
significant relation between 
levels of bupivacaine or 
fentanyl in cord blood and 
breastfeeding variables 
 
Small sample size, 
randomization method 
not truly random 
II 
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 Type of Study EDA  
(n) 
Comparison 
Group  
(n) 
Assessment Methods Findings Limitations Evidence 
Level 
Henderson et al.,  
2003 
Prospective 
observational 
(cohort) study; 
primiparas 
CSE with PCEA 
Bupi + Fent 
(n=690) 
Continuous 
midwifery 
support 
group, N2O 
and/or 
pethidine 
(n=302) 
Time and quality of 
first breastfeed and 
self-report at 2 and 
6 months 
Negative effect of EDA: EDA 
associated with shorter 
duration of breastfeeding. 
Factors that favored longer 
breastfeeding were higher 
education, older mothers, non-
smokers and no EDA 
Intended as a randomized 
clinical trial, but 
analyzed as a 
prospective 
observational study 
because of high 
crossover rates 
(43.4%), pethidine used 
in some EDA patients; 
self-report biased and 
unreliable 
II 
Baumgarder et 
al.,  
2003 
Prospective 
cohort study 
(consecutive 
breastfeeding 
mothers 
receiving 
EDA 
compared with 
next 
breastfeeding 
mother 
without EDA); 
mixed parity 
Drugs not 
specified 
(n=115) 
No analgesia 
(n=116) 
2 successful 
breastfeeding 
sessions in 24 hours 
as defined by 
LATCH 
Negative effect of EDA, with 
69.6% of mothers with EDA 
and 81% of nonmedicated 
mothers achieved successful 
breastfeeding in 24 hours; OR 
0.53; p=0.04 by LATCH  
Medications used not 
stated 
II 
Volmanen et al.,  
2004 
Retrospective 
survey, 
primiparas, 
vaginal 
delivery 
Bupi + 
occasional Fent 
(n=30) 
No EDA 
(n=34) 
Mailed questionnaire 
2-3 years after 
delivery asking 
about breastfeeding 
success or failure in 
the first 12 weeks 
Negative effect of EDA. Full 
breastfeeding: 33% with EDA, 
71% with no EDA; “not 
enough milk” was reported as 
reason more often with EDA 
Doesn't address 
breastfeeding in 
immediate PP, recall 
after 2-3 years may be 
faulty, failed to control 
for confounding 
variables after 
discharge 
III 
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 Type of Study EDA  
(n) 
Comparison 
Group  
(n) 
Assessment Methods Findings Limitations Evidence 
Level 
Chang & 
Heaman,  
2005 
Prospective 
cohort study; 
mixed parity 
Bupi or Ropi 
with Fent or 
occasionally 
epinephrine; no 
other analgesia 
(n=52) 
No analgesia 
(n=63) 
Assessed at 8-12 
hours PP LATCH 
and NACS 
telephone; phone 
interview at 4 weeks 
PP 
No differences between EDA 
and no analgesia regarding 
LATCH and NACS. Positive 
correlation between infant 
neurobehavior and 
breastfeeding effectiveness 
(p=0.01) 
No mention of 
breastfeeding hospital 
practices, no definition 
of exclusive 
breastfeeding, no 
mention of total EDA 
infusion time 
II 
Jordan et al.,  
2005 
Retrospective 
sample from 
birth register, 
primiparas 
Neuraxial 
analgesia 
(n=232) 
containing 
opioid (n=158) 
or local 
anesthetic 
(n=74) 
Nitrous oxide 
or IM opioid 
(n=570) 
Infant feeding at 
discharge as 
recorded in case 
notes: proportion 
with exclusive 
bottle feeding or 
breastfeeding (total 
or partial) 
Possible negative effect of EDA: 
Bottle feed: N2O+O2 (32%); 
IM opioids + N2o+O2 (42%); 
Neuraxial LA (44%); neuraxial 
+opioid (54%) with Fent (55%) 
and morphine (64%). Main 
determinants of bottle feed: 
maternal age, occupation, feed 
intention, cesarean, and Fent in 
a dose-response relationship  
IM pethidine used in 
some EDA patients; No 
formal breastfeeding 
assessment in discharge 
summary; exclusive 
breastfeeding not 
separately analyzed, no 
neurobehavior 
assessment 
III 
Beilin et al.,  
2005 
Randomized 
double-
blinded study 
of different 
doses of Fent 
in EDA; 
multiparas 
who had 
previously 
breastfed 
Bupi with 
intermediate-
dose Fent 
(n=59) or high-
dose Fent 
(n=58) 
EDA with Bupi 
only (no 
Fent) (n=60) 
PP day 1, mother and 
lactation consultant 
each assessed 
breastfeeding 
separately using “B-
R-E-A-S-T” feeding 
observation form, 
NACS and 6 weeks 
PP telephone 
interview 
Negative effect of high-dose Fent 
at 24 h on NACS scores but no 
difference in consultant 
assessment. Negative effect of 
increasing Fent dose at 6 
weeks, 17% of PP women in 
the high-dose Fent group, 5% 
with the interim dose, and 2% 
with no Fent reported stopping 
breastfeeding (p=0.005). High-
dose Fent group reported 
significantly more difficulty 
with breastfeeding than other 
groups  
No control group without 
EDA, breastfeeding 
assessed at 6 weeks 
II (for dose 
compari-
son) 
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 Type of Study EDA  
(n) 
Comparison 
Group  
(n) 
Assessment Methods Findings Limitations Evidence 
Level 
Wang et al.,  
2005 
Prospective 
observational 
study; 
unknown 
parity 
Continuous EDA, 
drug unknown 
(n=96) 
No EDA 
anesthesia or 
postpartum 
analgesia 
Starting time of 
lactation, milk 
quantity, feeding 
times in 24 h, 
prolactin level 48 h 
after delivery 
Positive effects of EDA: EDA 
group had earlier starting time 
of lactation, larger quantity of 
milk secretion, higher prolactin 
levels 48 h after delivery, better 
analgesia and PP mental state 
than control 
Article in Chinese –only 
abstract available in 
English 
II 
Torvaldsen et al.,  
2006 
Prospective 
cohort, 
primiparas and 
multiparas 
either 
intending or 
not intending 
to breastfeed 
(not 
differentiated) 
Bupi + Fent 
PCEA ± IM 
pethidine or 
N20 (n=416) 
 
No analgesia, 
N2O, 
pethidine 
(with or 
without N2O), 
or general 
anesthesia 
(n=762) 
Questionnaire on day 
4 and mailed at 8, 
16, and 24 weeks 
PP. Breastfeeding 
categorized as full, 
partial or not 
breastfeeding 
Possible negative effect of EDA: 
at week 1, EDA ± pethidine 
group had higher risk of partial 
instead of full breastfeeding 
compared with N2O, pethidine, 
and no analgesia groups. At 24 
weeks, both EDA and 
pethidine groups had higher 
risk of breastfeeding cessation 
than no analgesia group (p = 
<0.0001)  
Not possible to determine 
effects of EDA alone 
because no EDA 
patient had vaginal 
birth without pethidine 
(all EDA patients 
without pethidine had 
cesarean birth)  
III 
Chen et al.,  
2008 
Randomized 
study 
Ropi PCEA 
(n=75) 
No analgesia 
(n=49) 
 
Starting time of 
lactation, rate of 
abundant lactation, 
newborn weight 
reduction, and 
prolactin were 
recorded during first 
24 hours 
No differences between EDA 
and no analgesia in starting 
time of lactation, rate of 
abundant lactation, or newborn 
weight reduction 
Article in Chinese – only 
abstract available in 
English 
Not clear if 
I or II 
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 Type of Study EDA  
(n) 
Comparison 
Group  
(n) 
Assessment Methods Findings Limitations Evidence 
Level 
Jordan et al.,  
2009 
Retrospective 
analysis of 
survey data; 
(n=48,366) 
EDA drugs not 
specified, with 
or without IM 
opioid or spinal 
No analgesia Breastfeeding or not 
at 48 hours PP; as 
recorded in maternal 
notes. Regression 
analyses 
Negative effect of EDA: 
Regression analysis showed 
breastfeeding rate was 
significantly lower with EDA 
than with no EDA (p<0.001), 
even when adjusted for parity  
Drugs and doses not 
specified; incomplete 
coding for social class. 
Retrospective design 
cannot separate effects 
of confounding 
variables 
III 
Wiklund et al.,  
2009 
Retrospective 
matched case-
controlled 
study  
Bupi+Suf ± 
pudendal or 
paracervical 
block (n=351) 
No analgesia 
+/- pudendal 
or 
paracervical 
block 
(n=351) 
Breastfeeding 
assessed at 1 and 4 
hrs after birth, 
bottle-fed in hosp, 
breastfeeding at 
discharge; as 
recorded in 
maternity record 
Negative effect of EDA: Fewer 
babies of mothers who received 
EDAs suckled breast within 
first 4 hours (p<0.0004); babies 
with EDAs were more likely to 
receive supplement (p<0.0012), 
and fewer had exclusive 
breastfeeding at discharge 
(p<0.0430) 
Retrospective study III 
Wilson et al.,  
2010  
Prospective 
cohort study – 
secondary 
outcome 
measure from 
randomized 
trial 
comparing 
different types 
of EDA 
(COMET 
trial)  
High-dose Bupi 
(n=353); CSE 
with low-dose 
Bupi+Fent 
(n=351); low-
dose Bupi and 
Fent infusion 
(n=350) 
Nonrandomize
d matched 
comparison 
group with no 
EDA 
(n=351); 
pethidine 
(n=151) 
Interviewed 24-48 hrs 
PP. Postal 
questionnaire 12 
months PP asked 
duration of 
breastfeeding 
No difference between EDA and 
non-EDA groups in 
breastfeeding initiation; women 
with pethidine in non-EDA 
group reported lower 
breastfeeding initiation rates 
(p=0.002). Older age (p<0.001) 
and non-white ethnicity 
(p<0.026) predicted 
breastfeeding. Duration of 
breastfeeding similar across all 
EDA groups 
Maternal report of 
breastfeeding may not 
be accurate, sample 
size estimates not 
determined by 
breastfeeding initiation 
or duration, and no data 
on additional 
breastfeeding support 
women may have had 
II 
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 Type of Study EDA  
(n) 
Comparison 
Group  
(n) 
Assessment Methods Findings Limitations Evidence 
Level 
Bell et al.,  
2010  
Prospective 
cohort study 
EDA Bupi+Fent 
(n=34) 
No medication 
(n=18) 
Neonatal 
neurobehavior 
organization 
measured within 1 
hour after birth with 
sucking apparatus  
No difference in number of 
sucks; sucking pressure not 
related to EDA exposure 
overall, but unmedicated girls 
had more sucks (p=0.027) than 
girls in EDA group. Overall 
girls had stronger suck pressure 
than boys (p=0.042)  
Groups were self-
selected. Missing data 
on 4 neonates due to 
video recorder 
problems/ and 1 infant 
needing observation, no 
racial/ethnic diversity, 
and small sample size 
II 
Wieczorek et al., 
2010 
Prospective 
observational 
cohort study; 
multiparas 
who had 
previously 
breastfeeding 
successfully 
Bupi+Fent 
(n=87). 
Compared 
high-dose Fent 
(>150 g, 
n=47) vs low-
dose Fent 
(<150 g, n = 
40) 
No control 
without EDA 
Immediate PP 
questionnaire and 
telephone interview 
at 1 and 6 weeks 
with degree of 
breastfeeding 
classified 
No significant correlation 
between Fent dose and 
breastfeeding success. 
Breastfeeding success rate of 
>95% PP; cessation rate at 6 
weeks PP was much lower than 
in previously quoted literature 
Comparison was only 
high vs low dose of 
Fent. High 
breastfeeding rates 
resulted in insufficient 
power to detect a true 
difference between 
doses if one existed 
II (for dose 
comparison
) 
Gizzo et al.,  
2012 
Prospective 
cohort study; 
primiparas 
Bolus Fent+Ropi, 
booster boluses 
as need (n=64) 
No medication 
(n=64). 
Controls 
randomly 
selected from 
larger group 
who met 
inclusion 
criteria but 
did not 
receive EDA 
Within 2 hours of 
birth midwife 
completed grid 
follow-up and 
recorded data 
Negative effect of EDA: 
Duration of first breastfeeding 
was significantly shorter in the 
EDA group than in the 
nonmedicated group (p<0.001), 
and length of labor was longer 
in epid vs. nonmedicated 
(p<0.001) 
Abstract states 
“randomized” but 
assignment to study 
group was not random; 
narrow patient selection 
(patients with potential 
confounding factors 
excluded)  
II 
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 Type of Study EDA  
(n) 
Comparison 
Group  
(n) 
Assessment Methods Findings Limitations Evidence 
Level 
Armani et al.,  
2013 
Retrospective 
case-control 
study 
Bupi or Ropi 
combined with 
opiates 
administered as 
EDA top-up 
(n=287) 
No analgesia 
(n=1676) 
Gathered data on 
neonatal and 
obstetric outcomes, 
rates of 
breastfeeding, 
supplemental 
formula, and full 
formula 
No difference between EDA and 
no analgesia in breastfeeding 
rate or supplementation. EDA 
had higher rates of instrument 
deliveries (p<0.01; occiput post 
position (p<0.05, neonatal 
cephalohematoma (p=0.01) and 
lower 1 minute Apgar 
(p=0.016); more women with 
EDA had fever (p=0.003) 
Retrospective design; not 
possible to draw 
conclusions about 
duration of 
breastfeeding  
III 
Dozier et al.,  
2013 
Retrospective 
analysis of 
data from 2 
cohort studies 
of 
breastfeeding 
support: 1 
prospective in-
hospital and 1 
retrospective 
perinatal; 
primi- and 
multiparas 
EDA (any type, 
drugs not 
specified, 
excluded local, 
spinal, or 
general 
anesthesia) 
(n=437) 
No EDA 
(n=290) 
Data abstracted from 
birth certificate + 
EMR; breastfeeding 
cessation within 
first month assessed 
by maternal self-
report (mailed 
survey)  
Negative effect of EDA: Mothers 
with EDA more likely to 
discontinue breastfeeding 
during first 30 days (Kaplan-
Meier analysis with log-rank 
test), even considering BFH 
status and other factors (p<0.04 
for BFH; p<0.01 for non-BFH) 
(Cox proportional hazards). 
Mothers with EDA + oxytocin 
most likely to stop 
Medications not 
specified; breastfeeding 
data relied on maternal 
self-report; results 
applicable only to 
vaginal deliveries, full-
term singleton infants; 
secondary analysis – 
data not available for 
certain relevant 
variables; different data 
sources may introduce 
bias  
II-III 
ANCOVA = analysis of covariance; BFH = Baby-Friendly Hospital; Bupi = bupivacaine; CSE = combined spinal epidural; EDA = 
epidural analgesia; EMR = electronic medical record; Fent = fentanyl; IBFAT = Infant Breastfeeding Assessment Tool; IM = 
intramuscular; LATCH = breastfeeding assessment tool; Lido = lidocaine; NACS = Neonatal Neurologic and Adaptive Capacity Score; 
PCEA = patient-controlled epidural analgesia; PIBBS = Preterm Infant Breastfeeding Behavior Scale; PP = postpartum; Ropi = 
ropivacaine; Suf = sufentanil. 
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Only two randomized studies comparing epidural analgesia to no analgesia were found, 
and neither study justified classification at level I. One of these (Radzyminski, 2003; J. G. 
Wright, Swiontkowski, & Heckman, 2003) showed no difference in breastfeeding behaviors 
between infants of women who received epidural analgesia and those whose mothers received no 
analgesia, but the method of treatment allocation was not truly random. The second randomized 
trial (Chen et al., 2008) showed no difference between epidural analgesia and no pain-relieving 
measures. However, the number of patients in the two groups differed, and it was not possible to 
evaluate the study design because only the abstract was available in English. One problem with 
studies that find no differences between groups is that they are not always powered to detect a 
true difference, even if one did indeed exist. 
Another study (J. J. Henderson et al., 2003) was intended as a randomized trial, but 
breastfeeding outcomes were analyzed as a prospective observational study because of high 
crossover rates (43.4%). This study found an association between epidural analgesia and 
shortened duration of breastfeeding. A further randomized study compared different doses of 
epidural fentanyl without a non-epidural group and found a negative effect of increasing doses 
(Beilin et al., 2005).  
If epidural medications have a physiological effect on breastfeeding, and the half-life of 
epidural fentanyl in the maternal circulation is 2 to 2.5 hours, then breastfeeding should be 
studied the first few hours after delivery, before the drugs are cleared. However, breastfeeding 
was measured at time points ranging from immediate postpartum to 6 months, or assessed 
retrospectively through questionnaires mailed up to 2 or 3 years after delivery. Especially after 
so much time has elapsed, maternal self-report carries the risk of recall bias. After hospital 
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discharge, many new factors may confound the picture of breastfeeding success; for example, 
lack of social support, presence of siblings, or the mother’s need to return to work or school. In 
addition, studies did not always take into account maternal factors that may influence 
breastfeeding, such as the mother’s intention to breastfeed, level of education, marital status, 
BMI, and smoking behavior. 
Numerous differences among studies make it difficult to draw conclusions. Different 
definitions of breastfeeding success were used. In some studies, breastfeeding was considered 
successful only if exclusive, whereas other studies grouped partial and full breastfeeding 
together. Many of the studies did not consider other factors that may influence breastfeeding 
success, such as hospital practices in regard to provision of breastfeeding support, availability of 
supplemental formula, and the timing of breastfeeding initiation after delivery. A hospital 
environment strongly supportive of breastfeeding may be able to at least partially offset the 
potential negative effects of epidurals on breastfeeding (Halpern et al., 1999; Wieczorek et al., 
2010).  
To assess reflexes needed for rooting and swallowing, standardized breastfeeding 
assessment tools such as LATCH (D. Jensen et al., 1994), the IBFAT (Matthews, 1988), or the 
Preterm Infant Breastfeeding Behavior Scale (PIBBS) (Nyqvist, Rubertsson, Ewald, & Sjoden, 
1996) should be used. However, only a few studies reported such measures (Baumgarder et al., 
2003b; Beilin et al., 2005; Chang & Heaman, 2005; Radzyminski, 2003; J. Riordan et al., 2000).  
The drugs and doses used in labor epidural analgesia varied among study sites, but all 
contained a local anesthetic (usually bupivacaine) and an opioid (generally fentanyl or 
sufentanil). However, some studies failed to mention the exact name and/or dose of the 
medications used in the epidural. Furthermore, in several studies, women in the epidural 
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analgesia groups also received other medications, including pethidine, which has been shown to 
have an adverse effect on breastfeeding (Rajan, 1994; Wilson et al., 2010). This makes it very 
difficult to determine whether the observed breastfeeding outcome was associated with the 
pharmacokinetics of a specific epidurally administered drug given at a specific dose at a certain 
time or with some other variable related to the epidural.  
It is unclear whether and to what extent epidural medications exert a direct or indirect 
effect on breastfeeding. For example, epidurally administered local anesthetic and opioid drug 
combinations readily cross the placenta and fetal blood-brain barrier and may depress necessary 
neonatal reflexes needed for rooting, swallowing, or sucking (Chang & Heaman, 2005). A 
depressed neonate not responsive to sucking may prompt the mother to quit breastfeeding too 
soon. Because an intact and functioning central nervous system is necessary for an infant to latch 
on and feed, several studies have used the NACS (Amiel-Tison et al., 1982b) to address the 
association between epidural opioids and neonatal neurobehavior. Infants who score high on 
breastfeeding behaviors tend to have high NACS scores (Chang & Heaman, 2005; Radzyminski, 
2005). For example, Beilin et al. randomized 177 multiparas who had previously breastfed into 
three groups, with epidural bupivacaine and either no fentanyl, or fentanyl at <150 g or >150 
g (Beilin et al., 2005). More than 150 g of fentanyl was associated with significantly lower 
NACS scores compared to bupivacaine without fentanyl. Thus, it can be concluded that 
depression of the neonate’s tone by epidural opiates impedes the neonate’s ability to latch on to 
the breast. Such factors may result in a vicious circle, preventing good feeding behaviors in the 
first 24 hours of life, which may prompt the mother to quit breastfeeding too soon.  
Epidural analgesia has been consistently associated with maternal fever or temperature 
elevation. This may also affect breastfeeding, because the transfer of heat can cause fetal 
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hyperthermia. In one study (Greenwell et al., 2012), when the temperature of all women who 
received epidural analgesia was evaluated, a significant linear correlation was found between 
maximum maternal temperature and the infant’s Apgar scores, hypotonia, early-onset seizures, 
and need for assisted ventilation. Infants born to women with maternal fever ˃38.3ºC had a two- 
to six-fold increase in all the neonatal outcomes evaluated. Although no data are available on the 
specific effects of increased maternal temperature on breastfeeding, the many studies showing a 
negative effect of maternal fever on neonatal outcomes make it logical to postulate a negative 
effect on breastfeeding.  
Furthermore, it is not clear to what extent the combination of epidural analgesia with other 
intrapartum interventions has an indirect effect on breastfeeding (Montgomery et al., 2012). 
Recent emphasis has been placed on research involving the potential lowering effect of epidural 
analgesia on oxytocin levels in the maternal plasma during labor and birth and the relationship of 
epidural analgesia to the mother's endogenous release of oxytocin. Oxytocin use has been 
associated with delayed initiation of breastfeeding (Wiklund et al., 2009), and combined 
administration of epidural analgesia and oxytocin during labor has been negatively associated 
with breastfeeding success. The shortened breastfeeding duration shown in women who received 
epidural analgesia (Beilin et al., 2005; J. J. Henderson et al., 2003; Torvaldsen et al., 2006) may 
be a result of decreased maternal milk production due to low levels of maternal oxytocin at birth, 
which may interfere with the pattern of oxytocin secretion for milk production and impact 
maternal-infant bonding at birth (Jordan et al., 2009). Further research in this area is needed to 
ascertain the effects of intrapartum oxytocin combined with epidural analgesia on breastfeeding 
success. 
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Epidural analgesia is also associated with a significantly higher rate of instrumental 
vaginal delivery (Anim-Somuah et al., 2011; Nguyen et al., 2010). Two large cohort studies 
found that the use of epidural analgesia in nulliparous women was associated with a 4-fold 
increase in instrumental vaginal deliveries (Hawkins et al., 1995; Paterson et al., 1992). 
Instrumental vaginal delivery can have serious ramifications for the neonate and mother. A 
retrospective case-control study was designed to evaluate the relationship between epidural 
analgesia, labor length, and perinatal outcomes in 350 women who received epidural analgesia 
compared with 1400 patients without epidural. Epidural analgesia was associated with longer 
labors and increased rates of vacuum deliveries due to dystocia or fetal distress was higher than 
the control (Hasegawa et al., 2013).  
The tissue damage caused by episiotomies and lacerations due to instrumental delivery can 
take time to repair, which can delay immediate skin-to skin contact between the infant and 
mother. During early skin-to-skin contact, the neonate initiates breastfeeding, inducing the 
release of maternal oxytocin necessary for milk production and maternal and neonatal behaviors. 
When delivery is difficult, the baby may need medical assessment, thereby delaying immediate 
skin-to-skin contact during the crucial time. Being in pain may prevent the mother from getting 
breastfeeding off to a good start. The baby may have pain from bruising and facial injury caused 
by the forceps or vacuum delivery which inhibits movements of the baby’s head and neck, 
making it difficult for the baby to get into the breastfeeding position and to latch on effectively. 
Longer stage 2 labor caused by epidural analgesia tires mothers and stresses babies, making 
breastfeeding even more difficult. The delay in breastfeeding that this cascade of events creates 
requires extra support and postpartum follow-up for the mother and neonate. 
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This literature review demonstrates that the relationship between epidural analgesia and 
breastfeeding remains inconclusive. This is not surprising, considering that the available studies 
varied in design, outcome definition, sample size, control group, inclusion of many potential 
confounders, and rigor, making any statistical conclusion difficult. Poor study design is common. 
Few studies are able to use randomized treatment allocation, most do not use a breastfeeding 
assessment tool. Some studies have not mentioned the names of medications that were used, at 
what dose or concentration of the epidural infusion, making it difficult to determine whether any 
effects are caused by the specific drugs in the epidural infusate or the condition that the epidural 
analgesia itself has created (Szabo, 2013). 
Despite concern regarding adverse effects on breastfeeding, epidural analgesia and other 
intrapartum interventions are frequently used because of the benefits they confer. Therefore, it is 
important to find ways of ameliorating any adverse consequences. Hospital practices and 
providers can lend additional breastfeeding support to women who are at a higher risk of not 
initiating breastfeeding or for early cessation. Various strategies may be tried, but one promising 
way to achieve this goal is for hospitals to offer breastfeeding support by promoting unlimited 
skin-to-skin contact between mother and neonate. Skin-to-skin contact between the neonate and 
the mother during this sensitive period enhances the long-term interaction between mother and 
neonate. When this contact occurs, mothers have been shown to be more likely to be 
breastfeeding at 1 and 4 months after delivery and for a longer duration (Bystrova et al., 2009; 
Salariya et al., 1978; Wiberg et al., 1989) 
Building on the considerations discussed in this chapter, the current study attempts to 
provide more information on the relationship between epidural analgesia and breastfeeding 
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success. The next chapter discusses the methods used in this study to answer the research 
questions. 
  
116 
 
 
 
 
Chapter 3: Methods 
This prospective, observational study investigated whether breastfeeding would be less 
effective in infants whose mothers received epidural analgesia with hydromorphone compared 
with those whose mothers received no analgesia, and whether the total amount of drugs given or 
the presence of multiple stressful events or interventions during labor would be related to the 
effectiveness of breastfeeding. Chapter 3 presents the specific hypotheses, discusses the study 
design, and describes the selection of subjects, the setting of the study, the type of epidural 
analgesia used, the study variables and procedures (including procedures used to ensure rigor of 
the study and protection of human subjects), the risks and benefits of the study, and the methods 
used for statistical analysis. 
Hypotheses 
Based on the research questions posed in Chapter 1, the following hypotheses were 
formulated: 
H1: Compared with healthy term infants whose mothers received no analgesia, healthy 
term infants of mothers who receive epidural analgesia with hydromorphone will exhibit 
significantly less effective breastfeeding behaviors at 3, 12, and 24 hours of age. 
H2: Duration of infusion/amount of infusate will be significantly negatively related to 
breastfeeding behaviors at 3, 12, and 24 hours of age in healthy term infants whose mothers 
receive epidural analgesia with hydromorphone for labor pain. 
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H3: When multiple stressful events or interventions are present during labor or 
immediately after birth, healthy term infants will demonstrate significantly less effective 
breastfeeding behaviors at 3, 12, and 24 hours of age, whether or not labor analgesia was used.  
Study Design  
To test these hypotheses, a prospective, observational, single-blinded cohort design was 
used to compare breastfeeding behaviors of infants whose mothers chose to receive epidural 
analgesia containing hydromorphone with breastfeeding behaviors of infants whose mothers 
chose to receive no analgesia. An observational cohort design rather than a randomized 
controlled trial was necessary because it was not ethically possible to randomly assign 
participants to either receive an epidural or to be in a control group receiving no medication for 
labor pain. It would be unethical to withhold labor pain medication to someone who requests it 
or to give pain medication to someone who does not want it and would prefer to try non-
pharmacological methods. In an attempt to minimize bias due to differences between the study 
groups, the eligibility criteria were designed to make the study population as homogeneous as 
possible. For example, to reduce the likelihood of a prolonged labor, only women who had 
previously labored and delivered a viable infant were included. In addition, to increase the 
homogeneity of the sample, only multiparas who had previously breastfed were included.  
The time points of 3, 12, and 24 hours were selected because the plasma elimination half-
life of hydromorphone in the circulation is approximately 2-3 hours (Felden et al., 2011; 
Inturrisi, 2002). If epidurally administered medications do affect breastfeeding and 
neurobehavior, the first assessment should occur before the drugs have been cleared from 
maternal and neonatal circulation. Therefore, first breastfeeding assessment and neurobehavior 
tests were to be done within 4 hours after delivery. The 12-hour time point was selected because 
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8-24 hours is considered the crucial time for the establishment of breastfeeding, and the drugs 
would be expected to have been metabolized and cleared from mother and neonate. The 24-hour 
time point was selected to address breastfeeding status at time of discharge.  
Subjects 
The study population consisted of an unmedicated group (control group) of 51 mother-
infant dyads in which the mother did not receive any pain medication or CNS depressants and 51 
mother-infant dyads in which the mother elected to receive epidural analgesia for labor pain.  
Sample Size 
Sample size was determined for comparative analysis using repeated-measures analysis of 
variance. The minimum difference between groups that would be worth detecting was 
determined using Cohen’s d set at 0.5 (i.e., medium effect) (J. Cohen, 1988; Lakens, 2013). 
Assuming 80% power and an  value at 0.05, a sample size of 51 cases per group was needed to 
detect a true difference if it exists. Recruitment continued until the required number of subjects 
was achieved in each group.  
Selection Criteria 
Mother-infant dyads were included when the mother met the following criteria: (a) aged 18 
years or older; (b) used only epidural analgesia (continuous infusion) or no medication during 
labor and delivery; (c) had breastfed after previous deliveries; (d) intended to breastfeed again; 
(e) allowed breastfeeding to be observed at 3, 12, and 24 hours postpartum; (f) was English 
speaking; (g) had a singleton pregnancy; (h) had an infant ≥37 weeks and ≤42 weeks gestation; 
and (i) delivered vaginally. Exclusion criteria comprised (a) any complication of pregnancy such 
as pregnancy-induced hypertension or insulin-dependent gestational diabetes; (b) any 
complication of labor; (c) obesity (BMI ≥40); (d) alcohol or substance abuse; (e) infant with 
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congenital anomalies; (f) infant receiving antibiotics or intravenous therapy for hypoglycemia ; 
(g) infection as evidenced by maternal fever during labor; (h) infant with an Apgar score less 
than 8 at 5 minutes; (i) infant having resuscitation after delivery; (j) mother has undergone any 
type of procedure that required anesthesia or analgesia within 24 hours postpartum; (k) abnormal 
fetal presentation such as occipital posterior or breech.  
Setting 
The study took place at the Labor and Birth Unit and the Postpartum Unit of YNHH, a 
1500-bed teaching facility in New Haven, Connecticut. YNHH has a delivery rate of 
approximately 5,500 babies per year and is a major obstetrical referral center for physicians 
throughout the region. YNHH is located in a culturally, economically, and socially diverse 
neighborhood. Although many of the hospital patients live within the area surrounding the 
hospital, many come from cities throughout the state of Connecticut.   
YNHH is in the process of becoming Baby Friendly and has implemented The Ten Steps 
to Successful Breastfeeding. To control for delivery room practices known to have an influence 
on the neonate’s ability to suck and establish breastfeeding, the following steps were followed in 
the same way for all mother-infant dyads in this study. It was expected that all neonates would be 
placed skin-to-skin immediately after birth, and breastfeeding initiated within the first hour. This 
is the standard of care at this institution. If the neonate could not be placed immediately skin-to-
skin because of a complication with the mother, neonate, or delivery, the mother-infant dyad was 
excluded from the study. Thus, all babies were placed on the mother’s chest in a similar manner. 
Vitamin K and eye care were provided 24 hours postpartum. 
120 
 
 
 
Treatment - Epidural Analgesia 
Epidural analgesia was administered according to the standard protocol of Yale New 
Haven Hospital for healthy parturients who request epidural analgesia for vaginal delivery: The 
protocol called for 1.5% lidocaine with 1:200,000 epinephrine as a test dose and/or 0.25% 
bupivacaine with 1:200,000 epinephrine as a bolus, and 100 µg hydromorphone followed by a 
continuous infusion of 0.05% bupivacaine with 3 µg/mL hydromorphone at a rate of 14 
mL/hour. 
Study Variables 
Demographic and Clinical Characteristics 
At the time the participant signed the informed consent form, the study team filled out a 
patient information sheet related to labor, delivery, and medication received during labor 
(Appendix A: Patient Information Sheet). Clinical factors such as oxytocin (Pitocin, Syntocinon) 
use, instrument delivery, maternal temperature, and duration of labor were also recorded.  
Epidural Medications 
Data were collected regarding the continuous epidural infusion (extent of cervical dilation 
at the time of epidural placement, dose of the components, infusion rate, and total volume), type, 
and dose of local anesthetics, and any additional doses for breakthrough pain.  
LATCH Breastfeeding Assessment Tool 
The LATCH Breastfeeding Assessment Tool (D. Jensen et al., 1994) was used to measure 
breastfeeding effectiveness. Permission for its use was obtained from the copyright owner (John 
Wiley & Sons, Inc., Appendix B: Copyright Permission for LATCH Breastfeeding Assessment 
Tool). 
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LATCH is a breastfeeding charting system that assesses individual breastfeeding sessions 
using a systemic model to gather information (D. Jensen et al., 1994). The LATCH score 
includes all aspects of latching behavior by providing a score of 0, 1, or 2 for each key 
component of breastfeeding: L = the infant’s ability to latch onto the breast, A = the audible 
sound of swallowing, T = type of nipple the mother has, C = comfort of the mother’s breast and 
nipple, H = holding, which is the amount of assistance the mother needs to hold the neonate. To 
obtain the score for a particular breastfeeding session, the total of all the scores for the areas of 
assessment is calculated. A score of 2 on each item meets the criterion for effective 
breastfeeding. Thus, for this study, effective breastfeeding was defined as a total LATCH score 
of 10. 
The scales are described below: 
 L indicates how well the neonate latches on to breast during breastfeeding. A score of 2 is 
given if the neonate’s gum line is placed well over the mother’s lactiferous sinus, the lips 
are flagged outward, the infant’s tongue is positioned over the areola, and there is 
rhythmic sucking. If a neonate is too sleepy or reluctant to feed and repeated attempts are 
needed to meet the criteria, or a staff member must hold the nipple in the infant’s mouth, 
the score will be less than 2. A score of 2 means effective breastfeeding. 
 A indicates the audible swallowing of the infant during breastfeeding. Swallowing is an 
indicator of milk intake. A short forceful expiration of air should be heard for a score of 
2. During the first 24 hours of life, several bursts of intermittent sucking may be heard 
before the swallow. 
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 T stands for the mother’s nipple type. If the nipple is everted (project outward) after 
stimulation and rest, a score of 2 is given. An inverted or flat nipple receives a score less 
than 2. Effective breastfeeding is defined as a score of 2. 
 C stands for the mother’s comfort. Pain in the nipple area and breast will interfere with 
let-down and the mother’s willingness to continue to breastfeed. An assessment score of 
2 is given if the nipples have no visible signs of blisters, redness, bruising, cracking, or 
bleeding, and the breast is soft and tender. A score of 1 is given for moderate discomfort 
with reddened, small blisters, or bruising. A score of 0 is for severe discomfort and sore 
breasts. Effective breastfeeding is defined as a score of 2. 
 H indicates the mother’s positioning and holding of the neonate during breastfeeding and 
the amount of help she requires from staff. A score of 2 is given if the mother cradles the 
neonate like a football or side laying against the breast, head aligned with the mother’s 
trunk facing the breast, supporting her breast with a cupped hand.  
The interrater reliability of the LATCH tool was high among lactation consultants and 
ranged from 85.7% to 100% (Adams & Hewell, 1997). In a test of the validity of the LATCH 
tool, significant Spearman correlations were found between nurses’ assessment of LATCH 
scores and mothers’ ratings of how well they thought breastfeeding had gone (J. Riordan, Bibb, 
Miller, & Rawlins, 2001). Findings also showed total LATCH score and mothers’ assessment 
scores positively correlated with duration of breastfeeding. These findings support the construct 
validity of the LATCH tool.  
Because Yale New Haven Hospital uses the LATCH instrument to guide breastfeeding 
education of mothers, both the PI and the lactation consultant have used the LATCH tool 
extensively and have spent approximately 1 year in preparation for this study. Both were also 
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involved in LATCH training of nurses on the Postpartum Unit. Therefore, it was not deemed 
necessary to conduct an interrater reliability pilot study. 
Neurologic and Adaptive Capacity Score (NACS) 
The second assessment planned for evaluation of neonates in this study was the NACS. 
Permission for use was obtained from the copyright holder, Wolters Kluwer Health (Appendix 
C: Copyright Permission for the Neurologic and Adaptive Capacity Score [NACS]). The NACS 
was specifically designed to detect central nervous system depression of the neonate from drugs 
and to differentiate those effects from birth trauma and perinatal asphyxia (Amiel-Tison et al., 
1982b). The scale has been widely used by obstetric anesthesia researchers since it was 
developed in 1982.  
The NACS contains portions of the Brazelton Neonatal Behavior Assessment Scale 
(NBAS), the Amiel-Tison neurologic exam, and the Scanlon ENNS (Amiel-Tison et al., 1982b). 
The criteria chosen for the NACS were from those used in standard clinical and neurologic 
behavioral testing. Items chosen for the NACS were those that had been shown to be affected by 
perinatal asphyxia, birth trauma, or obstetric medications. The test does not specifically assess 
breastfeeding but uses 20 criteria to assess 5 general areas: adaptive capacity, passive tone, active 
tone, primary reflexes, and general neurologic status. Each of the 5 general areas is given a score 
of 0 = absent or grossly abnormal; 1 = mediocre or slightly abnormal; or 2 = normal, with a 
maximum total of 40. The total score of 35-40 to indicate a vigorous response, scores of 34 or 
below are low enough to detect neonates with possible problems. The neonatal neurobehavior 
was evaluated at 3, 12, and 24 hours after birth using the NACS test. 
 Birth trauma, obstetric medications, neurologic disease, and perinatal asphyxia all 
demonstrate abnormalities in tone; therefore the NACS uses 8 separate tests for tone. There are 4 
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tests of passive tone in the upper and lower extremities equally that enable detection of 
hypotonia, which is indicative of birth trauma or perinatal asphyxia if observed in one side of the 
body or only seen in the upper body (Amiel-Tison, Sureau, & Shnider, 1988). Drugs and 
anesthetics frequently show a more general mediocre tone presenting as more general 
depression. The test does not require any special equipment, it is not noxious to the neonate, and 
it is simple to perform and score, with an interrater reliability of 92.8% (Amiel-Tison et al., 
1982b).  
The PI attended the Brazelton Institute at Harvard Medical School and met all the 
requirements for certification to administer the Brazelton NBAS (Appendix D: Brazelton 
Institute Certification). The NBAS is a 45 minute thorough neurobehavior exam. The study site 
would not allow a 45-minute neurobehavior exam. Therefore, the NACS was used, as it contains 
some of the items from the NBAS but takes only 5 minutes to perform. Prior to data collection, 
the PI reviewed NBAS training films and completed training exercises for the NACS. The 
correct method of scoring the infant during an examination was to be observed by a pediatrician 
at Yale New Haven Hospital who was familiar with the NACS, and the PI was to perform 10 
NACS sessions simultaneously with the pediatrician prior to data collection for this study. 
However, as described in the Results section, because of difficulties in execution, evaluations 
with the NACS had to be discontinued.  
Study Procedures 
Procedures Prior to Recruitment 
 Approval for the research study was obtained from the Yale University Human 
Investigations Committee and the Institutional Review Board of the University of 
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Connecticut (Appendix E: Protocol Approval, IRB Approval, and IRB Authorization 
Agreement). 
 Letters were sent to physicians, midwives, unit managers, and nursing staff in the Labor 
and Birth Unit and the Postpartum Unit to inform them about the study (Appendix F: 
Study Information for Physicians, Midwives, etc.). 
 An in-service training session was held to educate registered nurses, lactation consultants, 
nurse anesthetists, anesthesiology residents, and nurse-midwives in these units regarding 
the study (purpose, inclusion/exclusion criteria, recruitment, and procedures for data 
collection). The training was conducted by the PI. 
 Flyers (Appendix G: Information Flyer for Nurses, Midwives, and Residents) were 
placed around both the Labor & Birth and Postpartum Units to keep providers aware of 
the purpose and procedures of the study. 
Recruitment Procedures  
 Recruitment of subjects was done by the study team of co-investigators, which consisted 
of two CRNAs who work in labor and delivery and an anesthesiology fellow specializing 
in obstetric anesthesia. They were trained in depth on study design, inclusion criteria, and 
recruitment strategies.  
 Nurses and midwives alerted a study team member of a possible candidate for the study 
based on the inclusion criteria and asked the patients if they wanted to speak with a 
member of the research team who could explain the study and answer any questions they 
may have (Appendix H: Text for Nurses and Midwives for Speaking With Prospective 
Subjects)  
 The principal investigator was notified of potential subjects. 
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 After being notified of potential subjects, study team members provided a detailed 
explanation of the study, answered questions, and obtained written informed consent if 
the patient agreed to participate (Appendix I: Oral Information for Prospective 
Participants). The written informed consent form is provided in Appendix J: Written 
Informed Consent Form. 
 Prospective subjects were approached in the labor room after they had made the decision 
as to whether to have epidural analgesia or within 1 hour after delivery. Women who had 
decided to have epidural analgesia were approached only after placement of the 
indwelling catheter. Most laboring women are competent to consent to research and other 
procedures after the administration of epidural analgesia containing opioid and local 
anesthesia, because the doses commonly used have little to no sedative effect, and the 
decrease in pain may make patients more able to consider and discuss options in their 
care.  
 If an unmedicated mother had consented before vaginal delivery but then decided to 
receive an epidural, she could remain in the study and cross over to the epidural cohort.  
 
LATCH and NACS Data Collection Procedure 
The following procedures were to take place at approximately 3, 12, and 24 hours after 
delivery. The PI was to contact the participant at these times. 
If at the time of contact with the participant, the neonate was due to feed, the PI or the 
lactation consultant was to conduct the NACS and record it on the NACS assessment 
sheet (Appendix K: Neurologic and Adaptive Capacity Score (NACS). The PI or the lactation 
consultant then observed a breastfeeding session. Breastfeeding data were recorded on the 
LATCH Feeding Record ( 
 Appendix L: LATCH Feeding Record). 
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 If at the time of contact the neonate was not due to feed, the NACS and breastfeeding 
observation were to be postponed until the next time that infant was due to feed. The 
same procedure as above was to be followed. 
 If the mother or infant required any help with breastfeeding the PI was to alert the 
patient’s nurse. 
 After completion of the three breastfeeding observations and NACS assessment, the PI 
informed the patients of the completion and thanked them for participation. 
Blinded Observation 
Observational data collection is susceptible to biases and distortions. Some of the biases 
may be due to personal interest of the data collector or anticipation of what is to be observed 
affecting what is actually being observed (Polit & Beck, 2010). Because scoring the LATCH and 
NACS depends on observational data, it is necessary for the data collector to be blind to the 
study group. Therefore, the data collectors (the PI and the lactation consultant) did not know 
whether the participant received analgesia for her labor and delivery.  
The consent form and patient information related to labor, delivery, and medication 
received during labor were placed in a sealed envelope and then coded with the patient’s study 
ID number. These envelopes were kept in a locked office in a locked file cabinet in the office of 
the Chief Certified Registered Nurse Anesthetist (CRNA). To ensure that the PI did not know 
which study group a subject was in during the time of data collection, these envelopes were 
given to the PI only after the study was complete. 
The PI also did not have access to the mother’s electronic medical record. While 
performing the study observations, there were to be no discussions about how the labor and 
delivery was managed. The staff was also instructed not to disclose the information. If at any 
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time the principal investigator became aware of the patient’s status, the participant was to be 
withdrawn from the study. 
Procedures for Ensuring Patient Safety 
 As part of the Yale University requirements for researchers, all members of the study 
team of co-investigators completed training in Human Protection for Research Subjects 
and HIPAA.  
 A HIPAA waiver from the Yale University Human Investigations Committee was 
granted to allow access to the following information during the recruitment phase of the 
study: name, medical record number, and whether or not a patient was in labor. The 
research could not be conducted without the waiver and without access to and use of the 
protected health information. Once patients entered the study, all data was 
anonymized/de-identified in the study database. 
 Before approaching a patient in the labor room, the PI obtained the permission of the 
patient’s obstetric care provider and also involved the patient’s primary nurse in 
discussions regarding the appropriateness of such an approach.  
 If the patient’s obstetric care provider and/or primary labor room nurse felt that a 
particular patient was not in a position to comprehend the research protocol and give 
informed consent, then that patient was not approached for research participation until the 
circumstances changed to the satisfaction of the primary care providers.  
 Whenever possible, the research investigators discussed the proposed research and 
obtained informed consent in the presence of one of the patient’s independent labor 
support persons (if such a support person was available and the patient had no objection 
to that person’s involvement).  
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 All conditions of the epidural were for clinical purposes only and no manipulation 
occurred for the study. The epidural catheter was placed only upon patient request for 
pain management. 
 The investigators refrained from approaching patients for research participation at certain 
times during the labor and delivery process when such an approach would have been 
inappropriate. During the first stage of labor (<4 cm dilation), most women were 
relatively comfortable and the intervals between contractions allowed for adequate 
explanation and discussion. Because the second stage of labor may be characterized by 
considerable pain and exhaustion, women were not approached during this phase.  
 Written evidence of informed consent was obtained in all subjects.  
 At the time of consent, a detailed explanation of the research was given and questions 
were answered.  
 After delivery, the medication data from the epidural group was collected by the co-
investigators: the two CRNAs, and the obstetric anesthesiology fellow. 
 
Risks/Benefits 
The study procedures presented no known risks. No experimental conditions were placed 
on the subjects. The independent variable (epidural analgesia) was the hospital’s standard 
treatment and was self-selected by participants prior to researcher contact. The participants had 
already decided to breastfeed and were aware of the data collection. Neonates were not 
awakened for study procedures. The LATCH evaluation tool was not adverse or noxious to the 
neonate. The PI and the lactation consultant were strictly observers of the breastfeeding. If 
assistance was needed, the patient’s nurse was contacted. 
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Every measure was taken to ensure patient privacy. To minimize risks to subjects’ privacy, 
patients were invited to participate in their private room. All data collection forms were coded 
and the master list of names and code numbers was kept in a locked office in a locked file 
cabinet. Once results were obtained, the patients’ medical record numbers were shredded and all 
that remained were the study ID numbers with no identifiable data. The information was stored 
on a secure network drive accessed through an encrypted computer belonging to the PI. 
No particular benefits accrued to the individual participants. The general benefits of the 
study were that participants could have the satisfaction of knowing they had contributed to 
identification of medical interventions that may adversely affect future newborns, helped health 
care providers anticipate mother-infant dyad’s breastfeeding needs, and facilitated women's 
informed choices during labor and delivery. 
Statistical Analysis 
The IBM SPSS Statistics Software Package Version 23 (IBM Corp., Armonk, NY) was 
used for data management and analysis, except for the mixed-effect regression model used to 
examine the dose relationship between epidural parameters (total amounts of infusate, lidocaine, 
bupivacaine, and degree of dilation) and LATCH score in the epidural group, which was 
performed using SAS software, version 9.3 (SAS Institute, Inc., Cary, North Carolina).  
The data were collected and then coded and examined graphically in box plots and within-
group histograms to determine whether the variables in each group were normally distributed 
and free of outliers and that the spread of data was consistent across the groups. Descriptive 
analyses of variables relating to demographic characteristics, obstetric history, characteristics of 
labor and delivery, neonatal characteristics, epidural medications, and breastfeeding behaviors 
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were performed using means, standard deviations, and ranges for continuous variables and 
frequencies and proportions for categorical variables. 
Group Comparisons 
The purpose of this study was to examine the relationship between epidural analgesia used 
for labor pain relief and effectiveness of breastfeeding in the first 24 hours postpartum. Women 
who received epidural analgesia during labor and their neonates were compared with those who 
used no analgesia for labor or delivery and their neonates (control). Hypothesis testing using 
inferential statistics was carried out to demonstrate any differences between groups regarding 
demographic and obstetric characteristics, labor variables, and neonatal variables, with 
independent t tests for continuous variables. The Kruskal-Wallis test was used for non-normally 
distributed data. The Pearson chi-square test or the Fisher exact test was used to test for 
associations among categorical data, for example when comparing groups regarding the 
proportion of women with certain characteristics, such as the percentage of women who received 
oxytocin. For determination of significance of differences between groups, p < 0.05 was selected 
as the level of significance.  
Correlational Analyses  
To test for bivariate relationships between variables, the Pearson product moment 
correlation was used. The variables included duration of labor; ruptured membranes; total IV 
fluids; amount of oxytocin augmentation; induction of labor; LATCH scores at 3, 12, and 24 
hours postpartum; meconium suctioning of the neonate; Apgar scores at 1 and 5 minutes; and 
percentage of weight loss of the neonate. 
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Multivariate Analyses 
Multivariate analysis refers to the modeling of data for related multiple measurements, for 
example when an outcome is measured for the same individual at multiple time points (repeated 
measures). If parametric assumptions were met, repeated-measures analyses of variance (RM-
ANOVA) were used to assess differences in breastfeeding outcomes on the LATCH total score 
and subscales over the three time points (3, 12, and 24 hours) and between the infants whose 
mothers received analgesic medication and whose mothers did not receive medication.  
We also examined the effect of epidural on the LATCH score by using a mixed-effect 
regression model, which included fixed effects of the treatment (epidural versus unmedicated), 
time post-labor, interaction of treatment and time, covariates that showed significant differences 
between the two groups at baseline (labor duration, total amount of oxytocin used, induction of 
labor type, and total fluids), and the random effect of intercept.  
Multivariable Analyses 
As outlined in the literature review, numerous factors can influence the initiation and 
success of breastfeeding. Multiple regression and logistic regression can be used to address the 
effects of potential confounding factors that may introduce bias because of the nonrandomized 
nature of the study. We therefore performed multiple linear regression analyses to describe the 
relationship between the LATCH score as the dependent variable and epidural analgesia as a 
predictor variable, while at the same time adjusting for other predictor variables in the model. 
Such analyses can predict the probability of outcomes for individuals with a certain set of 
characteristics (Fields, 2013). Thus, multiple linear regression analysis was performed in the 
total group to examine whether the following variables may influence total LATCH scores at the 
specific time points of 3, 12, and 24 hours postpartum:  
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 Maternal demographic variables, such as age, race, weight, height, BMI, gravidity, parity, 
and epidural placement 
 Neonatal variables such as Apgar scores at 1 and 5 minutes, baby’s weight at birth, 
baby’s weight change, meconium stain, sex of the neonate, and whether the baby was 
suctioned after delivery 
 
To test the hypothesis that infants whose mothers had multiple stressful events or 
interventions during labor would demonstrate less effective breastfeeding, independent of labor 
analgesia, labor variables such as duration of labor (2nd and 3rd stage and total), whether labor 
was induced, rupture of membranes, oxytocin augmentation, epidural placed, group B 
streptococcus (GBS) status, perineal laceration, and total amount of IV fluids were examined 
with multiple linear regression analysis. 
Regression analysis was also performed in the epidural group alone, with each total latch 
score at 3, 12 and 24 hours in the model with time of epidural placement to delivery, total 1.5% 
lidocaine dose, total 0.25% bupivacaine dose, oxytocin for labor augmentation, induction, total 
volume of epidural infusate, total duration of labor, ruptured membranes, total IV fluids, 
meconium stain, and baby suctioned. 
Summary of Study Methods 
This chapter attempted to give the reader a clear understanding of the study design, 
methodology, and analysis. Breastfeeding behaviors of infants whose mothers chose to receive 
epidural analgesia containing hydromorphone were compared with those whose mothers chose to 
receive no analgesia using inferential statistics. Repeated-measures analyses of variance were 
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used to test differences between groups over time. Multivariable analyses were used to 
investigate the effects of potential predictor variables on breastfeeding behaviors.   
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Chapter 4: Results 
Chapter 4 presents the findings of the study. The first section of the chapter describes the 
characteristics of the overall study population and compares the characteristics of the two 
cohorts. The second section describes the timing and type of medications that were used in the 
cohort that received epidural analgesia. The third section presents the results for Hypothesis 1—
that healthy term infants of mothers who receive epidural analgesia with hydromorphone would 
demonstrate less effective breastfeeding behaviors at 3, 12, and 24 hours of age when compared 
with infants whose mothers received no analgesia. The fourth section describes the results of 
multivariable analyses performed to assess the potentially confounding effects of other factors 
known to influence breastfeeding. The fifth section presents the results for Hypothesis 2—that 
healthy term infants of mothers who receive epidural analgesia with hydromorphone would 
demonstrate less effective breastfeeding behaviors at 3, 12, and 24 hours of age in relation to the 
duration of infusion and amount of drug given to the mother. The sixth section presents the 
results for Hypothesis 3—that when multiple stressful events or interventions occur during labor 
or immediately after birth, the infant would demonstrate less effective breastfeeding, whether or 
not labor analgesia was used. The last section summarizes the study results. 
Study Participants 
The study participants were recruited among parturient at the Labor and Birth Unit and the 
Postpartum Unit of Yale New Haven Hospital from March through April 2015. A total of 106 
women were invited to participate in this study. Two women approached to participate declined 
after the study was explained to them and two women were excluded because they did not meet 
eligibility criteria (one used formula and the neonate of one was admitted to the neonatal 
intensive care unit immediately postpartum for shoulder dystocia).  
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A total of 102 mother-infant dyads met the eligibility criteria and completed the study. No 
subjects were withdrawn after study entry, and no subjects in the unmedicated group asked to 
receive epidural analgesia. All mothers were multiparas who had previously breastfed. Of the 
102 participants, 51 mothers received epidural analgesia only and 51 mothers received no 
analgesia for labor or birth. The study flow chart is presented in Figure 1.  
 
Figure 1. Study Flow Chart 
 
137 
 
 
 
Data from the 102 mother-infant dyads were obtained, recorded, and coded for a total of 
306 breastfeeding observation sessions. Visual inspection of normal Q-Q plots and within-group 
histograms showed that the assumption of normality was satisfied, with the spread of variables 
fairly consistent between the epidural and unmedicated groups. 
Characteristics of the Overall Study Population 
Descriptive statistics describing the demographic characteristics and obstetric history of the 
overall study population are presented in Table 4.  
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Table 4. Demographic Characteristics and Obstetric History of the Overall Study 
Population (n = 102) 
Variable Value 
Age, years  
Mean ± SD 29.55 ± 4.74 
Range 21–43 
Race, n (%)  
White 66 (64) 
Hispanic 24 (23.5) 
African American 6 (5.9) 
Asian 6 (5.9) 
Maternal weight (kg)  
Mean ± SD 79.5 ± 14.5 
Range 53.6–151.8 
Maternal height (cm)  
Mean ± SD 163.3  ± 6.6 
Range 152.4–182.9 
BMI   
Mean ± SD 29.6 ± 4.5 
Range 19.8–50.8 
Number of pregnancies   
Mean ± SD 2.8 ± 0.8 
Range 2–5 
Number of previous live births  
Mean ± SD 1.4 ± 0.6 
Range 1–3 
SD = standard deviation. 
 
Labor and delivery characteristics of the overall study population are presented in Table 5. 
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Table 5. Labor and Delivery Characteristics in the Overall Study Population (n = 102) 
Variable Value 
Duration of labor (min)  
2nd stage    
Mean ± SD 20.2 ± 18.4 
Range 2–98 
3rd stage   
Mean ± SD 7.1 ± 5.2 
Range 1–39  
Total   
Mean ± SD 27.3 ± 19.4 
Range 6–108 
Oxytocin, n (%) 35 (34.3) 
Induced, n (%) 26 (25.5) 
Spontaneous rupture of membranes, n (%) 47 (46.0) 
Episiotomy, n (%) 7 (6.9) 
Perineal laceration with vaginal delivery, n (%) 66 (64.7) 
GBS+ and received antibiotics, n (%) 33 (32.4) 
Total IV fluids (mL)  
Mean ± SD 1094.6 ± 892.1 
Range 0–3900 
Type of delivery  
Forceps 0 (0) 
Vacuum 1 (1) 
GBS+ = positive for group B streptococcus; IV = intravenous; SD = standard deviation. 
 
Characteristics of the neonates are given for the overall study population in Table 6.  
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Table 6. Neonatal Characteristics in the Overall Study Population (n = 102) 
Variable Value 
Gestational age (weeks)  
Mean ±  SD 39.7 ± 0.9 
Range 37–41 
Apgar score  
1 min  
Mean ± SD 8.83 ± 0.37 
Range 8–9 
5 min  
Mean ± SD 8.98 ± 0.14 
Range 8–9 
Meconium stained, n (%) 16 (15.7) 
Baby suctioned, n (%) 39 (38) 
Sex of neonate, n (%)  
Male 50 (49) 
Female 52 (51) 
Baby weight at birth (kg)  
Mean ± SD 3.4 ± 0.48 
Range 2.67–4.80  
Baby weight change in 24 hours (%)   
Mean ± SD -4.52 ± 2.28 
Range -9.98 to 2.64 
SD = standard deviation. 
 
Comparisons of Participant Characteristics Across Study Groups 
The unmedicated control and epidural groups were compared regarding demographic 
characteristics, obstetric history, labor variables, and neonatal characteristics. No significant 
differences were observed regarding age, race, weight, height, BMI, gravidity, or parity (Table 
7).  
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Table 7. Demographic Characteristics and Obstetric History by Study Group 
 Unmedicated (n=51) Epidural(n=51) pa 
Age, mean ± SD 32.5 ± 4.3 32.6 ± 5.2 0.82 
Race, n (%)    
Hispanic/African American/Asian 16 (31.4) 20 (39.2) 0.27 
White 35 (68.6) 31 (60.8) 0.27 
Maternal weight (kg), mean ± SD 79.2 ± 12.6 79.8  ± 16.3  0.82 
Maternal height (cm), mean ± SD 163.3 ± 6.4 162.8 ± 6.4 0.88 
BMI, mean ± SD 29.4 ± 3.8 29.7 ± 5.1 0.67 
Number of pregnancies, mean ±SD 2.71± 0.78 2.82± 0.88 0.48 
Number of births, mean ± SD 1.51 ± 0.70 1.37 ± 0.60 0.29 
BMI = body mass index; SD = standard deviation 
aMeans were compared with a t test, and frequencies were compared with a chi-square or Fisher exact test.  
 
As shown in Table 8 below, the duration of the 2nd stage of labor (p = 0.001) and duration 
of the entire labor process (the sum of duration of the 2nd and 3rd stages; p <0.001) were 
significantly longer in the epidural group than in the unmedicated group. The percentage of 
women receiving oxytocin (p = 0.002), proportion of women with induced labor (p = 0.003), and 
total amount of IV fluids (lactated Ringer’s solution) administered (p <0.001) were also 
significantly greater in the epidural group than in the unmedicated group. No significant 
differences between the groups were observed regarding duration of the 3rd stage of labor (p = 
0.28), percentage of mothers with spontaneous rupture of membranes (p = 0.43), or degree of 
laceration (p = 0.35). 
Four of the 51 women in the epidural group and none of the women in the unmedicated 
group required corrective action for hypotension. There were no instances of fever, fetal 
bradycardia, or decreased fetal heart rate variability in either group. 
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Table 8. Labor Characteristics by Study Group 
 
Unmedicated 
(n=51) 
Epidural  
(n=51) pa 
Duration of labor (min)    
2nd stage   13.35 ± 12.5 27.12 ± 20.9 0.001 
3rd stage  6.51 ±4.12 7.63 ±6.05 0.28 
Total  19.86 ±13.79 34.75 ±21.35 <0.001 
Oxytocin, n (%) 11 (22.9) 24 (47.1) 0.002 
Induced, n (%) 6 (11.8) 20 (39.2) 0.003 
Rupture of membranes, n (%)   0.43 
Spontaneous rupture of membranes 26 (51.0) 21 (41.2)  
Artificial rupture of membranes 25(49.0) 30 (58.8)  
Degree of laceration, n (%)   0.35 
0 15 (29.4) 21 (41.2)  
1 17 (33.3) 17 (33.3)  
2 or 3 19 (37.3) 13 (25.5)  
GBS positive, n (%) 18 (35.3) 15 (29.4) 0.67 
Total IV fluids (mL), mean ± SD 576 ± 704 1612 ± 750 <0.001 
GBS = group B streptococcus. IV = intravenous; SD = standard deviation. 
aMeans were compared with a t test, and frequencies were compared with a chi-square or Fisher exact test.  
 
Characteristics of the 51 neonates born to mothers who received epidural analgesia and the 
51 neonates born to mothers who had no analgesia are shown in Table 9. The groups were not 
significantly different regarding birth weight, gestational age, Apgar scores at 1 and 5 minutes, 
meconium, suction at birth, sex and weight of the baby, or percent weight loss at 48 hours 
postpartum. 
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Table 9. Neonatal Characteristics by Study Group 
 Unmedicated (n = 51) Epidural (n = 51) pa 
Baby    
Gestational age, mean ± SD 39.7 ± 0.8 39.6 ± 1.0 0.54 
Apgar score    
1 min 8.9 ± 0.35 8.0± 0.40 0.43 
5 min 9.0 ± 0.14 9.0 ± 0.14 >0.99 
Meconium stained, n (%) 8 (15.7) 8 (15.7) >0.99 
Baby suctioned, n (%) 15 (29.4) 24 (47.1) 0.10 
Sex of neonate, n (%)   0.55 
Male 27 (52.9) 23 (45.1)  
Female 24 (47.1) 28 (54.9)  
Baby weight at birth (kg) 3.44 ± 0.71 3.33 ± 0.26 0.065 
Baby weight change in 24 hours (%), 
mean ± SD 
-4.61 ± 2.14 -4.44 ± 2.42 0.71 
aMeans were compared with a t test, and frequencies were compared with a chi-square or Fisher exact test.  
 
Epidural Medications 
Cervical dilation at the time of epidural placement in the epidural group ranged from 3 to 9 
cm (Table 10). All women in the epidural group received a continuous infusion of bupivacaine 
0.05% with hydromorphone 3 µg/mL at a rate of 14 mL/h. In addition to the continuous infusion, 
two types of local anesthetics were administered: bupivacaine 0.25% with epinephrine at a ratio 
of 1:200,000 (n = 49) and lidocaine 1.5% with epinephrine at a ratio of 1:200,000. Forty-four 
subjects received both lidocaine and bupivacaine, five subjects received bupivacaine only, and 
two subjects received lidocaine only. The total volumes are shown in Table 10. Fifteen of the 51 
epidural subjects (29.4%) required an additional bolus of bupivacaine 0.25% with epinephrine 
1:200,000 during labor for breakthrough pain.  
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Table 10. Extent of Dilation at the Time of Epidural Placement, Total Amount of Epidural 
Infusate, and Local Anesthetic Dose (Lidocaine or Bupivacaine)  
Name n Mean SD Range 
Extent of dilation at epidural placement 51 5.2 1.34 3–9 
Total epidural infusate 
(bupivacaine/hydromorphone), mL 
51 56.38 39.96 0–170 
Local lidocaine and/or bupivacaine, mL     
Lidocaine 1.5%a 46 3.4 0.92 3–6 
Bupivacaine 0.25%a 49 7.3 1.78 3–11 
SD = standard deviation 
 aWith epinephrine at a ratio of 1:200,000. 
 
Hypothesis 1: Effects of Epidural Analgesia on Breastfeeding 
The primary hypothesis was that healthy term infants of mothers who receive epidural 
analgesia with hydromorphone would exhibit less effective breastfeeding behaviors at 3, 12, and 
24 hours of age when compared with infants whose mothers received no analgesia. The likely 
differences would correspond to the neonates’ ability to maintain an active awake state, latch on 
to the breast, and coordinate the suck-breath-swallow actions necessary to remove milk from the 
breast.  
LATCH Assessment Tool 
To test the hypothesis, breastfeeding behaviors were observed at 3, 12, and 24 hours 
postpartum with the LATCH assessment tool. Repeated-measures ANOVA with independent t 
tests for pairwise comparisons at each time point were performed for unadjusted scores on the 
total LATCH score and individual LATCH subscales. Unadjusted total LATCH scores did not 
differ between the unmedicated and epidural groups at any of the time points, F (1.712, 
171.15) = 0.28, p = 0.07 (Table 11). Total scores tended to increase over time in both groups 
(Figure 2).  
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Table 11. Total LATCH Scores by Group at 3, 12, and 24 Hours Postpartum 
 Unmedicated  Epidural   Epidural vs Unmedicated 
 
(n = 51) 
Mean ± SD 
(n = 51) 
Mean ± SD  
Mean 
difference 95% CI pa 
First breastfeeding  
(3 h) 
8.35 ± 1.31 8.47 ± 1.34  0.12 -0.48 to 0.71 0.65 
Second breastfeeding  
(12 h) 
8.94 ± 1.06 8.90 ± 1.06  -0.04 -0.52 to 0.44 0.85 
Third breastfeeding  
(24 h) 
9.22 ± 0.86 9.18 ± 0.84  -0.04 -0.42 to 0.34 0.81 
CI = confidence interval. 
aRepeated-measures ANOVA with independent t tests for pairwise comparisons. 
 
 
Figure 2. Total LATCH Scores in Unmedicated (Control) and Epidural Groups at Each 
Time Point (1 = 3 h; 2 = 12 h; 3 = 24 h) 
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The numbers and percentages of women in each group with total LATCH scores >7 also 
did not differ between groups at any of the time points (Table 12). 
Table 12. Proportion of Women With Total LATCH Scores >7 
 Unmedicated (n = 51)  Epidural (n = 51)  pa 
 n (%)  n (%)   
First breastfeeding (3 h) 39 (76.5)  37 (72.5)  0.65 
Second breastfeeding (12 h) 42 (82.4)  45 (88.2)  0.40 
Third breastfeeding (24 h) 49 (96.1)  48 (94.1)  0.65 
aχ2-test 
As shown in Table 13 below, LATCH subscale scores did not differ significantly between 
groups at any of the time points.  
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Table 13. LATCH Subscale Scores by Group for Breastfeeding Behaviors at 3, 12, and 24 Hours Postpartum 
Breastfeeding session Unmedicated (n = 51) Epidural (n = 51)  Epidural vs Unmedicated 
Breastfeeding level Mean  ±  SD Mean  ±  SD  Mean difference 95%CI pa 
First breastfeeding (3 h)       
L1  1.71 ± 0.50 1.78 ± 0.46  0.08 -0.11 to 0.27 0.36 
A1  1.24 ± 0.62 1.45 ± 0.70  0.22 -0.04 to 0.48 0.06 
T1  2.00 ± 0.00 1.98 ± 0.14  -0.02 -0.06 to 0.02 0.32 
C1  1.92 ± 0.27 1.90 ± 0.30  -0.02 -0.13 to 0.09 0.73 
H1  1.50 ± 0.61 1.33 ± 0.59  -0.16 -0.39 to 0.08 0.15 
Second breastfeeding (12 h)       
L2  1.88 ± 0.32 1.86 ± 0.35  -0.02 -0.15 to 0.11 0.77 
A2  1.55 ± 0.58 1.57 ± 0.54  0.02 -0.20 to 0.24 0.94 
T2  2.00 ± 0.00 1.98 ± 0.14  -0.02 -0.06 to 0.20 0.32 
C2  1.96 ± 0.20 1.86 ± 0.35  -0.10 -0.21 to 0.01 0.08 
H2  1.55 ± 0.58 1.63 ± 0.50  0.08 -0.13 to 0.30 0.58 
Third breastfeeding (24 h)       
L3  1.94 ± 0.24 1.96 ± 0.20  0.02 -0.07 to 0.10 0.65 
A3  1.78 ± 0.41 1.73 ± 0.53  -0.06 -0.25 to 0.13 0.74 
T3  2.00 ± 0.00 2.00 ± 0.00    >0.99 
C3  1.82 ± 0.38 1.84 ± 0.367  0.02 -0.13 to 0.17 0.80 
H3  1.67 ± 0.48 1.67 ± 0.47  0.00 -0.19 to 0.19 >0.99 
L = infant’s ability to latch onto the breast; A = audible sound of swallowing; T = maternal nipple type; C = comfort of the mother’s breast and nipple; 
H = holding, i.e., amount of assistance the mother needs to hold the neonate. 
a Kruskal-Wallis test (all measures skewed). 
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The linear regression model was used to adjust the effects of epidural on the total LATCH 
score for the effects of labor duration, total amount of oxytocin used, total IV fluids (lactated 
Ringer’s solution), and labor type (induction). After adjusting for these variables, we still did not 
find statistically significant differences in LATCH scores between the two groups at any time 
point (Table 14). 
Table 14. Differences Between Neonates of Mothers With vs Those Without Epidural 
Analgesia in Total LATCH Scores Adjusted for Duration of Labor, Oxytocin 
Administration, Total IV Fluids, and Labor Type  
 Epidural vs. Unmedicated 
Time Difference 95% CI pa 
3 h  0.19 -0.37 to 0.74 0.51 
12 h 0.19 -0.27 to 0.64 0.42 
24 h 0.15 -0.22 to 0.52 0.43 
CI = confidence interval. 
aMixed-effect model. 
 
Thus, the data from the LATCH evaluation did not support the primary hypothesis that 
infants of mothers who receive epidural analgesia with hydromorphone would demonstrate less 
effective breastfeeding behaviors than infants of unmedicated mothers. 
NACS Assessment 
The study was originally designed to conduct the NACS and the LATCH together at 3, 12, 
and 24 hours after delivery. The exact times depended on the baby’s hunger and willingness to 
feed. According to the developers of the NACS, the test can be performed on the neonate in any 
sleep state (Amiel-Tison et al., 1982b). However, the babies performed best when the test was 
performed 30 minutes before they were due to breastfeed. Thus, neonates would be observed for 
signs of waking approximately 2 hours before the assessments needed to be done. This was to 
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ensure the neonate could be tested when they were awake and not distressed. This became 
increasingly difficult to time and babies were being tested at different states of arousal, which 
altered specific items on the tool. If the babies were examined when they were crying, they 
would have low active and adaptive tone scores. If the babies were sleeping, their adaptive and 
active tone scores were also lower. The NACS was designed to be sensitive to the effects of 
narcotics on the neonate. Therefore, those specific categories were especially important (Amiel-
Tison et al., 1982b). If the babies were distressed, they were permitted to feed, and the NACS 
would have to be done before the next feed. If the baby was sleeping, the parents became upset 
because they could not comfort the child or because the baby was awakened. If the LATCH was 
performed before the NAC, the infant would still be skin-to-skin with the mother after feeding, 
and the mothers did not want their babies tested at that time. To get the best results, it is 
recommended to wait at least 1 hour after feeding before conducting a neurobehavior exam on a 
neonate (Brazelton & Nugent, 2011). As part of the BFHI, it was also hospital policy to keep 
babies skin-to-skin with the mother as frequently and as long as possible. The NACS was 
therefore performed in only three patients (data not shown) and was then discontinued. Thus, 
only data from the LATCH breastfeeding observations are available for hypothesis testing. 
Effects of Confounding Variables on Breastfeeding  
Multivariable analyses were performed to assess the potentially confounding effects of 
other factors known to influence breastfeeding.  
Maternal Demographic and Obstetric variables 
Maternal demographic and obstetric variables, including maternal age, race, BMI, height, 
weight, gravidity, parity, and epidural placement were examined with total LATCH scores at 3, 
12, and 24 hours using multiple linear regression to test whether any of these variables could 
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predict total LATCH score at the three time points (Table 15). Neither epidural placement nor 
maternal demographic/obstetric history variables showed an independent effect. Table 16 shows 
the R2, F, and p values as variables are added to the regression analysis. Statistical significance 
was achieved for the overall model tested at 12 and 24 hours. Together, these maternal 
demographic and obstetric variables contributed 20% of the variability in total LATCH scores in 
the model at 3 hours postpartum, 30% at 12 hours, and 30% at 24 hours. The total LATCH score 
at the first feeding (3 hours postpartum) was the only variable that significantly contributed to 
the total LATCH score at the second feeding (12 hours postpartum) (p = <0.001), and the total 
LATCH score at the second feeding was the only variable that significantly contributed to the 
total LATCH score at the third feeding (24 hours postpartum) (p = <0.001). This indicates that 
the same infant improved their LATCH score between birth and 24 hours regardless of maternal 
demographic/obstetric factors and exposure to epidural analgesia medications.  
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Table 15. Summary of Multiple Linear Regression Analysis of the Effects of Maternal Demographic and Obstetric Variables 
as Predictors of Total LATCH Scores at 3, 12, and 24 Hours Postpartum: Total Sample (n = 102) 
 Total LATCH 3 h  Total LATCH 12 h  Total LATCH 24 h 
Variable Β  
(SE) 
p β 
(95%CI) 
 B 
(SE) 
p β 
(95%CI) 
 B 
(SE) 
p β 
(95%CI) 
Age  0.002 
(0.028) 
0.943 .007 
(.053-.057) 
 0.019 
(0.022) 
0.403 .056  
(-.026-.063) 
 -0.001 
(0.018) 
0.977 -.003 
(-.036-.035) 
Race  0.000 
(0.003) 
0.900 -.013 
(-.007- .006) 
 0.000 
(0.003) 
0.870 -.017 
(-.006-.005) 
 -0.002 
(0.002 
0.292 -.107 
(-.006-.002) 
Maternal weight  -0.004 
(0.004) 
0.290 -.109  
(-.013- .004) 
 -0.001 
(0.003) 
0.774 -.030 
(-.008-.006) 
 -0.002 
(0.003) 
0.456 -.076 
(-.007-.003) 
Maternal height 0.097 
(0.060) 
0.106 .191 
(-.021-.215) 
 0.039 
(0.049 
0.427 .094 
(-.058-.135) 
 -0.001 
(0.039) 
0.978 -.003 
(-.078-.076) 
BMI  -0.083 
(0.126) 
0.511 -.285 
(-.333-.167) 
 -0.004 
(0.103) 
0.969 -.017 
(-.208-.200) 
 -0.009 
(0.082) 
0.912 -.048 
(-.172-.154) 
Gravidity  0.158 
(0.162) 
0.333 .100  
(-.164-.480) 
 0.035 
(0.133) 
0.794 .028 
(-.229-.299) 
 -0.078 
(0.106 
0.460 .007 
(-.288-.131) 
Parity  -0.059 
(0.253) 
0.816 -.029     
(-.562- .444) 
 0.208 
(0.207) 
0.318 .128 
(-.203-.619) 
 0.091 
(0.165) 
0.071 .071 
(-.236-.419) 
Epidural placed -0.022 
(0.268) 
0.935 -.009 
(-.554-.511) 
 -0.004 
(0.219) 
0.987 -.002 
(-.439-.431) 
 -0.085 
(0.174) 
0.626 -.052 
(-.432-.261) 
Total LATCH 3h Constant    0.251 
(0.070) 
< 0.001 .312 
(.112-.390) 
 0.161 
(0.066) 
0.016 .250 
(.030-.291) 
Total LATCH 12 h 0.515 
(0.116) 
<0.001 .415 
(.285-.745) 
 Constant    0.425 
(0.070) 
<0.001 .533 
(.285-.564) 
Total LATCH 24 h 0.381 
(0.155) 
0.016 .244 
(.071-.688) 
 0.670 
(0.111) 
<0.001 .534 
(.450-.890) 
 Constant   
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Table 16. R2, F, and Probability for Regression Analysis of Maternal Demographic and Obstetric Variables as Predictors of 
Total LATCH Scores at 3, 12, and 24 Hours Postpartum: Total Sample (n = 102) 
 Total LATCH 3 h  Total LATCH 12 h  Total LATCH 24 h 
 R2 F p  R2 F p  R2 F p 
Age  0.000 0.005 0.943  0.007 0.704 0.403  0.000 0.001 0.977 
Race  0.000 0.011 0.990  0.007 0.362 0.697  0.011 0.562 0.572 
Maternal weight  0.012 0.385 0.764  0.008 0.267 0.849  0.017 0.560 0.643 
Maternal height 0.038 0.960 0.433  0.015 0.358 0.838  0.017 0.416 0.797 
BMI  0.042 0.851 0.517  0.015 0.284 0.921  0.017 0.332 0.893 
Gravity  0.052 0.866 0.523  0.015 0.246 0.960  0.023 0.367 0.898 
Parity  0.052 0.743 0.636  0.026 0.355 0.926  0.026 0.356 0.925 
Epidural placed 0.052 0.644 0.739  0.026 0.307 0.962  0.028 0.339 0.949 
Total LATCH 3h Constant    0.389 5.800 < 0.001  0.088 0.982 0.460 
Total LATCH 12h 0.220 2.881 0.005  Constant    0.305 4.479 <0.001 
Total LATCH  24h 0.110 1.268 0.460  0.303 4.441 <0.001  Constant   
Model   0.265    <0.001    <0.001 
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Neonatal Variables 
Multiple linear regression analysis was also performed to assess neonatal variables shown 
in the literature to be predictive of breastfeeding behaviors, including Apgar scores at 1 and 5 
minutes, baby weight at birth, weight change during the first 24 hours, sex of neonate, meconium 
stain, and whether the baby was suctioned after delivery (Table 17). None of the neonatal factors 
had a significant effect on total LATCH scores at 3, 12, or 24 hours. Altogether, these variables 
accounted for less than 10% of the variability in LATCH scores in the model at 3, 12, and 24 
hours (Table 18). 
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Table 17. Summary of Multiple Linear Regression Analysis for Neonatal Variables as Predictors of Total LATCH Scores at 3, 
12, and 24 Hours Postpartum: Total Sample (n = 102) 
 Total LATCH 3 h  Total LATCH 12 h  Total LATCH 24 h 
Variable Β  
(SE) 
p β 
(95%CI) 
 B  
(SE) 
p β 
(95%CI) 
 B 
(SE) 
p β 
(95%CI) 
Apgar score 1 min -0.303 
(0.375) 
0.422 .375 
(-1.048-.443) 
 0.418 
(0.310) 
0.181 .148 
(-.198-1.033) 
 0.084 
(0.243) 
0.729 -.037 
(-.567-.399) 
Apgar score 5 min 1.135 
(1.009) 
0.263 .121 
(-.868-3.139) 
 0.599 
(0.834) 
0.474 .079 
(-1.056-2.255) 
 1.282 
(0.654) 
0.053 .212 
(-.016-2.581) 
Baby weight at birth  -0.118 
(0.134) 
0.381 -.090 
(-.384-.148) 
 0.027 
(0.111) 
0.807 .026 
(-.193-.247) 
 -0.056 
(0.087) 
0.522 -.066 
(-.228-.117) 
% of baby weight 
change in 24 hours,  
0.062 
(0.059) 
0.293 .108 
(-.054-.178) 
 0.010 
(0.048) 
0.830 .023 
(-.086-.107) 
 0.025 
(0.038) 
0.505 .069 
(-.050-.101) 
Meconium stained 0.561 
(0.290) 
0.138 .157 
(-.184-1.306) 
 -0.227 
(0.310) 
0.466 -.079 
(-.843-.389) 
 0.015 
(0.243) 
0.952 .006 
(-.468-.497) 
Sex of neonate 0.108 
(0.269) 
0.690 .041 
(-.427-.642) 
 0.027 
(0.223) 
0.905 .013 
(-.416--.469) 
 -0.083 
(0.174) 
0.635 -.049 
(-.429-.263) 
Baby suctioned  0.251 
(0.290) 
0.390 .093 
(-.325-.827) 
 0.024 
(0.240) 
0.922 .011 
(-.453-.500) 
 -0.090 
(0.188) 
0.633 -.052 
(-.463-.283) 
 
  
155 
 
 
 
 
Table 18. R2, F, and Probability for Regression Analysis of Neonatal Variables as Predictors of Total LATCH Scores at 3, 12, 
and 24 hours Postpartum: Total Sample (n = 102) 
 Total LATCH 3 h  Total LATCH 12 h  Total LATCH 24 h 
 R2 F p  R2 F p  R2 F p 
Apgar score 1 min 0.000 0.040 0.422  0.028 2.846 0.181  0.000 0.011 0.729 
Apgar score 5 min 0.028 1.450 0.263  0.033 1.704 0.474  0.044 2.258 0.053 
Baby weight at birth  0.031 1.044 0.381  0.033 1.124 0.807  0.050 1.731 0.522 
% of baby weight change in 24 
hours  
0.044 1.120 0.293  0.034 0.843 0.830  0.055 1.416 0.505 
Meconium stained 0.074 1.525 0.138  0.038 0.765 0.466  0.055 1.123 0.952 
Sex of neonate 0.074 1.269 0.690  0.039 0.640 0.905  0.058 0.969 0.635 
Baby suctioned  0.079 1.158 0.390  0.040 0.555 0.922  0.058 0.832 0.633 
Model   0.334    0.790    0.563 
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Hypothesis 2: Effects of Extent of Epidural Drug Exposure on Breastfeeding Behaviors 
The second hypothesis was that healthy term infants of mothers who receive epidural 
analgesia with hydromorphone would demonstrate less effective breastfeeding behaviors at 3, 
12, and 24 hours of age in relation to the duration of infusion and amount of drug given to the 
mother. This hypothesis was based on the assumption that if exposure to the drug affects the 
neonate’s muscle tone and reflexes, then breastfeeding behaviors such as the necessary facial 
tone to maintain latch-on would be worse with longer epidural infusions and greater amounts of 
infusate. 
Examination of the dose relationship between epidural medication and LATCH score in 
the epidural group using the mixed-effect regression model did not show a significant effect for 
total amount of epidural infusate, total dose of lidocaine, or total dose of bupivacaine (Table 19). 
The degree of dilation at the time of placement of the epidural also did not significantly affect 
the LATCH score (Table 19). Thus, study findings did not support the hypothesis that healthy 
term infants born to mothers who received epidural analgesia would demonstrate less effective 
breastfeeding behaviors with greater exposure to epidural medications.  
Table 19. Mixed-effect Regression Analysis of Effects of Total Epidural Infusate, Dose, 
and Extent of Dilation on Total LATCH Score (n = 51) 
Name Coefficient 95% CI p 
Total amount of epidural infusate -0.039 -0.363 to -0.389 0.937 
Total dose of lidocaine  0.116 -0.157 to 0.388 0.396 
Total dose of bupivacaine -0.026 -0.154 to 0.102 0.686 
Degree of dilation at epidural placement -0.033 -0.200 to 0.134 0.690 
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Furthermore, multiple linear regression analysis in a model comprising multiple interventions 
during labor also did not find significant relationships of these variables with total LATCH 
scores within the epidural group (see Table 24 under Hypothesis 3: Effects of Multiple Stressful 
Events or Interventions, below). 
Hypothesis 3: Effects of Multiple Stressful Events or Interventions During Labor 
The third hypothesis predicted that when multiple stressful events or interventions are 
present during labor or immediately after birth, healthy term infants would demonstrate less 
effective breastfeeding, whether or not labor analgesia was used. Such factors might include 
maternal factors, e.g., long duration of labor (2nd stage, 3rd stage, or total stage 2/3), large total 
amount of IV fluids administered, oxytocin administration, induction of labor, epidural 
placement, group B streptococcus positive status, and perineal laceration, or neonatal factors, 
e.g., meconium staining, baby suctioned, low Apgar score at 1 and/or 5 minutes, and neonatal 
weight loss. Multiple linear regression analyses of these explanatory variables were therefore 
performed with total LATCH score at 3, 12, and 24 hours as dependent variables tested 
individually in the model. These analyses were performed both for the entire patient collective (n 
= 102) and for the epidural group alone (n = 51). 
Total Sample 
Prior to the multiple regression analyses, Pearson’s correlation coefficients were calculated 
to examine possible linear relationships between variables. The results of the correlation matrix 
for the entire patient collective are presented in Table 20. 
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Table 20. Correlation Matrix for Labor and Neonatal Variables and LATCH Scores in the Total Sample (n = 102) 
 
Duration 
Stage 2 
Rupture 
membranes 
Total IV 
fluids 
Oxytoci
n Induction 
Epidural 
placed 
Total 
stage 
2&3 
Baby 
suctioned Meconium 
Apgar  
1 min 
Apgar  
5 min 
Weight 
loss  
(%) 
3 h  
LATCH 
12 h  
LATCH 
24 h 
 LATCH 
Duration Stage 2                
Rupture of membranes -0.027               
Total  IV fluids 0.172 0.133              
Oxytocin  0.023 -0.254* -0.401**             
Induction -0.023 -0.315** -0.301** 0.620**            
Epidural placed -0.374** -0.098 -0.584** 0.268** 0.315**           
Total Stage 2 & 3 0.964** -0.012 0.199* -0.009 0.061 -0.386**          
Baby suctioned -0.074 -0.039 -0.116 0.069 0.003 0.182 -0.049         
Meconium -0.048 -0.016 -0.103 -0.080 -0.131 -0.004 -0.059 0.269**        
Apgar 1 min -0.041 0.009 -0.130 -0.046 0.040 0.079 -0.053 0.189 0.167       
Apgar 5 min -0.110 0.011 -0.065 -0.102 -0.083 0.000 -0.144 0.180 0.133 0.316**      
Weight loss (%) 0.040 0.087 0.061 0.107 0.049 -0.037 0.043 0.075 0.017 -0.109 0.066     
3 h LATCH -0.110 -0.055 -0.172 -0.041 -0.005 -0.045 -0.114 0.124 0.183 -0.020 0.153 0.137    
12 h LATCH -0.086 -0.125 -0.042 0.025 -0.001 -0.019 -0.053 0.056 -0.037 0.166 0.124 0.007 0.421**   
24 h LATCH -0.155 -0.135 -0.031 0.095 0.083 0.023 -0.169 -0.008 0.005 0.010 0.201* 0.096 0.239* 0.526**  
* Correlation is significant at the 0.05 level (2-tailed).   
** Correlation is significant at the 0.01 level (2-tailed).   
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The results of multiple linear regression analysis of multiple events or interventions during 
labor are presented in Table 21 for the entire study population. The only significant effect was a 
negative effect at the first breastfeeding (3 hours postpartum) when the mother received high 
volumes of IV fluids (lactated Ringer’s solution) (p = 0.021). Other labor and neonatal variables 
were not useful in predicting LATCH scores at 3, 12, or 24 hours postpartum. Table 22 shows 
the R2 values as variables are added to the model. The largest R2 value (0.083) was achieved at 
24 hours (Table 22), indicating that the variability of LATCH scores accounted for by the labor 
and neonatal variables altogether was not more than approximately 8% at any of the three time 
points. Thus, study findings did not support the hypothesis that healthy term infants born to 
mothers with multiple stressful labor interventions or events demonstrate less effective 
breastfeeding, whether or not labor analgesia was used. 
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Table 21. Multiple Linear Regression Analysis of Labor Variables as Predictors of Total LATCH Scores at 3, 12, and 24 
Hours Postpartum: Total Sample (n = 102) 
 Total LATCH 1 (3 h)  Total LATCH 2 (12 h)  Total LATCH 3 (24 h) 
Variable Β  
(SE) 
p β 
(95%CI) 
 B 
(SE) 
p β 
(95%CI) 
 B 
(SE) 
p β 
(95%CI) 
Duration of 2nd 
stage of labor 
-0.008 
(0.007) 
0.272 
 
-.110 
(-.022-.006) 
 -0.005 
(0.006) 
0.387 
 
-.086 
(-.016-.006) 
 -0.007 
(0.005) 
0.051 
 
-.155 
(-.016-.002) 
Duration of 3rd 
stage of labor 
-0.008 
(0.25) 
0.759 
 
-.031 
(-.058-.043) 
 0.023 
(0.020) 
0.254 
 
.114 
 (-.017-.064) 
 -0.012 
(0.016 
0.454 
 
-.075 
(-.044-.020) 
Duration of total 
labor 
-0.008 
(0.007) 
0.279 
 
-.008 
(-.002-.006) 
 -0.005 
(0.006 
0.365 
 
-.095 
(-.017-.006) 
 -0.007 
(0.005) 
0.127 
 
-.160 
(-.016-.002) 
Induction  -0.037 
(0.305) 
0.904 
 
-.012 
(-.641-.568) 
 0.034 
(0.244) 
0.891 
 
.014 
(-.451-.519) 
 0.135 
(0.194) 
0.487 
 
.070 
(-.249-.519) 
Rupture of 
membranes 
-0.175 
(0.279) 
0.532 
 
-.067 
(-.728-.378) 
 -0.302 
(0.222) 
0.176 
 
-.143 
(-.743-.138) 
 -0.214 
(0.176) 
0.228 
 
-.127 
(-.563-.136) 
Oxytocin  -0.173 
(0.357) 
0.629 
 
-.063 
(-.881-.535) 
 0.084 
(0.284) 
0.768 
 
.038 
(-.480-.648) 
 0.117 
(0.225) 
0.605 
 
.066 
(-.330-.564) 
Epidural placed -0.124 
(0.290) 
0.671 
 
-.048 
(-.700-.453) 
 -0.004 
(0.232) 
0.988 
 
-.002 
(-.463-.456) 
 -0.190 
(0.183) 
0.301 
 
-.116 
(-.552-.173) 
GBS positive -0.033 
(0.289) 
0.910 
 
-.012 
(-.608-.542) 
 -0.254 
(0.229) 
0.271 
 
-.113 
(-.710-.202) 
 -0.221 
(0.181) 
0.224 
 
-.123 
(-.580-.137) 
Perineal laceration  0.022 
(0.171) 
0.896 
 
.014 
(-.318-.363) 
 -0.044 
(0.136) 
0.744 
 
-.034 
(-.314-.225) 
 0.084 
(0.107) 
0.433 
 
.081 
(-.128-.295) 
Total IV fluids 
infused  
0.000  
(0.000) 
0.021 
 
-.304 
(-.001-.000) 
 -5.891 
(0.00) 
0.706 
 
-.051 
(.000-.000) 
 -8.377 
(0.000) 
0.945 
 
-.009 
(.000-.000) 
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Table 22. R2, F, and Probability for Regression Analysis of Labor Variables as Predictors of Total LATCH Scores at 3, 12, 
and 24 Hours Postpartum: Total Sample (n = 102) 
 Total LATCH 3 h  Total LATCH 12 h  Total LATCH 24 h 
Variable R2 F p  R2 F p  R2 F p 
Duration of 2nd stage labor 0.012 1.222 0.272  0.007 0.753 0.387  0.024 2.456 0.120 
Duration of 3rd stage labor   0.013 0.653 0.759  0.021 1.037 0.254  0.030 1.510 0.454 
Duration of total labor 0.013 0.653 0.279  0.021 1.037 0.365  0.030 1.510 0.127 
Induced  0.013 0.436 0.904  0.021 0.691 0.9891  0.034 1.164 0.487 
Rupture of membranes 0.017 0.423 0.532  0.039 0.987 0.176  0.049 1.246 0.228 
Oxytocin 0.020 0.383 0.629  0.040 0.800 0.768  0.052 1.043 0.605 
Epidural placed 0.021 0.347 0.671  0.040 0.660 0.988  0.062 1.050 0.301 
GBS positive  0.022 0.296 0.910  0.052 0.742 0.271  0.077 1.119 0.224 
Perineal laceration  0.022 0.258 0.896  0.053 0.656 0.744  0.083 1.052 0.433 
Total IV fluids infused 0.077 0.857 0.021  0.055 0.594 0.706  0.083 0.926 0.945 
Model   0.566    0.799    0.507 
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Within the Epidural Group 
Women who receive epidural analgesia may be even more likely than women without 
epidural analgesia to have multiple stressful interventions and events during labor or 
immediately postpartum (e.g., oxytocin administration, induction of labor, ruptured membranes, 
total IV fluids administered, longer long duration of labor, meconium staining, and need for baby 
suctioning), which might affect the neonates’ breastfeeding behaviors. Therefore, a second 
multiple linear regression analysis of the effects of labor and neonatal variables was performed in 
the epidural group alone.  
To examine possible linear relationships among labor and neonatal variables, Pearson 
correlation coefficients among variables were examined. The correlation matrix is presented in 
Table 23.  
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Table 23. Correlation Matrix for Labor Variables and LATCH Scores in the Epidural Group (n = 51) 
 
Duratio
n S2 
Rupture 
memb Total IV Oxytocin 
Inductio
n 
Dilatio
n 
Total 
S2&3 
1.5% 
lido 
0.25% 
bupiv 
Total 
epidural 
Baby 
suction Meconium 
Apgar 
1 min 
Apgar  
5 min 
Wt loss 
(%) 
3 h  
LATCH 
12 h 
LATCH 
24 h 
LATCH 
Duration S2                   
Rupture memb -0.082                  
Total IV -0.097 0.097                 
Oxytocin 0.182 -0.150 -0.182                
Induction 0.038 -0.263 0.104 0.530**               
Dilation -0.228 -0.239 0.110 -0.040 -0.092              
Total S2&3 0.959** -0.061 -0.074 0.154 0.051 -0.260             
1.5% lidocaine 0.130 -0.042 0.039 0.137 0.094 -0.026 0.086            
0.25% bupiv -0.255 -0.047 0.051 -0.312* -0.219 0.225 -0.189 -0.175           
Total epidural 0.165 0.091 0.150 -0.250 -0.346* -0.290* 0.155 0.193 -0.220          
Baby suction 0.710 0.009 -0.116 0.056 0.018 -0.129 0.013 -0.025 -0.080 0.320*         
Meconium -0.083 -0.032 -0.116 -0.083 -0.207 -0.209 -0.056 -0.005 0.134 -0.002 0.088        
Apgar 1 min 0.184 -0.012 -0.012 -0.070 0.089 -0.136 0.235 0.111 0.140 0.235 0.371 0.059       
Apgar 5 min -0.067 0.169 -0.169 -0.133 -0.139 -0.296* -0.115 -0.270 0.351* 0.038 0.263 0.328* 0.286*      
Wt loss (%) 0.064 0.115 0.047 0.233 0.152 0.018 0.086 0.568 0.017 0.258 -0.163 0.099 -0.099 -0.003     
3 h LATCH -0.125 -0.033 -0.289* -0.050 0.170 -0.096 -0.114 0.224 0.099 -0.091 0.038 0.193 -0.011 0.156 0.075    
12 h LATCH -0.117 -0.078 -0.258 0.099 0.095 -0.110 -0.072 0.205 0.051 -0.183 -0.050 0.062 0.142 -0.148 -0.054 0.620**   
24 h LATCH -0.253 0.082 -0.037 0.105 0.208 -0.020 -0.275 0.026 -0.111 -0.277 -0.129 0.091 -0.014 0.030 0.165 0.331* 0.467**  
Bupiv = bupivacaine; rupture memb = ruptured membrane; S2 = 2nd stage of labor; S2&3 = 2nd and 3rd stages of labor; total epidural = total epidural infusate; wt loss 
= neonatal weight loss. 
* Correlation is significant at the 0.05 level (2-tailed).  ** Correlation is significant at the 0.01 level (2-tailed)     
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The regression analysis for the epidural group is presented in Table 24. As in the total 
sample, only total IV fluids (lactated Ringer’s solution) contributed significantly to model for the 
first LATCH session at 3 hours postpartum (p = 0.012). Thus, high volumes of IV fluids may 
lower the total LATCH score at 3 hours postpartum. No variable showed an independent 
significant effect on LATCH scores during the second or third breastfeeding session. Table 25 
shows the R2 values as variables are added to the model. Altogether, in women undergoing 
epidural analgesia, these variables contributed 30% of the variability in LATCH scores in the 
model at 3 hours and 15% at 12 hours, and 30 % at 24 hours. However, no statistical significance 
was achieved for the model. 
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Table 24. Multiple Linear Regression Analysis for Labor and Neonatal Variables as Predictors of Total LATCH Scores at 3, 
12, and 24 Hours Postpartum: Epidural Group (n = 51) 
 Total LATCH 3 h  Total LATCH 12 h  Total LATCH 24 h 
Variable Β  
(SE) 
p β 
(95%CI) 
 B  
(SE) 
p β 
(95%CI) 
 B 
(SE) 
p β 
(95%CI) 
Oxytocin  -0.134 
(0.381) 
0.726 -.050 
(-.900-.632) 
 0.208 
(0.300) 
0.490 -.011 
(-.394-.811) 
 0.176 
(0.237) 
0.742 .105 
(-.301-.653) 
Induction  0.611 
(0.413) 
0.145 -.229 
(-.219-1.440) 
 0.138 
(0.331) 
0.679 .065 
(-.528-.804) 
 0.330 
(0.258) 
0.208 .198 
(-.189-.849) 
Total epidural 
infusate 
-0.001 
(0.005) 
0.811 -.036 
(-.011-.009) 
 -0.003 
(0.004) 
0.513 -.1099 
(-.011-.005) 
 -0.005 
(0.003) 
0.118 -.230 
(-.011-.001) 
Rupture of 
membranes 
0.014 
(0.405) 
0.972 .005 
(-.800-.829) 
 -0.116 
(0.323) 
0.722 -.054 
(-.766-.535) 
 0.248 
(0.244) 
0.314 .147 
(-.243-.740) 
Total IV fluids  -0.001 
(0.000) 
0.012 -.373 
(-.001-.000) 
 0.000 
(0.000) 
0.091 -.260 
(-.001-.000) 
 -5.351 
(0.000) 
0.748 -.048 
(.000-.000) 
Extent of dilation  -0.056 
(0.157) 
0.722 -.056 
(-.372-.259) 
 -0.092 
(0.129) 
0.482 -.115 
(-.352-.169) 
 -0.088 
(0.100) 
0.385 -.140 
(-.291-.114) 
Total stage 2 & 3 -0.009 
(0.009) 
0.327 -.144 
(-.028-.009) 
 -0.006 
(0.008) 
0.451 - .116 
(-.021-.010) 
 -0.011 
(0.006) 
0.054 -.287 
(-.023-.000) 
Meconium 0.735 
(0.534) 
0.176 .200 
(-.343-1.812) 
 0.053 
(0.453) 
0.907 .018 
(-.860-.967) 
 0.193 
(0.337) 
0.569 .084 
(-.487-.873) 
Baby suctioned -0.225 
(0.421) 
0.597 -.084 
(-1.075--.626) 
 -0.195 
(0.357) 
0.587 -.093 
(-.916-.526) 
 -0.232 
(0.264) 
0.384 -.139 
(-.766-.301) 
1.5% lidocaine 0.421 
(0.226) 
0.072 .290 
(-.040-.881) 
 0.295 
(0.196) 
0.142 .258 
(-.104-.694) 
 0.089 
(0.157) 
0.572 .092 
(-.229-.408 
0.25% 
bupivacaine 
0.137 
(0.150) 
0.370 .181 
(-.170-.444) 
 0.065 
(0.134) 
0.632 .106 
(-.208-.338) 
 -0.135 
(0.102) 
0.196 -.264 
(-.345-.074) 
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Table 25. R2, F, and Probability for Regression analysis of Labor and Neonatal Variables as Predictors of Total LATCH 
Scores at 3, 12, and 24 Hours Postpartum: Epidural Group (n = 51) 
 Total LATCH 1 (3 h)  Total LATCH 2 (12 h)  Total LATCH 3 (24 h) 
Variable R2 F p  R2 F p  R2 F p 
Oxytocin 0.003 0.124 0.726  0.010 0.483 0.490  0.011 0.550 0.462 
Induction  0.046 1.159 0.145  0.013 0.324 0.679  0.044 1.094 0.208 
Total epidural infusate 0.047 0.777 0.811  0.022 0.358 0.513  0.093 1.597 0.118 
Rupture of membranes 0.047 0.571 0.972  0.025 0.296 0.722  0.113 1.458 0.314 
Total IV fluids  0.172 1.873 0.012  0.086 0.845 0.091  0.115 1.165 0.748 
Extent of dilation  0.175 1.552 0.722  0.096 0.780 0.482  0.130 1.094 0.385 
Total stage 2 & 3 0.193 1.470 0.327  0.108 0.745 0.451  0.206 1.592 0.054 
Meconium 0.228 1.550 0.176  0.108 0.638 0.907  0.212 1.412 0.569 
Baby suctioned 0.233 1.386 0.597  0.115 0.591 0.587  0.227 1.334 0.384 
1.5% lidocaine 0.305 1.448 0.072  0.157 0.616 0.142  0.260 1.157 0.572 
0.25% bupivacaine 0.305 1.195 0.370  0.146 0.465 0.632  0.297 1.152 0.196 
Model   0.332    0.910    0.359 
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Summary of the Study Results 
Breastfeeding behaviors measured with the LATCH Breastfeeding Assessment Tool did 
not differ significantly between the groups at any of the three time points studied (3, 12, and 24 
hours after birth) and were not related to total amount of drugs administered. The presence of 
multiple stressful events and interventions during labor, e.g., duration of labor, large amount of 
IV fluids, oxytocin administration, induction of labor, and meconium staining/suctioning of the 
baby, did not significantly affect breastfeeding behavior in the overall study population (n = 
102), altogether contributing not more than 8% of the variability of LATCH scores in the 
regression model. Within the group receiving epidural analgesia (n = 51), which had 
significantly longer duration of labor, higher rates of oxytocin administration and induction of 
labor, and larger amounts of IV fluid administration, the combination of these factors contributed 
about 30% of the variability of LATCH scores in the regression model at 3 and 24 hours. 
However, the model was not significant in this group. These results are discussed in Chapter 5.  
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Chapter 5: Discussion 
This chapter discusses the results of the study in relation to the theoretical framework of 
neonatal breastfeeding behaviors, and the findings are compared to similar research studies in the 
scientific literature. The strengths and limitations of the study and implications for clinical 
practice are described, and recommendations for continued research are given.  
The current study assessed breastfeeding behaviors in the first 24 hours postpartum in 
neonates whose mothers used epidural analgesia with hydromorphone for labor and delivery 
compared with neonates whose mothers used no analgesia. The primary hypothesis of the study 
was that healthy term infants of mothers who receive epidural analgesia with hydromorphone 
would demonstrate less effective breastfeeding behaviors at 3, 12, and 24 hours of age when 
compared with infants whose mothers received no analgesia. The findings did not support this 
hypothesis. Assessment of breastfeeding behaviors with the LATCH Breastfeeding Assessment 
Tool (D. Jensen et al., 1994) showed no significant differences at any time point in breastfeeding 
behaviors between neonates born to mothers who used epidural analgesia containing 
hydromorphone and neonates whose mothers used no analgesia for labor. With a total sample 
size of 102, the study had the power to detect a medium effect size if a true effect existed.  
The second hypothesis—that effectiveness of breastfeeding would be related to the 
duration of infusion/amount of drug given—was also not supported. Regression analyses showed 
no significant effects of total amount of epidural infusate, total dose of lidocaine, total dose of 
bupivacaine, or degree of dilation at the time of placement of the epidural. 
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The third hypothesis—that the presence of multiple stressful events or interventions during 
labor or immediately after birth (e.g., duration of labor, large amount of IV fluids, oxytocin 
administration, induction of labor, and meconium staining/suctioning of the baby) would be 
related to less effective breastfeeding, whether or not labor analgesia was used—was also not 
supported. The only significant variable was administration of a large amount of IV fluids 
(lactated Ringer’s solution). Taken together, these variables accounted for no more than 
approximately 8% of the variability in LATCH scores in the overall study population (n = 102), 
and the model was not significant. This sample size was large enough to have an 80% chance of 
detecting a true difference if it had existed. 
Mothers who chose to receive epidural analgesia (n = 51) had significantly longer duration 
of labor, higher rates of oxytocin administration, induction of labor, and larger amounts of IV 
fluid administration compared to those who did not choose to have analgesia. Within the epidural 
group, the combination of stressful factors contributed about 30% of the variability of LATCH 
scores in the regression model at 3 and 24 hours, suggesting that having an epidural and then also 
needing multiple labor interventions may indeed have a negative effect on breastfeeding. 
However, this effect was not significant, and the sample size of 51 was too small to have the 
power to detect a true effect of this size if it did exist. Therefore, no conclusion can be drawn.  
These data indicate that, by itself, epidural analgesia with hydromorphone has no effect on 
breastfeeding behaviors as measured during the first 24 hours after birth by the LATCH 
assessment tool, at least in this population of healthy term neonates born in a hospital 
environment strongly supportive of breastfeeding.  
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Comparison with Results Reported in the Literature 
As discussed in Chapter 2, review of published reports of empirical studies specific to 
labor epidural analgesia and breastfeeding (French et al., in press) found conflicting results: 11 
studies found that epidural analgesia was not implicated in adverse breastfeeding outcomes (10 
found no effect and 1 found a positive effect), and 12 studies showed negative associations 
between epidural analgesia and breastfeeding success. Comparison of the current study with 
these published studies is difficult because of methodological differences, including differences 
in study design. Only three were randomized, some were prospective cohort studies, as was the 
current study, and some were retrospective surveys. The type and dosage of epidural drug used 
also varied. No study used hydromorphone as the epidural opioid. Most used fentanyl or did not 
give information on the opiate used. The studies also varied widely in timing and techniques for 
measuring breastfeeding success. Only a few studies reported using any kind of standardized 
breastfeeding instrument (Baumgarder, Muehl, Fischer, & Pribbenow, 2003a; Beilin et al., 2005; 
Chang & Heaman, 2005; Radzyminski, 2003; J. Riordan et al., 2000), and only three of these 
used the LATCH tool to assess breastfeeding behaviors. Two found negative effects of the 
epidural analgesia on LATCH scores (Baumgarder et al., 2003b; J. Riordan et al., 2000), and one 
found no effect (Chang & Heaman, 2005). All three of these studies performed at least one 
assessment during the first 24 hours after birth, and all three were prospective cohort studies.  
Potential Influences on the Study Results 
Furthermore, the following factors need to be considered: 
 It is possible that the LATCH assessment tool was not sensitive enough to detect subtle 
differences in breastfeeding behavior due to epidural analgesia.  
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 The type of epidural medications used in this study (ultralow-dose bupivacaine and 
hydromorphone) may have provided such a low amount of drug exposure to the neonate 
that any effects of the medication may have been too small to detect.  
 The study was not randomized, and factors that may play a role in determining 
breastfeeding behaviors were different in each group.  
 The breastfeeding support provided by the hospital’s BFHI environment may have helped 
to overcome potential negative effects of the epidural medications.  
Usefulness of Breastfeeding Assessment Tools in Detecting Effects of Epidural 
Analgesia 
LATCH Breastfeeding Assessment 
The LATCH breastfeeding tool was chosen because it reflects aspects of the individual 
neonate’s feeding activities as well as maternal variables that are used to predict breastfeeding 
problems. High interrater reliability (85.7-100%) was found among lactation consultants using 
the tool (Adams & Hewell, 1997). Significant correlation between mother’s ratings of how well 
she thought breastfeeding went (0 = not at all well to 3 = very well) and the evaluators’ LATCH 
scores (n = 132, r = 0.56, p = 0.001) supported the construct validity of the tool (J. Riordan et al., 
2001). In two studies (S. P. Kumar, Mooney, Wieser, & Havstad, 2006; J. Riordan et al., 2001), 
LATCH scores were predictive of breastfeeding duration up to 6 weeks. Both studies found 
higher LATCH scores for those who were still breastfeeding at 6 weeks compared with those 
who weaned before 6 weeks.  
The LATCH scoring system was a relatively easy data collection tool to use for this study, 
and easy to score, with clear criteria for each category of breastfeeding. It was observational and 
well tolerated by the mothers. Many of the women liked being in the study because they got 
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instant feedback on how well the neonate was feeding. Also, many liked the extra attention they 
were getting from the data collectors. This brought into question whether the presence of the data 
collector had any effect on the breastfeeding session. The system gave the caregiver key 
components of maternal and neonatal variables of effective breastfeeding behaviors and defined 
areas where intervention may be needed. The tool was defined to pick up abnormalities. When 
the observer in the room provided positive feedback, the mothers felt they were successful. Even 
neonates that breastfed poorly were able perform key components of an effective breastfeeding 
session, which were interpreted as positive feedback by the mother. This was part of the purpose 
of developing the instrument (D. Jensen et al., 1994).  
The LATCH score is based on observations by the data collectors and is subject to their 
interpretation. The score is dependent on the ability of the researcher to use the instrument. 
Subjectivity and bias can occur with instruments that rely on observation methods (Polit & Beck, 
2012). Observer bias was minimized by keeping the data collectors (or the PI and the lactation 
consultant) blinded to the participants’ use or non-use of epidural analgesia. Both the PI and the 
lactation consultant had extensive training in using the LATCH tool. 
There were some factors the LATCH tool did not assess that would have been helpful 
during the breastfeeding sessions. Attitudes and opinions of the mother related to frequency of 
feeding and who initiated or ended the feed—mother, baby, or possibly staff. All the mothers had 
breastfed previously and had predetermined from their experience the patterned frequency of 
feeding. When neonates were feeding well at the breast, many mothers would stop the feed, 
determining they had had enough milk or stop and ask for formula because they thought the baby 
wasn't getting enough milk. Information was given to mothers about infant feeding cues and 
baby-led feeding was optimal for the development of a mother/neonate feeding dyad. Because 
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the amount of milk being consumed by the infant can't be seen or measured, extra reassurance 
should be provided to these mothers. The attitudes of the mother and her perception of the 
breastfeeding experience contribute to the success of breastfeeding. A simple addition to the 
LATCH such as to how often the baby is fed or who initiates the feeding would add to the body 
of knowledge. 
It is important to note that during the first 24 hours of life a considerable number of 
neonates do not have a good latch or audible swallow, with several bursts of sucking preceding 
the swallow. The LATCH tool was designed to detect these differences in a neonate <24 hours 
old and therefore provided a mechanism to analyze the coordination of the suck-swallow cycle, 
which is so important when assessing breastfeeding behaviors. Items also included whether the 
infant was not able to latch, needed help with latch, or latched, or whether there were no audible 
swallows, a few audible swallows with stimulation, or spontaneous and intermittent swallows. 
The criteria for scoring were clear. The scores defined the breastfeeding behaviors and were 
useful in data interpretation. Although the LATCH lacked some measures that may have been 
helpful, and although it depended on the researcher’s ability to observe and use the instrument 
correctly, it was sensitive enough to detect differences between neonates. Thus, it proved to be a 
useful way to measure which neonates were able to exhibit successful breastfeeding behaviors in 
this study.   
As described in Chapter 4, the original study plan was to conduct the NACS and the 
LATCH together at the 3, 12 and 24 hours after delivery, but the test was discontinued because 
of difficulties in finding appropriate times when the neonates would be in equivalent states of 
arousal and when it could be performed without disturbing the neonate’s sleep or distressing the 
mother. There were also occasional difficulties in scheduling the LATCH test. During the first 24 
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hours of life, many neonates may be slow to feed and may have a long period of sleep after they 
are born (Holmes, 2013). All of the infants in this study were healthy and breastfed vigorously 
within 40 minutes of delivery. They would then sleep for hours, making it very difficult to get 
the first LATCH score at the 3-hour time point. Nevertheless, we were able to perform three 
LATCH breastfeeding assessments of all neonates in a 24 hour period.  
Assessment of Neonatal Neurobehavior 
It is well known that term infants are born with the reflexes such as rooting, sucking, and 
swallowing which are necessary for feeding. In order for the neonate to feed the behavioral states 
are also important in facilitating the reciprocal communication and relation with the mother 
during feeding. For assessment purposes there are predictable patterns of behavior in neonatal 
cranial nerve function and maturation as well as reflexes (Als, 1991). Cranial nerve function and 
maturation are required for the neonate to breastfeed, especially the cranial nerves V, VII, IX,X, 
XI, and XII. It therefore would seem logical that if some factor such as analgesia depresses the 
functioning of one of these cranial nerves, it would result in an altered corresponding feeding 
behavior associated with that nerve. Effective and efficient feeding requires the neonate to be in 
an awake state ( the psychomotor ability to cue they are ready to feed) must have enough 
oropharyngeal muscle strength (tone) to latch onto the breast and maintain the breast in the 
mouth, create enough oral pressure to form a maternal teat and maintain the muscle tone to 
elevate the tongue to massage the alveolar ducts and rhythmically coordination of breathing with 
sucking and swallowing which involves the functional interaction of lips, jaw, palate, tongue, 
larynx, pharynx and esophagus (Bu'Lock et al., 1990). To accomplish this, the neonate has to 
have intact function of their cerebral and brainstem structures and 6 of the 12 cranial nerves (V, 
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VII, IX, X, XI, and XII). These nerves are involved in the muscle tone of the face, structures of 
the mouth, swallowing and breathing. 
For the infant to latch onto the breast the infant must be able to respond to the environment 
in an organized alert state. The more an infant that can regulate and manage their state the more 
alert the neonate is. Awake and alert infants are able to latch onto the breast and maintain their 
latch; thus, the better they will feed. Cranial nerve V, the trigeminal nerve, and cranial nerve VII, 
the facial nerve, are necessary for the neonate to open its mouth, move its lips to the breast, and 
create suction with the tongue and soft palate involved in rooting, latching, and sucking 
responses. Cranial XI, the gloss pharyngeal nerve controls the gag reflex. Suctioning a neonate 
may cause hyper responsive gagging which in turn can inhibit deep latch at the breast. Cranial 
nerve X, the Vagus nerve allows for flexion and extension of the head, neck, and extremities. It 
also controls breathing and heart function, therefore disruption of this nerve could interfere with 
the suck-swallow-breath coordination. If the neonate cannot flexion their neck they will not be 
able to latch on. Cranial nerve XI, the spinal accessory nerve controls muscles involved in head 
position, torticollis, and airway patency. An active tone of these muscles allows the neonate to 
move their head and maintain spatial relation to the body and other objects (Amiel-Tison, 1976). 
Absence of active tone would mean the neonate could not lift their head or move their head 
toward the breast. Once the neonate is attached to the breast, Active tone allows the neonate to 
maintain the attachment without their head falling forward breaking the suction. 
Cranial nerve XII, the hypoglossal nerve controls tongue movements that produce 
sequential, smooth contractions of the voluntary and involuntary muscles of the tongue. 
Disruption of this nerve manifests as nonsequential, erratic, and weak tongue movements which 
interfere with normal sucking and swallowing and milk intake. 
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The information provided by the LATCH Breastfeeding Assessment Tool in relation to 
neurobehaviors involved in breastfeeding was clinically useful for the purposes of this study. The 
breastfeeding behaviors involved in the infants ability to breastfeed correlate with tests of 
passive tone, adaptive responses and primary reflexes on the NACS neurobehavior test. For 
example the NACS has 5 tests for adaptive response which is the ability of the neonate to 
respond to their environment. When observing the breastfeeding session, the infant’s ability to 
manage sensory stimuli and observations of consolability when the neonate is agitated would 
manifest as a good latch and the ability of the infant to feed well. There are three tests for 
reflexes on the NACS which are related to the function of cranial IX, X, XI, and XII. There are 4 
tests for passive tone on the NACS related to the function of cranial nerve V and VII.   
Severe neonatal injury or depression is easy to detect and readily apparent by standard 
neurologic exams that are performed on the neonate shortly after birth and again at 24 hours 
postpartum. However mild injury or depression is not as readily observable in the neonate. 
Infants that have subtle neurologic signs of drug depression display mild hypotonia, mediocre 
primary reflexes, and poor habituation to outside stimuli. Therefore many of the neurobehavior 
the NACS evaluates can be evaluated through breastfeeding observations using a valid tool such 
as the LATCH. If a normal healthy infant can't latch and maintain breastfeeding immediately 
after birth something is wrong. It was not necessary to put the baby through a neurologic exam 
when the information could be gleaned from the breastfeeding session.  
Ultralow-dose Epidural Analgesia Medications 
Most drugs, including those used for analgesia and anesthesia, readily cross the placenta by 
passive diffusion. Diffusion is dependent on a concentration gradient across the placenta with 
drugs, including opioids and local anesthetics passively moving from areas of high concentration 
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to low. Maternal blood concentration of local anesthetics and opioids is determined by the 
physiochemical characteristics of the drug, the amount of drug given, the site of administration, 
metabolism, and excretion and effects of adjuvants (Santos, Karpel, & Noble, 1999; Santos & 
Pedersen, 1994). In order for epidurally administered bupivacaine and hydromorphone to affect 
the fetus they must be absorbed into maternal circulation before fetal transfer, and the maternal 
blood concentration determines fetal drug exposure (Griffiths & Campbell, 2014).  
Hydromorphone is a mu receptor agonist with pharmacokinetic properties intermediate 
between highly hydrophilic morphine and highly lipophilic opioids such as fentanyl and 
sufentanil (Reisine & Pasternak, 1996). After epidural administration, the amount of drug that 
penetrates dura and pia-arachnoid to enter the CSF and spinal compartments is inversely 
proportional to its lipid solubility and polarity (Chrubasik et al., 1993; Herz & Teschemacher, 
1971; Plummer et al., 1990; Sinatra et al., 2000; Yaksh et al., 1988). For example, high lipid 
solubility increases systemic absorption and reduces availability of the drug in the dorsal horn of 
the spinal cord. Therefore, more drug is continually needed to extend the limited duration of 
action (Bernards, 2004; Sinatra et al., 2000). Hydrophilic opioids have more difficulty traversing 
neural and vascular membranes, staying in the spinal compartment, increasing the availability of 
drug on the dorsal horn of the spinal cord, ensuring that a lower concentration of drug is needed 
for continued receptor site activity (Sinatra et al., 2000). Because placental transfer of 
hydrophilic opioids is impeded, they diffuse across slowly and are unlikely to attain effective 
concentration in the fetus (Reynolds, 2011; Syme et al., 2004). 
This gain in opioid-mediated analgesic effect provides a local anesthetic “dose-sparing” 
effect, allowing the use of bupivacaine as an adjunct rather than primary analgesic where 
infusions are 2 to 2.5 times as dilute as those traditionally seen in continuous labor epidural 
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infusions (Sinatra et al., 2000). Very little data exists on neonatal exposure to epidurally 
administered hydromorphone in the mother. However, these theoretical considerations are 
supported by the unpublished study conducted by the author of this dissertation and colleagues at 
Yale New Haven Hospital (Shah, French, Dai, & Snegovskikh, unpublished data, 2012) 
described in the section on epidural medications in Chapter 2. In that study, 10 healthy 
parturients with uncomplicated pregnancies received an initial 100 g hydromorphone and a 9 
mL 0.25% bupivacaine bolus, followed by continuous infusion of 0.05% bupivacaine and 3 
g/mL hydromorphone. Whereas the average maternal venous concentration of bupivacaine was 
0.23 ± 0.18 μg/mL, only two of the 10 umbilical venous samples had detectable levels of 
bupivacaine, with an umbilical/maternal ratio approaching 0, much lower than in a comparable 
study of bupivacaine with fentanyl (Bader et al., 1995). The only umbilical vein samples with 
detectable bupivacaine levels were from patients who required more than one additional bolus. 
The average hydromorphone concentration was 0.26 ± 0.09 ng/mL in the maternal vein samples 
and 0.23 ± 0.09 ng/mL in the umbilical vein samples, with a calculated umbilical/maternal ratio 
of 0.88 ± 0.18, comparable to the fentanyl levels found in the Bader et al. (1995) study, despite 
the higher concentration of hydromorphone in the infusate. Neither our study nor the Bader et al 
(1995) study found evidence of drug accumulation with increasing length of infusion time, and 
results suggested rapid placental transfer and equilibration of both fentanyl and hydromorphone 
between maternal and neonatal blood.  
Thus, the lower overall concentration of bupivacaine in the infusate in the current study 
and the greater hydrophilicity of hydromorphone as compared to fentanyl may have contributed 
to the lack of detectable effects in the neonate. This conclusion is also consistent with our finding 
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that duration of epidural hydromorphone infusion (total amount of hydromorphone) had no effect 
on breastfeeding behaviors.   
Differences in the Patients’ Labor Experience  
As it was not ethically possible to perform a randomized controlled trial of epidural 
analgesia vs no epidural during labor, the study population was selected to be as homogeneous as 
possible to limit external influences on the results. To keep factors such as experience with labor, 
familiarity and confidence with the maternal role, and the mother’s comfort level in caring for 
her newborn as similar as possible, both groups consisted of multiparous women who had 
previously breastfed. Furthermore, the labor experience was similar for both groups regarding 
the care they received from caregivers, all participants had support persons, and high-risk 
pregnancies were excluded so that no complications were expected during labor or delivery. 
Nevertheless, there were differences between the group with epidural analgesia and the 
unmedicated group.  
Longer Duration of Labor 
Previous studies showed epidural analgesia is associated with a longer duration of stage 2 
labor (Anim-Somuah et al., 2011). Similarly, the women in the epidural group in the current 
study had a longer duration of labor measured from stage 2 through stage 3 compared with the 
unmedicated group (p = <0.0001). Longer duration of stage 2 labor can lead to very tired 
mothers and stressed babies, making breastfeeding difficult. However, when analyzed as an 
independent variable in the regression analyses in this study, duration of labor was not 
significantly related to breastfeeding effectiveness scores.  
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Instrumented Delivery 
Moreover, labor epidural analgesia and longer stage 2 labors have been associated with 
higher rates of instrumented vaginal delivery (forceps and vacuum) in some previous studies 
(Anim-Somuah et al., 2011; Nyuyen et al., 2010). One meta-analysis of randomized control trials 
found the use of epidural analgesia was associated with a 2-fold increase in instrumental vaginal 
deliveries (Halpern et al., 1999). However, others have found mixed results (Leighton & 
Halpern, 2002). In the present study, one woman in the epidural group had a vacuum-assisted 
delivery, but this did not produce any significant findings related to her infant’s breastfeeding 
behavior scores. Our study results suggest that, although the women in the epidural group had 
longer stage 2 labors, the low-dose epidural infusate was not potent enough to impair the strength 
of pushing and create a need for instrument delivery.  
Oxytocin Administration 
The women in the epidural group in our study were given oxytocin to induce or augment 
labor significantly more often than women who remained unmedicated during labor (47.1% vs. 
22.9%; p = 0.002). These data support the results of others showing that women who receive 
epidural analgesia for labor pain have higher rates of oxytocin augmentation than unmedicated 
parturients (Anim-Somuah et al., 2011; Chang & Heaman, 2005; Wiklund et al., 2009). Some 
studies suggest exogenous oxytocin augmentation along with epidural analgesia may reduce the 
normal rise in endogenous serum oxytocin levels in response to sucking (Jonas et al., 2009) and 
may shorten breastfeeding duration (Beilin et al., 2005). Other studies have found negative 
effects of synthetic oxytocin on feeding behaviors. In our study, multiple linear regression 
analyses showed that oxytocin did not have an independent effect on breastfeeding behavior.  
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Induction of Labor 
The epidural group also had significantly more women in whom labor was induced 
compared to the unmedicated group (39.2% vs. 22.9%; p = 0.0027). Women may have been 
more likely to request an epidural when they undergo labor induction because the intensity of 
labor tends to be greater after induction than with spontaneous labor. This is in agreement with 
other studies that also found significantly higher rates of epidural analgesia for relief of pain in 
induced labor (Alexander et al., 2001; Duff & Sinclair, 2000; Prysak & Castronova, 1998). 
While examining the effects of labor induction on obstetric outcomes in a study of 410 women, 
Bodner-Adler and colleagues also found that the use of epidural (p = 0.001) and oxytocin (p = 
0.006) was significantly increased in the induction group compared with the control group 
(Bodner-Adler et al., 2005). Furthermore, the need to augment labor with oxytocin was increased 
in women who were induced (Prysak & Castronova, 1998). Although the combination of these 
factors might be expected to negatively influence breastfeeding, we found no independent effects 
of labor induction on breastfeeding scores.  
Intravenous Fluids 
In addition, the epidural group received a greater amount of IV fluids compared to the 
unmedicated group (p = <0.001). This may be the result of factors related to the differences in 
the labor experience between women who received epidural analgesia and those who were 
unmedicated. Women who request an epidural must have an IV catheter in place, and before the 
epidural is placed they must receive a fluid bolus of 500-1000 mL of lactated Ringer’s solution. 
Most of the women in the unmedicated group were patients of a midwife group and often would 
come to the hospital only after they had been in an active labor pattern for some time and had 
had significant cervical dilation. If the women were not group B streptococcus positive and did 
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not require antibiotics, they could choose not to have an IV catheter placed. Twenty-six (51%) of 
the women in the nonmedicated group did not have an IV. Thus, the significant difference 
between groups in the amount of IV fluids received was not unexpected. Multiple linear 
regression analysis only of data from the epidural analgesia group showed that high volumes of 
IV fluids had a significant independent effect on the first breastfeeding session (p = 0.01). Given 
the difference in amount of IV fluids received, this result led to an expectation of a difference in 
breastfeeding behaviors between the groups, which was not the case.  
Multiple linear regression analysis also showed a significant independent effect of higher 
volumes of IV fluids on the 3-hour LATCH score in the entire study population (p = 0.02). As 
49% of the unmedicated group did receive IV administration of Ringer’s solution, it is also 
possible that factors related to the volume of IV fluids may have been at work in both groups. 
When mothers receive IV fluids, neonates also may have hyponatremia and lose more weight 
compared with neonates whose mothers received fluids only by mouth (Dahlenburg, Burnell, & 
Braybrook, 1980; Noel-Weiss, Woodend, Peterson, Gibb, & Groll, 2011). The neonates in both 
groups in our study were feeding well, with weight losses of less than 7% in all neonates. We 
found no significant difference between the groups in the percentage of neonatal weight loss 
during the first 48 hours postpartum. However, early postpartum maternal breast, nipple, and 
areola edema has been described in association with IV fluid hydration of the mother during 
labor (Kujawa-Myles, Noel-Weiss, Dunn, Peterson, & Cotterman, 2015; V. Miller & Riordan, 
2004). Edema may cause latching problems, nipple pain, low milk transfer, or poor breast milk 
volumes, which may in turn have a negative effect on neonatal breastfeeding behaviors. 
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Nevertheless, it is not clear whether the findings regarding IV fluid administration 
represent a true effect. We did not use a correction factor to compensate for the relatively large 
number of significance tests in this study. Thus, it may have been a chance result. 
Influence of the Baby-Friendly Hospital Environment 
We had expected that epidural analgesia and the various stressors it involves, particularly 
the combination of longer duration of labor, greater use of instruments during delivery, oxytocin 
administration, and more frequent induction of labor, would result in significantly reduced scores 
for breastfeeding effectiveness on the LATCH assessment scale in the epidural group. However, 
this hypothesis was not confirmed. One explanation for the lack of difference between groups 
may be that any negative effects of epidural analgesia might have been overcome by factors 
operating to promote breastfeeding success in both groups. High success rates in both groups 
may have precluded detection of any detrimental effects. 
As noted in Chapter 2, breastfeeding can be considered successful if the total LATCH 
score is greater than 7 at two feeds in 24 hours (Baumgarder et al., 2003b; Bramson et al., 2010). 
This criterion was reached by a high proportion of both groups in this study. Total LATCH 
scores above 7 were achieved in more than 70% of both groups at the 3-hour breastfeeding 
session, more than 80% at 12-hour session, and approximately 95% at the 24-hour session (see 
Table 12). The mean LATCH score was greater than 8 at all three feeds, and greater than 9 at 24 
hours in both groups.  
The study hospital was following the Baby-Friendly Hospital Initiative by implementing 
the 10 Steps for Successful Breastfeeding program and working toward achieving accreditation 
from Baby-Friendly USA as a Baby-Friendly Hospital (World Health Organization, 1998). All 
neonates in this study were placed skin-to-skin after delivery and all breastfed within the first 40 
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minutes. The infants “roomed in,” breastfed on demand, and the mothers had access to lactation 
consultants around the clock. All the postpartum nurses were trained in using the LATCH tool as 
an intervention and teaching instrument, and a LATCH score is documented in the electronic 
medical record every 8 hours as a matter of routine. LATCH assessments for the study were 
independent of these scores. None of the study neonates received a pacifier or formula. In 
addition, the vitamin K shot and eye ointment were not administered until 24 hours postpartum. 
These practices are the standard of care and a similar environment was provided for all the 
patients. This breastfeeding-friendly environment may have limited the effects of other variables 
on breastfeeding and may have ameliorated any negative influences of the epidural analgesia in 
this study.  
Breastfeeding is both a nutritional method and a process of connection between the mother 
and infant. John Bowlby first introduced the idea of attachment as a biological response between 
mother and infant that organized neurobehavior (Bowlby, 1982). Studies of mother-infant 
interaction have highlighted the role of the infant’s perceptual, communicative, and interactive 
competency (Brazelton et al., 1983). The bi-directionality of the mother-infant interaction is 
characterized by synchrony and reciprocity (Bowlby, 1982; Tronick & Cohn, 1989). The early 
postpartum period is an important time for mother and infant to develop this synchrony and 
reciprocity and is known as the “sensitive” period (Kennell et al., 1974). The neonate placed 
skin-to-skin with the mother during this sensitive period enhances the long-term interaction 
between mother and neonate and mothers were more likely to be breastfeeding at 1 and 4 months 
after delivery and for a longer duration (Bystrova et al., 2009; E. R. Moore et al., 2012; Salariya 
et al., 1978; Wiberg et al., 1989). If this interaction is interrupted for any reason, and the baby is 
less alert, less able to orient, and less able to show organized movement, this may interfere with 
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the mother-infant relationship (A.D. Murray et al., 1981; Sepkoski et al., 1992) and subsequently 
impact breastfeeding. 
Skin-to-skin contact in the immediate postpartum allows the neonates innate behaviors to 
occur. The neonate next to the mother’s skin helps regulate their temperature, crying, respirations 
and nursing behaviors. It assists the neonate in the transition to extrauterine life by decreasing the 
stress of birth through the mother's warmth, touch, and odor, guiding the neonate to her nipple 
and release of maternal oxytocin. Spontaneous vaginal delivery with immediate maternal-infant 
skin-to-skin contact increases the likelihood of successful baby-led breastfeeding (Righard & 
Alade, 1990; Widstrom et al., 2011). The timing of the first breastfeed is associated with 
duration of breastfeeding. Bramson and colleagues analyzed data from a prospective cohort on 
21,842 mother-infant pairs and determined the longer the mother and infant experienced skin-to-
skin in the first 3 hours after delivery the more likely she was to be exclusively breastfeeding 
during her hospital stay (Bramson et al., 2010). The earlier the initiation of the first breastfeed 
and/ or the mother-neonate contact the longer the duration of breastfeeding (Berra et al., 2003; 
Buxton et al., 1991; Salariya et al., 1978). The unstructured interactions and responses between 
mother and neonate allow hormonal levels in both to change in response to one another.  
Limitations and Strengths of the Study 
The study was limited by its nonrandomized nature, which rules out definitive conclusions 
regarding cause and effect (Polit & Beck, 2012). However, attempts at randomizing women to an 
epidural or unmedicated group have resulted in high crossover rates (Dickinson, Paech, 
McDonald, & Evans, 2002; Nikkola et al., 1997). Self-selection to epidural vs unmedicated 
groups would likely be associated with various confounding variables that would influence 
results, such as the general opinion of the mother regarding interventions for childbirth. Because 
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the decision to have epidural analgesia was voluntary, certain characteristics leading to the 
decision may also have influenced results. Two women declined to participate after the study 
was described to them. Demographic information on those who decline participation would have 
been valuable in determining the direction and nature of bias (Polit & Hungler, 1999).  
The study was limited regarding the selection of the convenience sample. Minorities were 
underrepresented, making the study less generalizable. However, white and minority women 
were equally represented in the two groups. In addition, the research findings apply only to 
healthy multiparous women and infants with no complications of pregnancy and delivery. The 
findings of this study are therefore generalizable only to healthy term infants born in a Baby-
Friendly environment where immediate skin-to-skin, rooming-in, and breastfeeding on demand 
are the standard of care. Also, the findings of this study also only apply to the first 3, 12, and 24 
hours of life.  
A further limitation was that only a certain number of potential predictor variables could be 
analyzed, and the study did not address the mothers’ attitudes, feelings, or opinions toward 
breastfeeding. 
There were several factors that strengthen the quality of this research. Many previous 
studies did not have any type of comparative group. Although this study was not randomized, it 
was able to compare women with epidural analgesia with unmedicated women in a similar 
environment. Equal numbers of women were included in each group, and efforts were made to 
achieve a relatively homogeneous study population. Also all the medicated women received the 
same medication at the same dose. Many studies have wide variations in the type and 
concentrations of epidural medications used or include systemic opioids which influence the 
findings. 
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The LATCH assessment method was noninvasive. Patients did not mind having an 
observer, and the assessment did not hinder the breastfeeding sessions or other interaction 
between the mother and infant. 
Implications for Nursing Practice 
The benefits of breastfeeding are important enough that healthcare providers should 
encourage and support breastfeeding. However, because their own beliefs and opinions may 
influence their patients, healthcare providers should remain cautious when providing information 
about possible risks and barriers to breastfeeding. Systemic opioids used in labor have been 
clearly associated with attenuating the neonate’s ability to breastfeed in the early postpartum, 
leading to concern on the part of both caregivers and mothers about pain medications during 
labor. The literature so far has provided inconsistent data on the effects of epidural analgesics on 
breastfeeding outcomes. Currently, most women in the US choose to have epidural analgesia, but 
they are often frightened about the effect labor analgesic medications might have on the fetus or 
neonate, and therefore they may decline to breastfeed if they need pain relief. Women in labor 
place a high priority on pain relief—so high that they may be willing to sacrifice breastfeeding 
for pain relief in the immediate moment. If the mother feels she did not make a good decision 
during labor, it can lead to anxiety during the feeding and anxiety about breastfeeding.  
Although no conclusions can be drawn from these data as to the comparative effects of 
different epidural medications, the current study shows that epidural analgesia with a low dose of 
hydromorphone is not likely to have an effect on breastfeeding behaviors. Women in this study 
breastfed equally well whether they had epidural analgesia or no analgesia. All of the babies in 
this study fed vigorously the first hour after birth. The neonates were alert, rooting, and searching 
for the breast. Based on these data, if a mother has decided to have epidural analgesia during 
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labor, nurses can recommend and facilitate breastfeeding without worrying that the epidural 
would harm the infant by decreasing breastfeeding success, at least if hydromorphone is used as 
the epidural opioid. We therefore conclude that in this population, it is unwarranted to counsel 
women to not receive epidural medication for labor pain relief because it may negatively affect 
breastfeeding. If the correct amount of medication is administered it, is now possible for women 
go through labor pain free and still breastfeed.  
Although not significant, the finding that the presence of multiple stressful events or 
interventions contributed about 30% of the variability of LATCH scores in the regression model 
at 3 and 24 hours suggests that mothers who have a long duration of labor, receive oxytocin 
administration or large amounts of IV fluid, or in whom labor is induced, may need more 
intensive help from the nurse or lactation consultant to achieve success in breastfeeding. 
This study highlighted the importance of objective assessments in enabling nurses to 
analyze and help the mother correct feeding problems. There are many reasons that some babies 
do not breastfeed well, and it is important to identify factors that may impede breastfeeding in 
the immediate postpartum. The identification of such factors can improve breastfeeding 
outcomes. The mothers in this study were interested in how we were measuring breastfeeding 
behaviors during the breastfeeding observation sessions, and the LATCH tool helped nurses to 
teach them how to recognize feeding cues, the infant’s ability to latch correctly, rhythmic 
sucking, audible swallows, mother’s comfort, and positioning. The LATCH scoring system is 
used at the study hospital for frequent breastfeeding evaluations from delivery room to discharge 
home. In addition to allowing objective assessments, this use of the LATCH tool provides 
mothers with nursing attendance throughout a breastfeeding session.  
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Assessment of LATCH scores can serve as a basis for nurses to give breastfeeding 
assistance and anticipatory guidance. Lactation consultants and nurses can prioritize assistance, 
focusing on mothers and infants with low LATCH scores that indicate a need for prompt 
intervention and support. Breastfeeding is strongly encouraged in the current healthcare 
environment but so is early discharge home. Use of the LATCH tool can help postnatal 
caregivers to identify mothers at risk for weaning and who need postdischarge follow-up. The 
most frequent causes of breastfeeding difficulties in hospital and at home are sore nipples, 
problems with the infant latching on or sucking, and “not enough milk.” Many women may stop 
breastfeeding before they want to as a result of these problems. Nurses in the hospital play a 
significant role in providing the support needed by women in breastfeeding establishment. To 
prevent the common breastfeeding problems, early assessment, support, and education are 
imperative. All breastfeeding issues should be attended to during the hospital stay with a follow-
up plan in place for unresolved issues.  
Clinicians should provide anticipatory guidance about common breastfeeding issues likely 
to occur in the coming weeks, such as management of sore nipples, correct latching and 
unlatching techniques, and alternating feeding positions to reduce friction exerted by the infant’s 
mouth during feeding. Without guidance, many women stop breastfeeding prematurely as a 
result of these problems. With continued support in the community, many of these problems are 
preventable. The early discontinuation of breastfeeding can cause distress and disappointment to 
the mothers and health problems for her and her infant. This is where public health nurses can 
continue the work and care of hospital nurses in providing breastfeeding support and education 
to the mother-infant dyad. Breastfeeding support can consist of praise, reassurance, instruction, 
and time to answer the mothers’ questions.  
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Support by both professionals and lay supporters has a positive impact on breastfeeding 
outcomes (Renfrew, McCormick, Wade, Quinn, & Dowswell, 2012). However, lay support and 
combinations of lay and professional support were more effective for exclusive breastfeeding 
continuation than professional support alone (Renfrew et al., 2012). The authors indicated that as 
a strategy to improve breastfeeding behaviors, face-to-face support was associated with greater 
success than telephone support. When support was offered only if women sought help, it was 
unlikely to be effective. This suggests women should be offered regular scheduled ongoing 
visits. 
Prenatal nurses are in an excellent position to educate mothers about the benefits of 
breastfeeding. Decisions about how a women is going to feed her baby are made before the 
pregnancy or in the prenatal course (Earle, 2002; Ertem et al., 2001; Scott, Binns, & Aroni, 1997; 
Scott et al., 2001). Up-to-date information on the benefits of breastfeeding and positive messages 
about breastfeeding by prenatal clinicians during the pregnancy help mothers make informed 
choices. Prolonged breastfeeding is associated with high maternal self-efficacy (Dennis, 2002; 
Meedya et al., 2010). A women's exposure to breastfeeding and her personal experience with 
breastfeeding have a positive effect on her confidence in her breastfeeding ability (Blyth et al., 
2002; Dennis, 2002). Maternal attitudes toward breastfeeding also affect duration of 
breastfeeding. Women who perceived breastfeeding to be easier, more convenient, and healthier 
than bottle feeding breastfed longer than those who regarded breastfeeding as inconvenient, 
uncomfortable, or more difficult (Dennis, 2002). Similarly, intended duration of breastfeeding 
was associated with actual duration of breastfeeding (Dennis, 2002; Meedya et al., 2010). This is 
important to prenatal nurses, because it has been suggested that simply asking women who 
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intend to breastfeed how long they plan to do so is an efficient method of identifying prenatally 
those who are at risk for short breastfeeding duration (O'Campo, Faden, Gielen, & Wang, 1992). 
Providing effective breastfeeding support requires highly skilled and knowledgeable nurses 
or lactation consultants who can be available to provide the necessary guidance needed by the 
mother and infant in their early breastfeeding experience. Nurse managers and hospital 
administrators must evaluate the resources available to meet the needs of mothers and infants to 
extend the breastfeeding success from birth, through discharge, and into the home environment. 
Communication between hospital and community nurses is vital to the continuity of 
breastfeeding supportive care. The community setting would benefit from an objective 
breastfeeding assessment tool, such as the LATCH scale, in order to help public health nurses to 
reinforce and continually reassess breastfeeding skills and knowledge, while providing the eye of 
the skilled observer and the experience of a trained clinician. 
Implications for Future Research 
To be useful clinically, the results of this study need to be generalizable to other 
populations and other types of epidural medications. Thus, future studies should include 
primiparas and women of different ethnic backgrounds and birth experiences. As the results of 
this study apply only to epidural analgesia with ultralow-dose bupivacaine and hydromorphone, 
comparative studies should be conducted with different concentrations of bupivacaine and 
fentanyl doses compared with the hydromorphone to determine whether the type of drug, dose, 
or drug interaction affects breastfeeding behavior. When it is not ethically possible or feasible to 
randomly assign patients to receive different treatments, carefully planned prospective 
comparative cohort studies should be performed to provide at least some means of comparing 
interventions.  
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Studies should measure breastfeeding success using an objective breastfeeding scoring 
system, such as the LATCH system, and record the specific time point after delivery when the 
first breastfeeding attempt occurred. A breastfeeding analysis should be completed in the first 3 
hours after delivery and then at 24 hours postpartum. Evidence-based recommendations can then 
be made to change practice in order to improve labor outcomes and provide additional 
breastfeeding support to the women who need it most postpartum.  
This study has highlighted the complexity of the potential influences on breastfeeding. 
Epidural analgesia is just one of the intrapartum interventions that can affect the course of labor 
and breastfeeding. The relationship of epidural analgesia with breastfeeding involves complex 
interactions among the various intrapartum interventions. One intervention may lead to another 
in a cascade that may either directly or indirectly affect breastfeeding. Future studies on labor 
epidural analgesia and breastfeeding need to view labor, birth, and interventions as a whole—in 
an integrated process that must be evaluated for potential adverse effects on the course of labor, 
neonatal and maternal behavior, and breastfeeding. 
Conclusion  
Labor epidural analgesia provides women with excellent pain relief. Although the study 
was limited by its nonrandomized nature, these data indicate that, by itself, epidural analgesia 
with low-dose hydromorphone does not decrease the effectiveness of breastfeeding behaviors as 
measured during the first 24 hours after birth by the LATCH assessment tool. However, women 
who receive epidural analgesia have an increased risk of experiencing multiple stressful events 
or interventions during labor, which may contribute to breastfeeding difficulties. Women in this 
situation may need more intensive help from the nurse or lactation consultant to achieve success 
in breastfeeding.   
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Appendices 
 
Appendix A: Patient Information Sheet 
 
 
 
 
The research group of the Department of Anesthesiology of Yale University, School of Medicine. 
                                                                
Effect of Labor Epidural Analgesia With Hydromorphone on Neonatal Neurobehavior and 
Breastfeeding Behavior in the First 24 Hours of Life 
 
 
 
A. PATIENTSTUDY  ID 
NUMBER_________________________ 
B. Maternal INFORMATION 
1.   ASA:    I    II     III    IV       
      Height: ________Weight: 
___________LMP__________ 
2. 
PMH:______________________________________
_________ 
     
___________________________________________
__________ 
     ____________________________________ 
3.  
PSH:______________________________________
__________  
4.   Allergy: 
___________________________________________ 
5.   MEDICATIONS: 
__________________________________ 
___________________________________________
______________GESTATIONAL 
INFORMATION 
1. Gestational Age______________________ 
 
2. G____P_____ 
 
C. DELIVERY INFORMATION 
1. Time of 
Delivery________________________________ 
2. Time of 
Placenta________________________________ 
3. Apgars 1 minute____________5 
minutes__________ 
4. Baby Weight at 
Birth__________________________ 
5. Weight at 24 
hours___________________________ 
 
5. Duration of Labor_____________________ 
 First stage______________________________ 
Second 
stage_______________________________ 
Third 
Stage________________________________ 
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D. EPIDURAL-RELATED COMPLICATIONS 
     
1. Maternal 
Hypotension____________________  
Corrective Action____________ 
Duration_____________ 
     
 
2. Fetal Bradycardia_______________  
  Corrective Action___________       
Duration_______________ 
    
3.MaternalTemp______________ 
Corrective Action___________________ 
Duration_____________________ 
     
4.Pitocin During Labor Yes____No_______ 
Total ML of Infusion______________ 
  
5. AROM   SROM 
 
6. Total Fluids 
E. EPIDURAL INFORMATION 
1. TIME EPIDURAL 
PLACED_________________________ 
2.TOTAL DOSE AND TYPE LOCAL 
ANESTHETIC 1.5% 
LIDO____________________________TIME_____
_____ 
.25% 
BUPIE_______________TIME_________________
____ 
3.TOTAL DOSE DILAUDID AT 
INSERTION_________ 
TIME__________________ 
4.INFUSION RATE_________________________ 
5.TIME EPIDURAL 
REMOVED_____________________ 
6. NUMBER OF BOLUSES AND TIMES OF  
BOLUS____________________________________
________ 
BOLUS____________________________________
________ 
BOLUS____________________________________
________ 
7. DILATION AT TIME OF EPIDURAL 
PLACEMENT_______________________________
_______ 
 
 
F. INSTRUMENT DELIVERY 
Yes_______ (Circle Vacuum or 
Forceps)No________  
 
G. 
Episiotomty____________Tear________________
_ 
Use of Local Anesthetic Yes   No   (Circle) 
If yes type and amount_____________________ 
Time______________________________________
________ 
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Appendix B: Copyright Permission for LATCH Breastfeeding Assessment Tool 
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Appendix C: Copyright Permission for the Neurologic and Adaptive Capacity Score 
[NACS] 
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Appendix D: Brazelton Institute Certification 
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Yale University  
Human Investigation Committee 
                                                    Request for Approval of Amendment to Add or Remove  
Co-Investigator(s) and Study Personnel 
100 FR 11 (2014-1) 
Instructions: This form should be used only to submit to the HIC requests to add or remove co- 
investigators or other study personnel* from active protocols.  The updated HIC application and 
any other study documents incorporating requested changes should be submitted as usual to the 
HIC at time of reapproval unless the personnel are individually named on the consent form (e.g., 
consenting personnel; medical back-up; etc.)  If so, the updated consent form must be submitted 
with this request.  
* A separate form is available and must be used for a change in principal investigator.   
HIC Protocol Number:_1407014373_                   Date: 3/28/15 
Title of Research Project:_ :Effect of Labor Epidural Analgesia With Hydromorphone on 
Neonatal Neurobehavior and Breastfeeding Behavior in the First 24 Hours of Life 
 
Name of Principal Investigator:_Keun Sam Chung MD 
PI Signature:____________________________________________________________ 
PI Campus Address: Yale University School of Medicine, 333 Cedar Street, TMP 3, P.O. Box 208051, 
New Haven, CT, 06520-8051 
Email: keun.chung@yale.edu Phone Number: 203-737-1818 
Correspondent Name: Cynthia French E-mail: cyntfre@aol.com 
Yale Cancer Center CTO Correspondent (If 
applicable) Name:  
E-mail: 
 
 
 
Please complete a new line for each addition or removal of study personnel (to extend the grid, press 
TAB from the last cell in the last row of the grid, and a new row will automatically be created): 
 Name – Enter the full name and degree of the person to be added to or removed from the study. 
 Add or Remove – Enter ‘Add’ or ‘Remove’ as appropriate for each person being added or 
removed from the protocol. 
 Role of Personnel – Please identify the study role  of the added or removed personnel: Co-
Investigator, Study Personnel, Correspondent or Consultant (see definitions in the HIC 
Application Instructions, p. 10, at http://www.yale.edu/hrpp/forms-templates/biomedical.html) 
 HSPT Training – Has this person completed required Human Subjects Protection Training? If 
not completed through Yale University, please submit copies of any certificate of completion. 
 HIPAA Training – Has this person completed the required HIPAA Training? If not completed 
through Yale University, please submit copies of any certificate of completion.  
 Yale Affiliation – Please identify whether this person is a faculty member, an employee, trainee 
or student of Yale University. If Yale-affiliated, please identify their position with Yale. If non-
Yale-affiliated, please identify the organization with which they are affiliated. 
 NetID – Please indicate the Yale researcher’s NetID. This will provide accurate information for 
training completion information. 
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 In Investigator Interests: 
Do any new research personnel who are responsible for the design, conduct or reporting of this 
project, or any of their family members (spouse or dependent child) have an incentive or interest, 
financial or otherwise, that may affect the protection of the human subjects involved in this 
project, the scientific objectivity of the research or its integrity? Note: The Principal Investigator 
(Project Director), upon consideration of the individual’s role and degree of independence in 
carrying out the work, will determine who is responsible for the design, conduct, or reporting of 
the research.  
See Disclosures and Management of Personal Interests in Human Research 
http://www.yale.edu/hrpp/policies/index.html#COI  
  Yes X  No  
 
Does a newly added member on the research team who is determined by you to be responsible 
for the design, conduct or reporting of this research have any patent (sole right to make, use or 
sell an invention) or copyright (exclusive rights to an original work) interests related to this 
research protocol? 
  Yes X  No  
   
If yes to either question above, list names of the investigator or responsible person: 
 
 
 
The Yale University Principal Investigator, all Yale University co-investigators, and all Yale 
University individuals who are responsible for the design, conduct or reporting of research must 
have a current financial disclosure form on file with the University’s Conflict of Interest Office. 
Yale New Haven Hospital personnel who are listed as con-investigators on a protocol with a 
Yale University Principal Investigator must also have a current financial disclosure form on file 
with the University’s Conflict of Interest Office. If this has not been done, the individual(s) 
should follow this link to the COI Office Website to complete the form:  
http://www.yale.edu/coi/   
 
NOTE: The requirement for maintaining a current disclosure form on file with the University’s 
Conflict of Interest Office extends primarily to Yale University and Yale-New Haven Hospital 
personnel.  Whether or not they are required to maintain a disclosure form with the 
University’s Conflict of Interest Office, all investigators and individuals deemed otherwise 
responsible by the PI who are listed on the protocol are required to disclose to the PI any 
interests that are specific to this protocol. 
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Name 
Add or 
Remov
e 
Ability to 
consent 
(check box 
if Yes) 
Co-
Investigator, 
Study 
Personnel, 
Correspondent 
or Consultant? 
HSPT  & 
HIPAA 
Training
? 
Y/N/ 
N/A 
Yale 
Affiliation/non-
Yale Affiliation 
(identify 
institution)  
 
NetID 
Katrina Pinkerton-
Lloyd 
Add  Co-Investigator 
Yes 
Yale University 
Student 
Kp389 
       
       
 
 
 
Does this amendment add any new study locations?     Yes  X  No 
If yes, list location: 
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Yale University  
Human Investigation Committee 
                                                    Request for Approval of Amendment to Add or Remove  
Co-Investigator(s) and Study Personnel 
100 FR 11 (2014-1) 
Instructions: This form should be used only to submit to the HIC requests to add or remove co- 
investigators or other study personnel* from active protocols.  The updated HIC application and 
any other study documents incorporating requested changes should be submitted as usual to the 
HIC at time of reapproval unless the personnel are individually named on the consent form (e.g., 
consenting personnel; medical back-up; etc.)  If so, the updated consent form must be submitted 
with this request.  
* A separate form is available and must be used for a change in principal investigator.   
HIC Protocol Number:___1407014373____________________                     Date: Jan 27, 
2015 
 
Title of Research Project:__ Title of Research Project:  Old Title Maternal and Neonatal 
Hydromorphone and Bupivacaine Concentrations After Epidural Analgesia During Labor and its 
Effect on Neonatal Neurobehavior and Breastfeeding  
New Title: Effect of Labor Epidural Analgesia With Hydromorphone on Neonatal Neurobehavior and 
Breastfeeding Behavior in the First 24 Hours of Life 
______________________________________________________________ 
 
Name of Principal Investigator:_Denis Snegovskikh MD 
PI Signature:____________________________________________________________ 
PI Campus Address: Yale University School of Medicine 333 Cedar St, TMP 3, P.O. Box 208051, New 
Haven, Ct 06520-8051 
Email: denis.snegovskikh@yale.edu Phone Number: 203-737-1818 
Correspondent Name: Cynthia French CRNA E-mail: cyntfre@aol.com 
Yale Cancer Center CTO Correspondent (If 
applicable) Name:  
E-mail: 
 
 
 
Please complete a new line for each addition or removal of study personnel (to extend the grid, press 
TAB from the last cell in the last row of the grid, and a new row will automatically be created): 
 Name – Enter the full name and degree of the person to be added to or removed from the study. 
 Add or Remove – Enter ‘Add’ or ‘Remove’ as appropriate for each person being added or 
removed from the protocol. 
 Role of Personnel – Please identify the study role  of the added or removed personnel: Co-
Investigator, Study Personnel, Correspondent or Consultant (see definitions in the HIC 
Application Instructions, p. 10, at http://www.yale.edu/hrpp/forms-templates/biomedical.html) 
 HSPT Training – Has this person completed required Human Subjects Protection Training? If 
not completed through Yale University, please submit copies of any certificate of completion. 
 HIPAA Training – Has this person completed the required HIPAA Training? If not completed 
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through Yale University, please submit copies of any certificate of completion.  
 Yale Affiliation – Please identify whether this person is a faculty member, an employee, trainee 
or student of Yale University. If Yale-affiliated, please identify their position with Yale. If non-
Yale-affiliated, please identify the organization with which they are affiliated. 
 NetID – Please indicate the Yale researcher’s NetID. This will provide accurate information for 
training completion information. 
 
 In Investigator Interests: 
Do any new research personnel who are responsible for the design, conduct or reporting of this 
project, or any of their family members (spouse or dependent child) have an incentive or interest, 
financial or otherwise, that may affect the protection of the human subjects involved in this 
project, the scientific objectivity of the research or its integrity? Note: The Principal Investigator 
(Project Director), upon consideration of the individual’s role and degree of independence in 
carrying out the work, will determine who is responsible for the design, conduct, or reporting of 
the research.  
See Disclosures and Management of Personal Interests in Human Research 
http://www.yale.edu/hrpp/policies/index.html#COI  
  Yes X  No  
 
Does a newly added member on the research team who is determined by you to be responsible 
for the design, conduct or reporting of this research have any patent (sole right to make, use or 
sell an invention) or copyright (exclusive rights to an original work) interests related to this 
research protocol? 
  Yes X  No  
   
If yes to either question above, list names of the investigator or responsible person: 
 
 
 
The Yale University Principal Investigator, all Yale University co-investigators, and all Yale 
University individuals who are responsible for the design, conduct or reporting of research must 
have a current financial disclosure form on file with the University’s Conflict of Interest Office. 
Yale New Haven Hospital personnel who are listed as con-investigators on a protocol with a 
Yale University Principal Investigator must also have a current financial disclosure form on file 
with the University’s Conflict of Interest Office. If this has not been done, the individual(s) 
should follow this link to the COI Office Website to complete the form:  
http://www.yale.edu/coi/   
 
NOTE: The requirement for maintaining a current disclosure form on file with the University’s 
Conflict of Interest Office extends primarily to Yale University and Yale-New Haven Hospital 
personnel.  Whether or not they are required to maintain a disclosure form with the 
University’s Conflict of Interest Office, all investigators and individuals deemed otherwise 
responsible by the PI who are listed on the protocol are required to disclose to the PI any 
interests that are specific to this protocol. 
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Name 
Add or 
Remove 
Ability to 
consent 
(check box 
if Yes) 
Co-Investigator, 
Study 
Personnel, 
Correspondent 
or Consultant? 
HSPT  & 
HIPAA 
Training? 
Y/N/ 
N/A 
Yale 
Affiliation/non-
Yale Affiliation 
(identify 
institution)  
 
NetID 
Zachary 
Walton MD 
Add  Co-Investigator 
Y 
Yale 
Anesthesiology 
Fellow 
Zdw4 
       
       
 
 
 
Does this amendment add any new study locations?     Yes  X  No 
If yes, list location: 
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Yale University and University of Connecticut  IRB Authorization Agreement 
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Appendix F: Study Information for Physicians, Midwives, etc. 
Effect of Labor Epidural Analgesia with Hydromorphone on Breastfeeding and Neonatal 
Neurobehavioral Outcomes in the First 24 Hours of Life 
 
Given the benefits of breastfeeding and widespread recommendations for its promotion, it is 
important to identify factors that impact early breastfeeding success. Epidural analgesia is the 
most effective method of pain relief currently available for women during labor, and the majority 
of infants born in the United States are exposed to maternal analgesia, however, effects of 
specific types of epidural analgesia on breastfeeding and neonatal neurobehavioral outcomes are 
still unknown. The use of hydromorphone as the narcotic in the epidural infusion appears to 
represent a promising alternative to fentanyl and may deliver acceptable analgesia without the 
unintended side effects seen with traditional opioid infusions. If so, neonates whose mothers 
receive labor epidural analgesia with hydromorphone and those whose mothers do not receive 
labor analgesia may show similar breastfeeding and neurobehavioral outcomes, however, results 
of previous research are inconclusive and further studies are needed. 
The primary purpose of this study is to assess breastfeeding and neonatal neurobehavior  in 
neonates whose mothers have received a continuous epidural infusion of bupivacaine (local 
anesthetic) and hydromorphone (narcotic) for labor pain in comparison with neonates whose 
mothers have not received epidural analgesia. A secondary purpose of the study is to determine 
whether there is a relationship between the duration of continuous epidural infusion and 
breastfeeding or neurobehavioral outcomes. 
A prospective observational cohort study will be conducted at Yale New Haven Hospital. 
Eligible subjects will be mothers who intend to breastfeed and who will self-select to undergo 
labor with epidural analgesia containing hydromorphone as the narcotic or labor without pain 
medication. A total of 102 mother-infant dyads will be recruited, with 51 dyads in each group. 
Infant breastfeeding behaviors will be measured using the LATCH breastfeeding assessment 
tool, and neurobehavioral responses (central nervous system function) will be measured with the 
Neurologic and Adaptive and Capacity Scoring System (NACS). Assessments will take place at 
approximately 3, 12, and 24 hours of postnatal age.  
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Appendix G: Information Flyer for Nurses, Midwives, and Residents 
 
Hi, my name is Cynthia French MS CRNA, I'm a nurse anesthetist at Yale New Haven Hospital 
and a PhD candidate at University of Connecticut. My dissertation is titled 'Effect of Labor 
Epidural Analgesia With Hydromorphone on Neonatal Neurobehavior and Breastfeeding 
Behavior in the First 24 Hours of Life 'and has been approved by the Human Investigation 
Committee at Yale University and we will begin data collection soon.  
Purpose: The primary purpose of this study is to assess breastfeeding and neonatal 
neurobehavior  in 51 neonates whose mothers have received a continuous epidural infusion of 
bupivacaine (local anesthetic) and hydromorphone (narcotic) for labor pain in comparison with 
51 neonates whose mothers have not received epidural analgesia.  
Participants: Healthy multips with previous breastfeeding and a desire to breastfeed again. 
Healthy babies with no complications of pregnancy. Infant breastfeeding behaviors will be 
measured using the LATCH breastfeeding assessment tool, and neurobehavioral responses 
(central nervous system function) will be measured with the Neurologic and Adaptive and 
Capacity Scoring System (NACS). Assessments will take place at approximately 3, 12, and 24 
hours of postnatal age.  
Recruitment on Labor and Birth: Rachel Rachler CRNA, Angelique Garay CRNA and Zach 
Walton MD will recruit and consent the patients.  
Nurses, midwives and residents can alert a study team member of a possible candidate for the 
study based on the inclusion criteria. 
Call: Rachel and Angelique 688-2676; Zach Walton MD Anesthesia Workroom 
Your support is appreciated so much, thank-you! 
If you have any questions or want to discuss this further please contact Cynthia French MS 
CRNA 307-699-2410 
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Appendix H: Text for Nurses and Midwives for Speaking With Prospective Subjects 
For the Labor and Delivery Nurses 
Cynthia French is a nurse anesthetist at Yale and PhD candidate at UConn. Her study is looking 
at labor epidural analgesia and its effect on breastfeeding initiation in the first 24 hours. The 
study will compare babies born to mothers who had no medication for pain during labor and 
mothers who had epidural analgesia for labor pain.  Would you like to talk with a co-investigator 
about the study? They could explain it to you and you can decide if you want to participate. 
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Appendix I: Oral Information for Prospective Participants 
 
Text to be used when obtaining informed consent: 
 
My name is ________________________ and I'm a ________________________(CRNA, 
Resident, Fellow) at Yale. One of the nurse anesthetists at Yale is a PhD candidate at UConn and 
she is doing a study to find out if medication used in epidurals for labor has an effect on babies 
ability to initiate breastfeeding in the first few hours after birth. We are asking you if you would 
participate in this study that will compare babies born to mothers with no pain medication during 
labor and babies born to mothers who used epidural medication for pain relief during labor. 
Your participation is entirely voluntary and you can withdraw at any time without the care you 
are receiving being affected. 
If you agree to participate Cynthia French  or a nurse will observe a breastfeeding session at 
approximately 4, 12 and 24 hours depending on when the baby feeds. The nurses on the 
postpartum unit observe  breastfeeding as part of the normal care you receive.  We will 
coordinate with the postpartum nurse to observe breastfeeding at the same time, so there will be 
as few interruptions as possible during this very special time for your family.  
After the breastfeeding assessments are done, information about your labor and delivery such as 
types of medication used, babies Apgar scores, and weight will be reviewed and deidentified, 
meaning your name is not linked with the information. 
Again your participation is entirely voluntary and you can withdraw at any time without the care 
you are receiving being affected. 
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Appendix J: Written Informed Consent Form 
 
  
320 
 
 
 
 
321 
 
 
 
  
322 
 
 
 
 
  
323 
 
 
 
 
  
324 
 
 
 
  
325 
 
 
 
 
  
326 
 
 
 
 
  
327 
 
 
 
 
  
328 
 
 
 
 
  
329 
 
 
 
 
 
330 
 
 
 
 
  
331 
 
 
 
 
Appendix K: Neurologic and Adaptive Capacity Score (NACS)  
 
 
Reproduced with permission of the copyright owner (John Wiley & Sons). 
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Appendix L: LATCH Feeding Record 
Effect of Labor Epidural Analgesia With Hydromorphone on Neonatal Neurobehavior and 
Breastfeeding Behavior in the First 24 Hours of Life 
 
Participant Study Id Number _______________       Delivery 
Date/Time:__________________ 
Age in hours and minutes_________________                                                                                
 
LATCH FEEDING RECORD 
Method : BR= Breast F= Formula/ml  EBM=Expressed breast milk             
 Other Feeding Method: Specify                
Date Time Feeding Method L A T C H 
Tota
l 
Comments/Neonate 
BS 
Amt BR/F in ml 
                    
                    
                    
 15 minutes observation sessions 
 
  0 1 2 
Latch 
To sleepy or reluctant                     
No latch achieved 
Repeated attempts                      
Hold nipple to mouth                  
Stimulate to suck 
Grasp breast                                     
Tongue down                                       
Lips flanged                                          
Rythmical sucking 
Audible 
Swallow 
None A few with stimulation 
Spontaneous and 
intermittent<24 hrs                       
Spontaneous and 
freq˃24 hrs     
Type of Nipple Inverted Flat Everted after stimulation 
Comfort of 
Breast 
Engorged                                            
Cracked bleeding large 
blisters or bruising                                          
Severe discomfort 
Filing                                                      
Reddened small blisters 
or bruising                                               
Mild/moderate 
discomfort 
Soft                                                       
Tender 
Hold Full assist 
Minimal assist                                
Teach one side mother 
does other                                                  
Staff holds mother takes 
over 
No assist from staff                       
Mother able to position 
and hold baby 
Reproduced with permission of the copyright owner (Wolters Kluwer Health). 
